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Appendix A: Biochemical Reactions  
We give below full details of the set of biochemical reactions used in this 
dissertation. This set has been taken from the metabolic network of E.Coli presented by 
Reed et al., 2003, which is available from 
http://systemsbiology.ucsd.edu/In_Silico_Organisms/E_coli/E_coli_reactions. 
Please note that for some reactions listed below the reaction has not been 
reduced to its lowest form. For example: 
R192  (100)h2o + (2) pa_EC --> (2) 12dgr_EC + (100) pi    
can clearly be further reduced to 
R192  (50)h2o + (1) pa_EC --> (1) 12dgr_EC + (50) pi   
We automatically perform such reductions. Therefore any reference to a reaction 
in any discussion/pathway picture should be taken to refer to the reaction in its most 
reduced form. 
 
 
1  R1a  akg + ala-L → glu-L + pyr      
2  R2a  ala-L → ala-D      
3  R3  asn-L + h2o → asp-L + nh4      
4  R4  asp-L + atp + nh4 → amp + asn-L + h + ppi      
5  R5  asp-L + atp + gln-L + h2o → amp + asn-L + glu-L + h + ppi      
6  R6  asp-L → fum + nh4      
7  R7a  akg + asp-L → glu-L + oaa      
8  R8  3mob + ala-L → pyr + val-L      
9  R9  ala-D + fad + h2o → fadh2 + nh4 + pyr      
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10  R10  h2o + suc6p → fru + g6p      
11  R11a  ru5p-D → ara5p      
12  R12a  mmcoa-R → mmcoa-S      
13  R13  2mcacn + h2o → micit      
14  R14a  glyald + h + nadh → glyc + nad      
15  R15a  tagdp-D → dhap + g3p      
16  R16a  h2o + lald-L + nad → (2) h + lac-L + nadh      
17  R17  acald + h2o + nad → ac + (2) h + nadh      
18  R18a  arab-L → rbl-L      
19  R19  atp + rbl-L → adp + h + ru5p-L      
20  R20a  ru5p-L → xu5p-D      
21  R21  acac + accoa → aacoa + ac      
22  R22  accoa + but → ac + btcoa      
23  R23  arbt6p + h2o → g6p + hqn      
24  R24a  man1p → man6p      
25  R25a  2dr1p → 2dr5p      
26  R26a  r1p → r5p      
27  R27  2dr5p → acald + g3p      
28  R28  galctn-D → 2dh3dgal + h2o      
29  R29a  2dh3dgal6p → g3p + pyr      
30  R30  2dh3dgal + atp → 2dh3dgal6p + adp + h      
31  R31  dha + pep → dhap + pyr      
32  R32  btcoa + fad + h2o + nad → aacoa + fadh2 + h + nadh      
33  R33  h2o + nad + pacald → (2) h + nadh + pac      
34  R34  atp + f1p → adp + fdp + h      
35  R35a  fc1p → dhap + lald-L      
36  R36a  fuc-L → fcl-L      
37  R37  atp + fcl-L → adp + fc1p + h      
38  R38a  h + lald-L + nadh → 12ppd-S + nad      
39  R39a  udpg → udpgal      
40  R40a  atp + gal → adp + gal1p + h      
41  R41a  gal1p + udpg → g1p + udpgal      
42  R42a  g1p + h + utp → ppi + udpg      
43  R43  galct-D → 5dh4dglc + h2o      
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44  R44a  galt1p + nad → h + nadh + tag6p-D      
45  R45  glyclt + q8 → glx + q8h2      
46  R46  glyclt + mqn8 → glx + mql8      
47  R47  2dmmq8 + glyclt → 2dmmql8 + glx      
48  R48  glyc + nad → dha + h + nadh      
49  R49  atp + glyc → adp + glyc3p + h       
50  R50  2pglyc + h2o → glyclt + pi      
51  R51a  glyc3p + nadp → dhap + h + nadph      
52  R52  5dh4dglc → 2h3oppan + pyr      
53  R53  cechddd + nad → dhpppn + h + nadh      
54  R54  cenchddd + nad → dhcinnm + h + nadh      
55  R55  h + nadh + o2 + pppn → cechddd + nad      
56  R56  cinnm + h + nadh + o2 → cenchddd + nad      
57  R57a  hpyr → 2h3oppan      
58  R58a  5dglcn + h + nadh → idon-L + nad      
59  R59  5dglcn + h + nadph → idon-L + nadp      
60  R60  atp + glcn → 6pgc + adp + h      
61  R61a  5dglcn + h + nadph → glcn + nadp      
62  R62  2ddglcn + atp → 2ddg6p + adp + h      
63  R63  h2o + lcts → gal + glc-D      
64  R64a  maltpt + pi → g1p + maltttr      
65  R65a  malthx + pi → g1p + maltpt      
66  R66a  malthp + pi → g1p + malthx      
67  R67  malt + malttr → glc-D + maltttr      
68  R68  malt + maltttr → glc-D + maltpt      
69  R69  malt + maltpt → glc-D + malthx      
70  R70  malt + malthx → glc-D + malthp      
71  R71  h2o + malttr → glc-D + malt      
72  R72  h2o + maltttr → glc-D + malttr      
73  R73  h2o + maltpt → glc-D + maltttr      
74  R74  h2o + malthx → glc-D + maltpt      
75  R75  h2o + malthp → glc-D + malthx      
76  R76a  man6p → f6p      
77  R77  h2o + melib → gal + glc-D      
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78  R78  3hcinnm + h + nadh + o2 → dhcinnm + h2o + nad      
79  R79  3hpppn + h + nadh + o2 → dhpppn + h2o + nad      
80  R80  dhcinnm + o2 → hkntd      
81  R81  dhpppn + o2 → hkndd      
82  R82  h2o + hkndd → (2) h + op4en + succ      
83  R83  h2o + hkntd → fum + (2) h + op4en      
84  R84  h2o + op4en → 4h2opntn      
85  R85  4h2opntn → acald + pyr      
86  R86  acald + coa + nad → accoa + h + nadh      
87  R87a  mnl1p + nad → f6p + h + nadh      
88  R88  acgam6p + h2o → ac + gam6p      
89  R89  gam6p + h2o → f6p + nh4      
90  R90  acnam → acmana + pyr      
91  R91  g6p + udpg → h + tre6p + udp      
92  R92  h2o + tre6p → pi + tre      
93  R93  atp + coa + pac → amp + phaccoa + ppi      
94  R94  atp + tag6p-D → adp + h + tagdp-D      
95  R95a  g1p → g6p      
96  R96a  micit → pyr + succ      
97  R97  h2o + oaa + ppcoa → 2mcit + coa + h      
98  R98  2mcit → 2mcacn + h2o      
99  R99  atp + coa + ppa → adp + pi + ppcoa      
100  R100  pi + ppcoa → coa + ppap      
101  R101  atp + rib-D → adp + h + r5p      
102  R102a  rmn → rml      
103  R103  atp + rml → adp + h + rml1p      
104  R104a  rml1p → dhap + lald-L      
105  R105  succoa → mmcoa-R      
106  R106  3dgulnp + h → co2 + xu5p-L      
107  R107  xu5p-L → ru5p-L      
108  R108a  nad + sbt6p → f6p + h + nadh      
109  R109  akg + o2 + taur → aacald + co2 + h + so3 + succ      
110  R110a  adp + ppap → atp + ppa      
111  R111  2obut + coa → for + ppcoa        
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113  R113  h2o + tre6p → g6p + glc-D      
114  R114  tartr-L → h2o + oaa      
115  R115  h2o + o2 + peamn → h2o2 + nh4 + pacald      
116  R116  altrn → 2ddglcn + h2o      
117  R117a  altrn + nad → h + nadh + tagur      
118  R118a  glcur → fruur      
119  R119a  galur → tagur      
120  R120  mana → 2ddglcn + h2o      
121  R121a  mana + nad → fruur + h + nadh      
122  R122  fru → glc-D      
123  R123a  xyl-D → xylu-D      
124  R124  atp + xylu-D → adp + h + xu5p-D      
125  R125  25dkglcn + h + nadph → 2dhguln + nadp      
126  R126  h + hpyr + nadh → glyc-R + nad      
127  R127  h + hpyr + nadph → glyc-R + nadp      
128  R128  glcr → 5dh4dglc + h2o      
129  R129  h + mmcoa-S → co2 + ppcoa      
130  R130  ppcoa + succ → ppa + succoa      
131  R131  25dkglcn + h + nadph → 5dglcn + nadp      
132  R132  2dhglcn + h + nadh → glcn + nad      
133  R133  2dhglcn + h + nadph → glcn + nadp      
134  R134  25dkglcn + h + nadh → 5dglcn + nad      
135  R135  2dhguln + h + nadh → idon-L + nad      
136  R136  2dhguln + h + nadph → idon-L + nadp      
137  R137  23doguln + h + nadh → 3dhguln + nad      
138  R138  icit → glx + succ      
139  R139  accoa + glx + h2o → coa + h + mal-L      
140  R140  mal-L + nadp → co2 + nadph + pyr      
141  R141  atp + oaa → adp + co2 + pep      
142  R142  h2o + ppi → h + (2) pi      
143  R143  co2 + h2o + pep → h + oaa + pi      
144  R144  mal-L + nad → co2 + nadh + pyr      
145  R145  5mdru1p → dkmpp + h2o      
146  R146  dkmpp + (3) h2o → 2kmb + for + (6) h + pi      
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147  R147  akg + ptrc → 4abutn + glu-L      
148  R148  h2o + nad + sucsal → (2) h + nadh + succ      
149  R149  4abutn + h2o + nad → 4abut + (2) h + nadh      
150  R150  5mtr + atp → 5mdr1p + adp + h      
151  R151a  5mdr1p → 5mdru1p      
152  R152  dkmpp + h2o + o2 → 2kmb + for + (2) h + pi      
153  R153  glu5sa → 1pyr5c + h + h2o      
154  R154  2kmb + glu-L → akg + met-L      
155  R155  accoa + glu-L → acglu + coa + h      
156  R156  acglu + atp → acg5p + adp      
157  R157a  acg5sa + nadp + pi → acg5p + h + nadph      
158  R158a  acorn + akg → acg5sa + glu-L      
159  R159  acg5sa + h2o → ac + glu5sa      
160  R160  acorn + h2o → ac + orn      
161  R161  asp-L + atp + citr-L → amp + argsuc + h + ppi      
162  R162a  argsuc → arg-L + fum      
163  R163a  cbp + orn → citr-L + h + pi      
164  R164  arg-L + succoa → coa + h + sucarg      
165  R165  akg + sucorn → glu-L + sucgsa      
166  R166  (2) h + (2) h2o + sucarg → co2 + (2) nh4 + sucorn      
167  R167  h2o + nad + sucgsa → (2) h + nadh + sucglu      
168  R168  h2o + sucglu → glu-L + succ      
169  R169  (2) atp + gln-L + h2o + hco3 → (2) adp + cbp + glu-L + (2) h + pi      
170  R170  h2o + nadp + sucsal → (2) h + nadph + succ      
171  R171  4abut + akg → glu-L + sucsal      
172  R172  gtspmd + h2o → gthrd + spmd      
173  R173  atp + gthrd + spmd → adp + gtspmd + h + pi      
174  R174  5mta + h2o → 5mtr + ade      
175  R175  glu5p + h + nadph → glu5sa + nadp + pi      
176  R176  atp + glu-L → adp + glu5p      
177  R177  1pyr5c + (2) h + nadph → nadp + pro-L      
178  R178  1pyr5c + (2) h2o + nad → glu-L + h + nadh      
179  R179  fad + pro-L → 1pyr5c + fadh2 + h      
180  R180  arg-L + h → agm + co2      
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181  R181  agm + h2o → ptrc + urea      
182  R182  h + orn → co2 + ptrc      
183  R183a  amet + h → ametam + co2      
184  R184  ametam + ptrc → 5mta + h + spmd      
185  R185  accoa + spmd → N1aspmd + coa + h      
186  R186  accoa + spmd → coa + h + n8aspmd      
187  R187  akg + orn → glu-L + glu5sa      
188  R188  uaagmda → h + peptido_EC + udcpdp      
189  R189  h2o + udcpdp → h + pi + udcpp      
190  R190  h2o + kdo8p → kdo + pi      
191  R191a  (100) cmp + (100) h + (2) pe_EC → (2) 12dgr_EC + (100) cdpea      
192  R192  (100)h2o + (2) pa_EC → (2) 12dgr_EC + (100) pi      
193  R193  unagamuf → eca_EC + h + udcpdp      
194  R194  ACP + atp + ttdca → amp + myrsACP + ppi      
195  R195  ACP + atp + ttdcea → amp + ppi + tdeACP      
196  R196  ACP + atp + hdca → amp + palmACP + ppi      
197  R197  ACP + atp + hdcea → amp + hdeACP + ppi      
198  R198  ACP + atp + ocdcea → amp + octeACP + ppi      
199  R199a  (2) ala-D + atp → adp + alaala + h + pi      
200  R200  (2) 12dgr_EC + (100) atp → (100) adp + (100) h + (2) pa_EC      
201  R201  etha → acald + nh4      
202  R202  gdpddman → gdpofuc      
203  R203  gdpofuc + h + nadph → gdpfuc + nadp      
204  R204  udpgal → udpgalfur      
205  R205  f6p + gln-L → gam6p + glu-L      
206  R206  acgam1p + h + utp → ppi + uacgam      
207  R207  accoa + gam1p → acgam1p + coa + h      
208  R208  g3pc + h2o → chol + glyc3p + h      
209  R209  g3pe + h2o → etha + glyc3p + h      
210  R210  g3ps + h2o → glyc3p + h + ser-L      
211  R211  g3pg + h2o → glyc + glyc3p + h      
212  R212  g3pi + h2o → glyc3p + h + inost      
213  R213  gdpmann → gdpddman + h2o      
214  R214  s7p → gmhep7p      
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215  R215  gmhep17bp + h2o → gmhep1p + pi      
216  R216  ara5p + h2o + pep → kdo8p + pi      
217  R217  ctp + kdo → ckdo + ppi      
218  R218  ckdo + lipidA → cmp + h + kdolipid4      
219  R219  ckdo + kdolipid4 → cmp + h + kdo2lipid4      
220  R220a  3hmrsACP + uacgam → ACP + u3aga      
221  R221  lipidX + u23ga → h + lipidAds + udp      
222  R222  h2o + u3aga → ac + u3hga      
223  R223  3hmrsACP + u3hga → ACP + h + u23ga      
224  R224  atp + lipidAds → adp + h + lipidA      
225  R225  ddcaACP + kdo2lipid4 → ACP + kdo2lipid4L      
226  R226  hdeACP + kdo2lipid4 → ACP + kdo2lipid4p      
227  R227  gdp + h + man1p → gdpmann + pi      
228  R228  udcpp + ugmda → uagmda + ump      
229  R229a  gam1p → gam6p      
230  R230  kdo2lipid4p + myrsACP → ACP + lipa_cold      
231  R231  kdo2lipid4L + myrsACP → ACP + lipa      
232  R232  pep + uacgam → pi + uaccg      
233  R233  h + nadph + uaccg → nadp + uamr      
234  R234  ala-L + atp + uamr → adp + h + pi + uama      
235  R235  atp + glu-D + uama → adp + h + pi + uamag      
236  R236  26dap-M + atp + uamag → adp + h + pi + ugmd      
237  R237  alaala + atp + ugmd → adp + h + pi + ugmda      
238  R238  uacgam + uagmda → h + uaagmda + udp      
239  R239a  glu-D → glu-L      
240  R240  (100) h2o + (2) pc_EC → (2) agpc_EC + (100) h + (36) hdca + (7) 
hdcea + (50) ocdcea + (2) ttdca + (5) ttdcea      
241  R241  (100) h2o + (2) pg_EC → (2) agpg_EC + (100) h + (36) hdca + (7) 
hdcea + (50) ocdcea + (2) ttdca + (5) ttdcea      
242  R242  (100) h2o + (2) pe_EC → (2) agpe_EC + (100) h + (36) hdca + (7) 
hdcea + (50) ocdcea + (2) ttdca + (5) ttdcea      
243  R243  (2) agpg_EC + (100) h2o → (100) g3pg + (100) h + (36) hdca + (7) 
hdcea + (50) ocdcea + (2) ttdca + (5) ttdcea      
244  R244  (2) agpe_EC + (100) h2o → (100) g3pe + (100) h + (36) hdca + (7) 
hdcea + (50) ocdcea + (2) ttdca + (5) ttdcea      
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245  R245  (2) agpc_EC + (100) h2o → (100) g3pc + (100) h + (36) hdca + (7) 
hdcea + (50) ocdcea + (2) ttdca + (5) ttdcea      
246  R246  (2) agpe_EC + (2) pg_EC → (2) apg_EC + (100) g3pe      
247  R247  (2) agpc_EC + (2) pg_EC → (2) apg_EC + (100) g3pc      
248  R248  (2) agpg_EC + (2) pg_EC → (2) apg_EC + (100) g3pg           
251  R251  atp + gmhep7p → adp + gmhep17bp + h      
253  R253  dttp + g1p + h → dtdpglu + ppi      
254  R254  dtdpglu → dtdp4d6dg + h2o      
255  R255  dtdp4d6dg → dtdp4d6dm      
256  R256  dtdp4d6dm + h + nadph → dtdprmn + nadp      
257  R257  h2o + mi1p-D → inost + pi      
258  R258  h2o + (2) nad + udpg → (3) h + (2) nadh + udpglcur      
259  R259  h2o + u23ga → (2) h + lipidX + ump      
260  R260  uacgam + udcpp → ump + unaga      
261  R261  uacgam → uacmam      
262  R262  h2o + (2) nad + uacmam → (3) h + (2) nadh + uacmamu      
263  R263  accoa + dtdp4addg → coa + dtdp4aaddg + h      
264  R264  dtdp4d6dg + glu-L → akg + dtdp4addg      
265  R265  dtdp4aaddg + unagamu → dtdp + h + unagamuf      
266  R266  uacmamu + unaga → h + udp + unagamu      
267  R267a  cit → icit      
268  R268  cit → ac + oaa      
269  R269  fum + mql8 → mqn8 + succ      
270  R270  2dmmql8 + fum → 2dmmq8 + succ      
271  R271a  fum + h2o → mal-L      
272  R272  accoa + h2o + oaa → cit + coa + h      
273  R273a  icit + nadp → akg + co2 + nadph      
274  R274  akg + coa + nad → co2 + nadh + succoa      
275  R275a  mal-L + nad → h + nadh + oaa      
276  R276  mal-L + q8 → oaa + q8h2      
277  R277  mal-L + mqn8 → mql8 + oaa      
278  R278  fad + succ → fadh2 + fum      
279  R279a  atp + coa + succ → adp + pi + succoa      
280  R280  5aprbu + h2o → 4r5au + pi      
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281  R281  dhpmp + h2o → dhnpt + pi      
282  R282  h2o + nadp → nad + pi      
283  R283  h2o + nmn → h + ncam + r5p      
285  R285  4ppcys + h → co2 + pan4p      
286  R286  atp + dpcoa → adp + coa + h      
287  R287  h2o + pyam5p → pi + pydam      
288  R288  h2o + pydx5p → pi + pydx      
289  R289  h2o + pdx5p → pi + pydxn      
290  R290  h2o + nmn → nh4 + nicrnt      
291  R291a  atp + thm → adp + h + thmmp      
292  R292  4ppan + ctp + cys-L → 4ppcys + cmp + h + ppi      
293  R293  apoACP + coa → ACP + h + pap      
294  R294a  8aonn + amet → amob + dann      
295  R295a  cys-L + dtbt → ala-L + btn + (2) h      
296  R296a  atp + co2 + dann → adp + dtbt + (3) h + pi      
297  R297a  ala-L + h + pmcoa → 8aonn + co2 + coa      
298  R298  btnso + h + nadh → btn + h2o + nad      
299  R299  btnso + h + nadph → btn + h2o + nadp      
300  R300a  atp + cbi + h2o → adocbi + pi + ppi      
301  R301a  atp + cbl1 + h2o → adocbl + pi + ppi      
302  R302  atp + pnto-R → 4ppan + adp + h      
303  R303  atp + h + pan4p → dpcoa + ppi      
304  R304  agdpcbi + rdmbzi → adocbl + gmp + h      
305  R305  dmbzid + nicrnt → 5prdmbz + h + nac      
306  R306  adocbi + atp → adocbip + adp + h      
307  R307  adocbip + gtp + h → agdpcbi + ppi      
308  R308  frdp + h2o + pheme → hemeO + ppi      
309  R309  nad + shcl → h + nadh + srch      
310  R310  fe2 + srch → (3) h + sheme      
311  R311  dxyl5p + h + nadph → 2me4p + nadp      
312  R312  g3p + h + pyr → co2 + dxyl5p      
313  R313a  23ddhb + nad → 23dhb + h + nadh      
314  R314  h2o + ichor → 23ddhb + pyr      
315  R315  (3) 23dhba + (3) seramp → (6) amp + enter + (6) h      
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316  R316a  23dhb + atp → 23dhba + ppi      
317  R317a  atp + h + ser-L → ppi + seramp      
318  R318a  e4p + h2o + nad → 4per + (2) h + nadh      
319  R319a  dhf + h + nadph → nadp + thf      
320  R320  dhnpt → 6hmhpt + gcald      
321  R321  atp + dhpt + glu-L → adp + dhf + pi      
322  R322  gtp + h2o → ahdt + for      
323  R323  6hmhpt + atp → 6hmhptpp + amp + h      
324  R324  4abz + 6hmhptpp → dhpt + h + ppi      
325  R325  2mecdp + h → h2mb4p + h2o      
326  R326  atp + glu-L + trnaglu → amp + glutrna + ppi      
327  R327  ala-D + pydx5p → pyam5p + pyr      
328  R328  ala-L + pydx5p → pyam5p + pyr      
329  R329a  gthox + h + nadph → (2) gthrd + nadp      
330  R330  atp + cys-L + glu-L → adp + glucys + h + pi      
331  R331  atp + glucys + gly → adp + gthrd + h + pi      
332  R332  glutrna + h + nadph → glu1sa + nadp + trnaglu      
333  R333  (2) 5aop → h + (2) h2o + ppbng      
334  R334  h2o + (4) ppbng → hmbil + (4) nh4      
335  R335  hmbil → h2o + uppg3      
336  R336  (4) h + uppg3 → (4) co2 + cpppg3      
337  R337  cpppg3 + (2) h + o2 → (2) co2 + (2) h2o + pppg9      
338  R338  (3) o2 + (2) pppg9 → (6) h2o + (2) ppp9      
339  R339  fe2 + ppp9 → (2) h + pheme      
340  R340  glu1sa → 5aop      
341  R341  (2) amet + uppg3 → (2) ahcys + h + shcl      
342  R342  ipdp → dmpp      
343  R343  dmpp + ipdp → grdp + ppi      
344  R344  grdp + ipdp → frdp + ppi      
345  R345  frdp + (5) ipdp → octdp + (5) ppi      
346  R346  2me4p + ctp + h → 4c2me + ppi      
347  R347  4c2me + atp → 2p4c2me + adp + h      
348  R348  2p4c2me → 2mecdp + cmp      
349  R349  h + h2mb4p + nadh → dmpp + h2o + nad      
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350  R350  h + h2mb4p + nadh → h2o + ipdp + nad      
351  R351  dhna + octdp → 2dmmq8 + co2 + h + ppi      
352  R352  sbzcoa → coa + dhna      
353  R353  2shchc → h2o + sucbz      
354  R354  akg + h + thmpp → co2 + ssaltpp      
355  R355  ichor + ssaltpp → 2shchc + pyr + thmpp      
356  R356  atp + coa + sucbz → amp + ppi + sbzcoa      
357  R357  chor → ichor      
358  R358  2dmmq8 + amet → ahcys + h + mqn8      
359  R359  dhap + iasp → h + (2) h2o + pi + quln      
360  R360  asp-L + q8 → iasp + q8h2      
361  R361  asp-L + mqn8 → iasp + mql8      
362  R362  asp-L + fum → iasp + succ      
363  R363  asp-L + o2 → h2o2 + iasp      
364  R364  (2) h + prpp + quln → co2 + nicrnt + ppi      
365  R365  atp + h + nicrnt → dnad + ppi      
366  R366  atp + h + nmn → nad + ppi      
367  R367  atp + dnad + nh4 → amp + h + nad + ppi      
368  R368  ahdt + h2o → dhpmp + h + ppi      
369  R369  chor + gln-L → 4adcho + glu-L      
370  R370  4adcho → 4abz + h + pyr      
371  R371  3mob + h2o + mlthf → 2dhp + thf      
372  R372  ala-B + atp + pant-R → amp + h + pnto-R + ppi      
373  R373  asp-L + h → ala-B + co2      
374  R374  2dhp + h + nadph → nadp + pant-R      
375  R375  dxyl5p + nad + phthr → co2 + h + (2) h2o + nadh + pdx5p + pi      
376  R376a  4per + nad → h + nadh + ohpb      
377  R377a  o2 + pdx5p → h2o2 + pydx5p      
378  R378  h2o + o2 + pyam5p → h2o2 + nh4 + pydx5p      
379  R379  atp + pydxn → adp + h + pdx5p      
380  R380  atp + pydam → adp + h + pyam5p      
381  R381  atp + pydx → adp + h + pydx5p      
382  R382  5prdmbz + h2o → pi + rdmbzi      
383  R383  h2o + ncam → nac + nh4      
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384  R384  atp + h2o + nac + prpp → adp + nicrnt + pi + ppi      
385  R385  gtp + (3) h2o → 25drapp + for + (2) h + ppi      
386  R386  ru5p-D → db4p + for + h      
387  R387  5apru + h + nadph → 5aprbu + nadp      
388  R388  25drapp + h + h2o → 5apru + nh4      
389  R389  4r5au + db4p → dmlz + (2) h2o + pi      
390  R390  atp + ribflv → adp + fmn + h      
391  R391  atp + fmn + h → fad + ppi      
392  R392  (2) dmlz → 4r5au + ribflv      
393  R393a  glu-L + ohpb → akg + phthr      
394  R394  air + h2o → 4ampm + (2) for + (4) h      
395  R395  4ampm + atp → 2mahmp + adp      
396  R396  4ahmmp + atp → 4ampm + adp + h      
397  R397  2mahmp + 4mpetz + h → ppi + thmmp      
398  R398a  atp + thmmp → adp + thmpp      
399  R399  4mhetz + atp → 4mpetz + adp + h      
400  R400  atp + cys-L + dxyl5p + tyr-L → 4hba + 4mpetz + ala-L + amp + co2 
+ h + h2o + ppi      
401  R401  h2o + phthr → 4hthr + pi      
402  R402  4hbz + octdp → 3ophb + ppi      
403  R403  (2) 2oph + (1) o2 → (2) 2ohph      
404  R404  chor → 4hbz + pyr      
405  R405  3ophb + h → 2oph + co2      
406  R406  2ombzl + amet → 2ommbl + ahcys + h      
407  R407  (2) 2ommbl + (1) o2 → (2) 2omhmbl      
408  R408  2ohph + amet → 2omph + ahcys + h      
409  R409  2omhmbl + amet → ahcys + h + q8h2      
410  R410  (2) 2omph + (1) o2 → (2) 2ombzl      
411  R411  frdp + (8) ipdp → (8) ppi + udcpdp      
412  R412  atp + dxyl → adp + dxyl5p + h      
413  R413  atp + nad → adp + h + nadp      
414  R414  h2o + pap → amp + pi      
415  R415  aps + atp → adp + h + paps      
416  R416  atp + gtp + h2o + so4 → aps + gdp + pi + ppi      
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417  R417a  accoa + ser-L → acser + coa      
418  R418  paps + trdrd → (2) h + pap + so3 + trdox      
419  R419a  (3) h2o + h2s + (3) nadp → (5) h + (3) nadph + so3      
420  R420  acser + h2s → ac + cys-L + h      
421  R421  cys-L + h2o → h2s + nh4 + pyr      
422  R422  gcald + h2o + nad → glyclt + (2) h + nadh      
423  R423a  h2o + methf → 10fthf      
424  R424a  mlthf + nadp → h + methf + nadph      
425  R425  gly + nad + thf → co2 + mlthf + nadh + nh4      
426  R426  h + mlthf + nadh → 5mthf + nad      
427  R427  10fthf + h2o → for + h + thf      
428  R428  glu-L + h → 4abut + co2      
429  R429a  glu-L + h2o + nadp → akg + h + nadph + nh4      
430  R430  atp + glu-L + nh4 → adp + gln-L + h + pi      
431  R431  akg + gln-L + h + nadph → (2) glu-L + nadp      
432  R432  gln-L + h2o → glu-L + nh4      
433  R433  ser-D → nh4 + pyr      
434  R434  ser-L + thf → gly + h2o + mlthf      
435  R435  2aobut + coa → accoa + gly      
436  R436  3pg + nad → 3php + h + nadh      
437  R437  h2o + pser-L → pi + ser-L      
438  R438  3php + glu-L → akg + pser-L      
439  R439  ser-L → nh4 + pyr      
440  R440  nad + thr-L → 2aobut + h + nadh      
441  R441  coa + nad + pyr → accoa + co2 + nadh      
442  R442  g1p + h2o → glc-D + pi      
443  R443a  2pg → h2o + pep      
444  R444a  fdp → dhap + g3p      
445  R445  fdp + h2o → f6p + pi      
446  R446a  f6p → dha + g3p      
447  R447a  g3p + nad + pi → 13dpg + h + nadh      
448  R448  adpglc → adp + glycogen + h      
449  R449  atp + g1p + h → adpglc + ppi      
450  R450  glycogen + pi → g1p      
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451  R451  atp + glc-D → adp + g6p + h      
452  R452a  2pg → 3pg      
453  R453  atp + f6p → adp + fdp + h      
454  R454a  g6p → f6p      
455  R455a  3pg + atp → 13dpg + adp      
456  R456  atp + h2o + pyr → amp + (2) h + pep + pi      
457  R457  adp + h + pep → atp + pyr      
458  R458a  dhap → g3p      
459  R459  2h3oppan + h + nadh → glyc-R + nad      
460  R460  (2) glx + h → 2h3oppan + co2      
461  R461  atp + glyc-R → 3pg + adp + h      
462  R462  glx + h + nadph → glyclt + nadp      
463  R463  glx + h + nadh → glyclt + nad      
464  R464  prfp → prlp      
465  R465  eig3p → h2o + imacp      
466  R466  h2o + hisp → histd + pi      
467  R467  glu-L + imacp → akg + hisp      
468  R468  h2o + histd + (2) nad → (3) h + his-L + (2) nadh      
469  R469  gln-L + prlp → aicar + eig3p + glu-L + h      
470  R470  atp + prpp → ppi + prbatp      
471  R471  h2o + prbatp → h + ppi + prbamp      
472  R472  h2o + prbamp → prfp      
473  R473a  atp + r5p → amp + h + prpp      
474  R474a  accoa + atp + hco3 → adp + h + malcoa + pi      
475  R475a  (2) accoa → aacoa + coa      
476  R476  (2) cdpdag1 + (100) h2o → (100) cmp + (200) h + (2) pa_EC      
477  R477a  (100) ctp + (100) h + (2) pa_EC → (2) cdpdag1 + (100) ppi      
478  R478a  (4) pg_EC → (2) clpn_EC + (100) glyc      
479  R479  actACP + (17) h + (5) malACP + (12) nadph → (5) ACP + (5) co2 + 
(6) h2o + myrsACP + (12) nadp      
480  R480  actACP + (14) h + (4) malACP + (10) nadph → (4) ACP + (4) co2 + 
ddcaACP + (5) h2o + (10) nadp      
481  R481  h + malACP → acACP + co2      
482  R482  acACP + h + malACP → ACP + actACP + co2      
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483  R483a  ACP + malcoa → coa + malACP      
484  R484  actACP + (20) h + (6) malACP + (14) nadph → (6) ACP + (6) co2 + 
(7) h2o + (14) nadp + palmACP      
485  R485  ddcaACP + (2) h + malACP + nadph → 3hmrsACP + ACP + co2 + 
nadp      
486  R486  actACP + (22) h + (7) malACP + (15) nadph → (7) ACP + (7) co2 + 
(8) h2o + (15) nadp + octeACP      
487  R487  actACP + (16) h + (5) malACP + (11) nadph → (5) ACP + (5) co2 + 
(6) h2o + (11) nadp + tdeACP      
488  R488  accoa + h + malACP → actACP + co2 + coa      
489  R489a  ACP + accoa → acACP + coa      
490  R490  actACP + (19) h + (6) malACP + (13) nadph → (6) ACP + (6) co2 + 
(7) h2o + hdeACP + (13) nadp      
491  R491  atp + (8) coa + (7) fad + (7) h2o + hdca + (7) nad → (8) accoa + amp 
+ (7) fadh2 + (7) h + (7) nadh + ppi      
492  R492  atp + (7) coa + (6) fad + (6) h2o + (6) nad + ttdca → (7) accoa + amp 
+ (6) fadh2 + (6) h + (6) nadh + ppi      
493  R493  atp + (9) coa + (8) fad + (8) h2o + (8) nad + ocdca → (9) accoa + 
amp + (8) fadh2 + (8) h + (8) nadh + ppi      
494  R494  (100) h2o + (2) pgp_EC → (2) pg_EC + (100) pi      
495  R495a  (2) cdpdag1 + (100) glyc3p → (100) cmp + (100) h + (2) pgp_EC      
496  R496  (100) glyc3p + (14) hdeACP + (4) myrsACP + (100) octeACP + (72) 
palmACP + (10) tdeACP → (200) ACP + (2) pa_EC      
497  R497  (100) h + (2) ps_EC → (100) co2 + (2) pe_EC      
498  R498a  (2) cdpdag1 + (100) ser-L → (100) cmp + (100) h + (2) ps_EC      
499  R499a  ahcys + h2o → adn + hcys-L      
500  R500  dhptd → h2o + hmfurn      
501  R501  rhcys → dhptd + hcys-L      
502  R502  hom-L + succoa → coa + suchms      
503  R503  cys-L + suchms → cyst-L + h + succ      
504  R504  cyst-L + h2o → hcys-L + nh4 + pyr      
505  R505  5mthf + hcys-L → met-L + thf      
506  R506  atp + h2o + met-L → amet + pi + ppi      
507  R507  ahcys + h2o → ade + rhcys      
508  R508  gthrd + mthgxl → lgt-S      
509  R509  h2o + lgt-S → gthrd + h + lac-D      
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510  R510  dhap → mthgxl + pi      
511  R511  (2) h + h2o + urdglyc → co2 + glx + (2) nh4      
512  R512  alltn + h2o → alltt + h      
513  R513  alltt + h2o → urdglyc + urea      
514  R514  cynt + (3) h + hco3 → (2) co2 + nh4      
515  R515  cmp + h2o → csn + r5p      
516  R516  adn + h + h2o → ins + nh4      
517  R517  dad-2 + h + h2o → din + nh4      
518  R518  adn + atp → adp + amp + h      
519  R519a  amp + atp → (2) adp      
520  R520a  atp + damp → adp + dadp      
521  R521a  amp + itp → adp + idp      
522  R522a  amp + gtp → adp + gdp      
523  R523  amp + h2o → ade + r5p      
524  R524  ap4a + h2o → (2) adp + (2) h      
525  R525  gp4g + h2o → (2) gdp + (2) h      
526  R526  ap5a + h2o → adp + atp + (2) h      
527  R527  ade + prpp → amp + ppi      
528  R528  cytd + h + h2o → nh4 + uri      
529  R529  dcyt + h + h2o → duri + nh4      
530  R530a  atp + dcmp → adp + dcdp      
531  R531a  atp + cmp → adp + cdp      
532  R532a  atp + ump → adp + udp      
533  R533  csn + h + h2o → nh4 + ura      
534  R534  atp → camp + ppi      
535  R535  dctp + h + h2o → dutp + nh4      
536  R536a  pi + thymd → 2dr1p + thym      
537  R537a  duri + pi → 2dr1p + ura      
538  R538  dgtp + h2o → dgsn + pppi      
539  R539  gtp + h2o → gsn + pppi      
540  R540  dutp + h2o → dump + h + ppi      
541  R541a  atp + gmp → adp + gdp      
542  R542a  atp + dgmp → adp + dgdp      
543  R543  prpp + xan → ppi + xmp      
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544  R544  hxan + prpp → imp + ppi      
545  R545  gua + prpp → gmp + ppi      
546  R546  atp + ins → adp + h + imp      
547  R547  atp + gsn → adp + gmp + h      
548  R548  dctp + h2o → dcmp + h + ppi      
549  R549  ctp + h2o → cmp + h + ppi      
550  R550  datp + h2o → damp + h + ppi      
551  R551  atp + h2o → amp + h + ppi      
552  R552  dttp + h2o → dtmp + h + ppi      
553  R553  h2o + utp → h + ppi + ump      
554  R554  dgtp + h2o → dgmp + h + ppi      
555  R555  gtp + h2o → gmp + h + ppi      
556  R556a  atp + gdp → adp + gtp      
557  R557a  atp + udp → adp + utp      
558  R558a  atp + cdp → adp + ctp      
559  R559a  atp + dgdp → adp + dgtp      
560  R560a  atp + dudp → adp + dutp      
561  R561a  atp + dcdp → adp + dctp      
562  R562a  atp + dadp → adp + datp      
563  R563a  atp + dtdp → adp + dttp      
564  R564  adp + trdrd → dadp + h2o + trdox      
565  R565  gdp + trdrd → dgdp + h2o + trdox      
566  R566  trdrd + udp → dudp + h2o + trdox      
567  R567  cdp + trdrd → dcdp + h2o + trdox      
568  R568  atp + trdrd → datp + h2o + trdox      
569  R569  gtp + trdrd → dgtp + h2o + trdox      
570  R570  ctp + trdrd → dctp + h2o + trdox      
571  R571  trdrd + utp → dutp + h2o + trdox      
572  R572a  atp + dump → adp + dudp      
573  R573  atp + duri → adp + dump + h      
574  R574  atp + thymd → adp + dtmp + h      
575  R575  dump + mlthf → dhf + dtmp      
576  R576a  atp + dtmp → adp + dtdp      
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577  R577  gtp + uri → gdp + h + ump      
578  R578  cytd + gtp → cmp + gdp + h      
579  R579a  pi + uri → r1p + ura      
580  R580  prpp + ura → ppi + ump      
581  R581  dump + h2o → duri + pi      
582  R582  dtmp + h2o → pi + thymd      
583  R583  damp + h2o → dad-2 + pi      
584  R584  dgmp + h2o → dgsn + pi      
585  R585  dcmp + h2o → dcyt + pi      
586  R586  cmp + h2o → cytd + pi      
587  R587  amp + h2o → adn + pi      
588  R588  gmp + h2o → gsn + pi      
589  R589  h2o + imp → ins + pi      
590  R590  h2o + xmp → pi + xtsn      
591  R591  h2o + ump → pi + uri      
592  R592a  din + pi → 2dr1p + hxan      
593  R593a  ins + pi → hxan + r1p      
594  R594a  dad-2 + pi → 2dr1p + ade      
595  R595a  dgsn + pi → 2dr1p + gua      
596  R596a  adn + pi → ade + r1p      
597  R597a  gsn + pi → gua + r1p      
598  R598a  pi + xtsn → r1p + xan      
599  R599  gua + h + h2o → nh4 + xan      
600  R600  ade + h + h2o → hxan + nh4      
601  R601  lac-L + q8 → pyr + q8h2      
602  R602  lac-L + mqn8 → mql8 + pyr      
604  R604a  bbtcoa + crn → crncoa + gbbtn      
605  R605a  crn + ctbtcoa → crncoa + ctbt      
606  R606a  crncoa → ctbtcoa + h2o      
609  R609  lac-D + q8 → pyr + q8h2                         
617  R617  2dmmq8 + glyc3p → 2dmmql8 + dhap      
618  R618  glyc3p + mqn8 → dhap + mql8      
619  R619  glyc3p + q8 → dhap + q8h2            
625  R625  h + nadh + q8 → nad + q8h2      
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626  R626  2dmmq8 + h + nadh → 2dmmql8 + nad      
627  R627  h + mqn8 + nadh → mql8 + nad      
628  R628  (5) h + (3) nadh + no2 → (2) h2o + (3) nad + nh4                
633  R633  h2o + pyr + q8 → ac + co2 + q8h2      
634  R634a  fadh2 + q8 → fad + q8h2      
635  R635  nad + nadph → nadh + nadp      
636  R636  h + nadph + trdox → nadp + trdrd      
637  R637  6pgl + h2o → 6pgc + h      
638  R638  2ddg6p → g3p + pyr      
639  R639  6pgc → 2ddg6p + h2o      
640  R640  6pgc + nadp → co2 + nadph + ru5p-D      
641  R641a  ru5p-D → xu5p-D      
642  R642a  r5p → ru5p-D      
643  R643a  g3p + s7p → e4p + f6p      
644  R644a  r5p + xu5p-D → g3p + s7p      
645  R645a  e4p + xu5p-D → f6p + g3p      
646  R646a  g6p + nadp → 6pgl + h + nadph      
647  R647  atp + gln-L + h2o + xmp → amp + glu-L + gmp + (2) h + ppi      
648  R648  h2o + imp + nad → h + nadh + xmp      
649  R649  gmp + (2) h + nadph → imp + nadp + nh4      
650  R650  asp-L + gtp + imp → dcamp + gdp + (2) h + pi      
651  R651a  25aics → aicar + fum      
652  R652a  dcamp → amp + fum      
653  R653a  5aizc + asp-L + atp → 25aics + adp + h + pi      
654  R654a  atp + gly + pram → adp + gar + h + pi      
655  R655a  5aizc → 5caiz      
656  R656  gln-L + h2o + prpp → glu-L + ppi + pram      
657  R657a  10fthf + aicar → fprica + thf      
658  R658a  h2o + imp → fprica      
659  R659  air + atp + hco3 → 5caiz + adp + h + pi      
660  R660  atp + fgam + gln-L + h2o → adp + fpram + glu-L + h + pi      
661  R661  atp + fpram → adp + air + (2) h + pi      
662  R662a  10fthf + gar → fgam + h + thf      
663  R663  atp + for + gar → adp + fgam + h + pi      
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664  R664  asp-L + cbp → cbasp + h + pi      
665  R665a  dhor-S + h2o → cbasp + h      
666  R666  dhor-S + q8 → orot + q8h2      
667  R667  dhor-S + mqn8 → mql8 + orot      
668  R668a  orot5p + ppi → orot + prpp      
669  R669  h + orot5p → co2 + ump      
670  R670  atp + gln-L + h2o + utp → adp + ctp + glu-L + (2) h + pi      
671  R671  atp + co2 + nh4 → adp + cbp + (2) h      
672  R672  acmanap → acgam6p      
673  R673  acmana + atp → acmanap + adp + h      
674  R674a  ac + atp → actp + adp      
675  R675  ac + atp + coa → accoa + amp + ppi      
676  R676a  accoa + (2) h + (2) nadh → coa + etoh + (2) nad      
677  R677a  lac-D + nad → h + nadh + pyr      
678  R678  for + h → co2 + h2      
679  R679a  accoa + pi → actp + coa      
680  R680  coa + pyr → accoa + for      
681  R681a  akg + sl26da → glu-L + sl2a6o      
682  R682a  aspsa + nadp + pi → 4pasp + h + nadph      
683  R683  aspsa + pyr → 23dhdp + h + (2) h2o      
684  R684  23dhdp + h + nadph → nadp + thdp      
685  R685  h2o + succoa + thdp → coa + sl2a6o      
686  R686  h2o + sl26da → 26dap-LL + succ      
687  R687a  26dap-LL → 26dap-M      
688  R688  h + lys-L → 15dap + co2      
689  R689a  thr-L → acald + gly      
690  R690  26dap-M + h → co2 + lys-L      
691  R691a  hom-L + nadp → aspsa + h + nadph      
692  R692a  asp-L + atp → 4pasp + adp      
693  R693  atp + hom-L → adp + h + phom      
694  R694  h2o + phom → pi + thr-L      
695  R695  2dda7p → 3dhq + pi      
696  R696  3psme → chor + pi      
697  R697a  3dhq → 3dhsk + h2o      
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698  R698a  3dhsk + h + nadph → nadp + skm      
699  R699  e4p + h2o + pep → 2dda7p + pi      
700  R700  atp + skm → adp + h + skm5p      
701  R701  h + pphn → co2 + h2o + phpyr      
702  R702  chor → pphn      
703  R703a  h2o + trp-L → indole + nh4 + pyr      
704  R704  indole + ser-L → h2o + trp-L      
705  R705  3ig3p → g3p + indole      
706  R706  3ig3p + ser-L → g3p + h2o + trp-L      
707  R707  pran → 2cpr5p      
708  R708  2cpr5p + h → 3ig3p + co2 + h2o      
709  R709  chor + gln-L → anth + glu-L + h + pyr      
710  R710  anth + prpp → ppi + pran      
711  R711  nad + pphn → 34hpp + co2 + nadh      
712  R712a  akg + tyr-L → 34hpp + glu-L      
713  R713a  akg + phe-L → glu-L + phpyr      
714  R714  atp + h2o → adp + h + pi      
715  R715  betald + h2o + nad → glyb + (2) h + nadh      
716  R716  betald + h2o + nadp → glyb + (2) h + nadph      
717  R717a  co2 + h2o → h + hco3      
718  R718  cyan + tsul → h + so3 + tcynt      
719  R719  (2) h2o2 → (2) h2o + o2      
720  R720  atp + h2o + seln → amp + pi + selnp      
721  R721  (2) h + (2) o2- → h2o2 + o2      
722  R722  acon-T + amet → aconm + ahcys      
723  R723  thr-L → 2obut + nh4      
724  R724  2obut + h + pyr → 2ahbut + co2      
725  R725  h + (2) pyr → alac-S + co2      
726  R726  2ahbut + h + nadph → 23dhmp + nadp      
727  R727  alac-S + h + nadph → 23dhmb + nadp      
728  R728  23dhmp → 3mop + h2o      
729  R729  23dhmb → 3mob + h2o      
730  R730a  akg + ile-L → 3mop + glu-L      
731  R731a  akg + val-L → 3mob + glu-L      
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732  R732  4mop + glu-L → akg + leu-L      
733  R733  3mob + accoa + h2o → 3c3hmp + coa + h      
734  R734  3c2hmp + nad → 3c4mop + h + nadh      
735  R735  3c4mop + h → 4mop + co2      
736  R736a  3c2hmp → 2ippm + h2o      
737  R737a  2ippm + h2o → 3c3hmp      
738 R1b  glu-L + pyr → akg + ala-L 
739  R2b  ala-D → ala-L       
740  R7b  glu-L + oaa → akg + asp-L       
741  R11b  ara5p → ru5p-D       
742  R12b  mmcoa-S → mmcoa-R       
743  R14b  glyc + nad → glyald + h + nadh       
744  R15b  dhap + g3p → tagdp-D       
745  R16b  (2) h + lac-L + nadh → h2o + lald-L + nad       
746  R18b  rbl-L → arab-L       
747  R20b  xu5p-D → ru5p-L       
748  R24b  man6p → man1p       
749  R25b  2dr5p → 2dr1p       
750  R26b  r5p → r1p       
751  R29b  g3p + pyr → 2dh3dgal6p       
752  R35b  dhap + lald-L → fc1p       
753  R36b  fcl-L → fuc-L       
754  R38b  12ppd-S + nad → h + lald-L + nadh       
755  R39b  udpgal → udpg       
756  R40b  adp + gal1p + h → atp + gal       
757  R41b  g1p + udpgal → gal1p + udpg       
758  R42b  ppi + udpg → g1p + h + utp       
759  R44b  h + nadh + tag6p-D → galt1p + nad       
760  R51b  dhap + h + nadph → glyc3p + nadp       
761  R57b  2h3oppan → hpyr       
762  R58b  idon-L + nad → 5dglcn + h + nadh       
763  R61b  glcn + nadp → 5dglcn + h + nadph       
764  R64b  g1p + maltttr → maltpt + pi       
765  R65b  g1p + maltpt → malthx + pi       
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766  R66b  g1p + malthx → malthp + pi       
767  R76b  f6p → man6p       
768  R87b  f6p + h + nadh → mnl1p + nad       
769  R95b  g6p → g1p       
770  R96b  pyr + succ → micit       
771  R102b  rml → rmn       
772  R104b  dhap + lald-L → rml1p       
773  R108b  f6p + h + nadh → nad + sbt6p       
774  R110b  atp + ppa → adp + ppap       
775  R117b  h + nadh + tagur → altrn + nad       
776  R118b  fruur → glcur       
777  R119b  tagur → galur       
778  R121b  fruur + h + nadh → mana + nad       
779  R123b  xylu-D → xyl-D       
780  R151b  5mdru1p → 5mdr1p       
781  R157b  acg5p + h + nadph → acg5sa + nadp + pi       
782  R158b  acg5sa + glu-L → acorn + akg       
783  R162b  arg-L + fum → argsuc       
784  R163b  citr-L + h + pi → cbp + orn       
785  R183b  ametam + co2 → amet + h       
786  R191b  (2) 12dgr_EC + (100) cdpea → (100) cmp + (100) h + (2) pe_EC       
787  R199b  adp + alaala + h + pi → (2) ala-D + atp       
788  R220b  ACP + u3aga → 3hmrsACP + uacgam       
789  R229b  gam6p → gam1p       
790  R239b  glu-L → glu-D       
791  R267b  icit → cit       
792  R271b  mal-L → fum + h2o       
793  R273b  akg + co2 + nadph → icit + nadp       
794  R275b  h + nadh + oaa → mal-L + nad       
795  R279b  adp + pi + succoa → atp + coa + succ       
796  R291b  adp + h + thmmp → atp + thm       
797  R294b  amob + dann → 8aonn + amet       
798  R295b  ala-L + btn + (2) h → cys-L + dtbt       
799  R296b  adp + dtbt + (3) h + pi → atp + co2 + dann       
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800  R297b  8aonn + co2 + coa → ala-L + h + pmcoa       
801  R300b  adocbi + pi + ppi → atp + cbi + h2o       
802  R301b  adocbl + pi + ppi → atp + cbl1 + h2o       
803  R313b  23dhb + h + nadh → 23ddhb + nad       
804  R316b  23dhba + ppi → 23dhb + atp       
805  R317b  ppi + seramp → atp + h + ser-L       
806  R318b  4per + (2) h + nadh → e4p + h2o + nad       
807  R319b  nadp + thf → dhf + h + nadph       
808  R329b  (2) gthrd + nadp → gthox + h + nadph       
809  R376b  h + nadh + ohpb → 4per + nad       
810  R377b  h2o2 + pydx5p → o2 + pdx5p       
811  R393b  akg + phthr → glu-L + ohpb       
812  R398b  adp + thmpp → atp + thmmp       
813  R417b  acser + coa → accoa + ser-L       
814  R419b  (5) h + (3) nadph + so3 → (3) h2o + h2s + (3) nadp       
815  R423b  10fthf → h2o + methf       
816  R424b  h + methf + nadph → mlthf + nadp       
817  R429b  akg + h + nadph + nh4 → glu-L + h2o + nadp       
818  R443b  h2o + pep → 2pg       
819  R444b  dhap + g3p → fdp       
820  R446b  dha + g3p → f6p       
821  R447b  13dpg + h + nadh → g3p + nad + pi       
822  R452b  3pg → 2pg       
823  R454b  f6p → g6p       
824  R455b  13dpg + adp → 3pg + atp       
825  R458b  g3p → dhap       
826  R473b  amp + h + prpp → atp + r5p       
827  R474b  adp + h + malcoa + pi → accoa + atp + hco3       
828  R475b  aacoa + coa → (2) accoa       
829  R477b  (2) cdpdag1 + (100) ppi → (100) ctp + (100) h + (2) pa_EC       
830  R478b  (2) clpn_EC + (100) glyc → (4) pg_EC       
831  R483b  coa + malACP → ACP + malcoa       
832  R489b  acACP + coa → ACP + accoa       
833  R495b  (100) cmp + (100) h + (2) pgp_EC → (2) cdpdag1 + (100) glyc3p       
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834  R498b  (100) cmp + (100) h + (2) ps_EC → (2) cdpdag1 + (100) ser-L       
835  R499b  adn + hcys-L → ahcys + h2o       
836  R519b  (2) adp → amp + atp       
837  R520b  adp + dadp → atp + damp       
838  R521b  adp + idp → amp + itp       
839  R522b  adp + gdp → amp + gtp       
840  R530b  adp + dcdp → atp + dcmp       
841  R531b  adp + cdp → atp + cmp       
842  R532b  adp + udp → atp + ump       
843  R536b  2dr1p + thym → pi + thymd       
844  R537b  2dr1p + ura → duri + pi       
845  R541b  adp + gdp → atp + gmp       
846  R542b  adp + dgdp → atp + dgmp       
847  R556b  adp + gtp → atp + gdp       
848  R557b  adp + utp → atp + udp       
849  R558b  adp + ctp → atp + cdp       
850  R559b  adp + dgtp → atp + dgdp       
851  R560b  adp + dutp → atp + dudp       
852  R561b  adp + dctp → atp + dcdp       
853  R562b  adp + datp → atp + dadp       
854  R563b  adp + dttp → atp + dtdp       
855  R572b  adp + dudp → atp + dump       
856  R576b  adp + dtdp → atp + dtmp       
857  R579b  r1p + ura → pi + uri       
858  R592b  2dr1p + hxan → din + pi       
859  R593b  hxan + r1p → ins + pi       
860  R594b  2dr1p + ade → dad-2 + pi       
861  R595b  2dr1p + gua → dgsn + pi       
862  R596b  ade + r1p → adn + pi       
863  R597b  gua + r1p → gsn + pi       
864  R598b  r1p + xan → pi + xtsn           
866  R604b  crncoa + gbbtn → bbtcoa + crn       
867  R605b  crncoa + ctbt → crn + ctbtcoa       
868  R606b  ctbtcoa + h2o → crncoa       
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869  R634b  fad + q8h2 → fadh2 + q8       
870  R641b  xu5p-D → ru5p-D       
871  R642b  ru5p-D → r5p       
872  R643b  e4p + f6p → g3p + s7p       
873  R644b  g3p + s7p → r5p + xu5p-D       
874  R645b  f6p + g3p → e4p + xu5p-D       
875  R646b  6pgl + h + nadph → g6p + nadp       
876  R651b  aicar + fum → 25aics       
877  R652b  amp + fum → dcamp       
878  R653b  25aics + adp + h + pi → 5aizc + asp-L + atp       
879  R654b  adp + gar + h + pi → atp + gly + pram       
880  R655b  5caiz → 5aizc       
881  R657b  fprica + thf → 10fthf + aicar       
882  R658b  fprica → h2o + imp       
883  R662b  fgam + h + thf → 10fthf + gar       
884  R665b  cbasp + h → dhor-S + h2o       
885  R668b  orot + prpp → orot5p + ppi       
886  R674b  actp + adp → ac + atp       
887  R676b  coa + etoh + (2) nad → accoa + (2) h + (2) nadh       
888  R677b  h + nadh + pyr → lac-D + nad       
889  R679b  actp + coa → accoa + pi       
890  R681b  glu-L + sl2a6o → akg + sl26da       
891  R682b  4pasp + h + nadph → aspsa + nadp + pi       
892  R687b  26dap-M → 26dap-LL       
893  R689b  acald + gly → thr-L       
894  R691b  aspsa + h + nadph → hom-L + nadp       
895  R692b  4pasp + adp → asp-L + atp       
896  R697b  3dhsk + h2o → 3dhq       
897  R698b  nadp + skm → 3dhsk + h + nadph       
898  R703b  indole + nh4 + pyr → h2o + trp-L       
899  R712b  34hpp + glu-L → akg + tyr-L       
900  R713b  glu-L + phpyr → akg + phe-L       
901  R717b  h + hco3 → co2 + h2o       
902  R730b  3mop + glu-L → akg + ile-L       
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903  R731b  3mob + glu-L → akg + val-L       
904  R736b  2ippm + h2o → 3c2hmp       
905  R737b  3c3hmp → 2ippm + h2o  
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Appendix B: Biochemical compounds  
We give below full details of the set of biochemical compounds used in this 
dissertation. As noted above, this set has been taken from the metabolic network of 
E.Coli presented by Reed et al., 2003, which is available from 
http://systemsbiology.ucsd.edu/In_Silico_Organisms/E_coli/E_coli_reactions. 
 
10fthf  10-Formyltetrahydrofolate   
12dgr_EC  1,2-Diacylglycerol   
12ppd-S  (S)-Propane-1,2-diol   
13dpg  3-Phospho-D-glyceroyl  phosphate 
15dap  1,5-Diaminopentane   
1pyr5c  1-Pyrroline-5-carboxylate   
23ddhb  2,3-Dihydro-2,3-dihydroxybenzoate   
23dhb  2,3-Dihydroxybenzoate   
23dhba  (2,3-Dihydroxybenzoyl)adenylate   
23dhdp  2,3-Dihydrodipicolinate   
23dhmb  (R)-2,3-Dihydroxy-3-methylbutanoate 
23dhmp  (R)-2,3-Dihydroxy-3-methylpentanoate 
23doguln  2,3-Dioxo-L-gulonate   
25aics  (S)-2-[5-Amino-1-(5-phospho-D-ribosyl)imidazole-4-
carboxamido]succinate   
25dkglcn  2,5-diketo-D-gluconate   
25drapp  2,5-Diamino-6-(ribosylamino)-4-(3H)-pyrimidinone  5'-phosphate 
26dap-LL  LL-2,6-Diaminoheptanedioate   
26dap-M  meso-2,6-Diaminoheptanedioate   
2ahbut  (S)-2-Aceto-2-hydroxybutanoate   
2aobut  L-2-Amino-3-oxobutanoate   
2cpr5p  1-(2-Carboxyphenylamino)-1-deoxy-D-ribulose  5-phosphate 
2dda7p  2-Dehydro-3-deoxy-D-arabino-heptonate  7-phosphate 
2ddg6p  2-Dehydro-3-deoxy-D-gluconate  6-phosphate 
Metabolic pathway analysis via integer linear programming 
Francisco J. Planes                 May 2008 30
2ddglcn  2-Dehydro-3-deoxy-D-gluconate   
2dh3dgal  2-Dehydro-3-deoxy-D-galactonate   
2dh3dgal6p  2-Dehydro-3-deoxy-D-galactonate  6-phosphate 
2dhglcn  2-Dehydro-D-gluconate   
2dhguln  2-Dehydro-L-gulonate   
2dhp  2-Dehydropantoate   
2dmmq8  2-Demethylmenaquinone  8   
2dmmql8  2-Demethylmenaquinol  8   
2dr1p  2-Deoxy-D-ribose  1-phosphate 
2dr5p  2-Deoxy-D-ribose  5-phosphate 
2h3oppan  2-Hydroxy-3-oxopropanoate   
2ippm  2-Isopropylmaleate 
2kmb  2-keto-4-methylthiobutyrate   
2mahmp  2-Methyl-4-amino-5-hydroxymethylpyrimidine  diphosphate 
2mcacn  cis-2-Methylaconitate   
2mcit  2-Methylcitrate   
2me4p  2-C-methyl-D-erythritol  4-phosphate 
2mecdp  2-C-methyl-D-erythritol  "2,4-cyclodiphosphate" 
2obut  2-Oxobutanoate   
2ohph  2-Octaprenyl-6-hydroxyphenol   
2ombzl  "2-Octaprenyl-6-methoxy-1,4-benzoquinol"   
2omhmbl  "2-Octaprenyl-3-methyl-5-hydroxy-6-methoxy-1,4-benzoquinol"   
2ommbl  2-Octaprenyl-3-methyl-6-methoxy-  "1,4-benzoquinol" 
2omph  2-Octaprenyl-6-methoxyphenol   
2oph  2-Octaprenylphenol   
2p4c2me  2-phospho-4-(cytidine  5'-diphospho)-2-C-methyl-D-erythritol 
2pg  D-Glycerate  2-phosphate 
2pglyc  2-Phosphoglycolate   
2shchc  2-Succinyl-6-hydroxy-2,4-cyclohexadiene-1-carboxylate   
34hpp  3-(4-Hydroxyphenyl)pyruvate   
3c2hmp  3-Carboxy-2-hydroxy-4-methylpentanoate 
3c3hmp  3-Carboxy-3-hydroxy-4-methylpentanoate   
3c4mop  3-Carboxy-4-methyl-2-oxopentanoate 
3dgulnp  3-keto-L-gulonate-6-phosphate   
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3dhguln  3-Dehydro-L-gulonate   
3dhq  3-Dehydroquinate   
3dhsk  3-Dehydroshikimate   
3hcinnm  3-hydroxycinnamic  acid 
3hmrsACP  R-3-hydroxy-myristoyl-ACP   
3hpppn  3-(3-hydroxy-phenyl)propionate   
3ig3p  C'-(3-Indolyl)-glycerol  3-phosphate 
3mob  3-Methyl-2-oxobutanoate   
3mop  (S)-3-Methyl-2-oxopentanoate   
3ophb  3-Octaprenyl-4-hydroxybenzoate   
3pg  3-Phospho-D-glycerate   
3php  3-Phosphohydroxypyruvate   
3psme  5-O-(1-Carboxyvinyl)-3-phosphoshikimate   
4abut  4-Aminobutanoate   
4abutn  4-Aminobutanal   
4abz  4-Aminobenzoate   
4adcho  4-amino-4-deoxychorismate   
4ahmmp  4-Amino-5-hydroxymethyl-2-methylpyrimidine   
4ampm  4-Amino-2-methyl-5-phosphomethylpyrimidine   
4c2me  4-(cytidine  5'-diphospho)-2-C-methyl-D-erythritol 
4h2opntn  4-Hydroxy-2-oxopentanoate   
4hba  4-Hydroxy-benzyl  alcohol 
4hbz  4-Hydroxybenzoate   
4hthr  4-Hydroxy-L-threonine   
4mhetz  4-Methyl-5-(2-hydroxyethyl)-thiazole   
4mop  4-Methyl-2-oxopentanoate   
4mpetz  4-Methyl-5-(2-phosphoethyl)-thiazole   
4pasp  4-Phospho-L-aspartate   
4per  4-Phospho-D-erythronate   
4ppan  D-4'-Phosphopantothenate   
4ppcys  N-((R)-4-Phosphopantothenoyl)-L-cysteine   
4r5au  4-(1-D-Ribitylamino)-5-aminouracil   
5aizc  5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxylate   
5aop  5-Amino-4-oxopentanoate   
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5aprbu  5-Amino-6-(5'-phosphoribitylamino)uracil   
5apru  5-Amino-6-(5'-phosphoribosylamino)uracil   
5caiz  5-phosphoribosyl-5-carboxyaminoimidazole   
5dglcn  5-Dehydro-D-gluconate   
5dh4dglc  5-Dehydro-4-deoxy-D-glucarate   
5mdr1p  5-Methylthio-5-deoxy-D-ribose  1-phosphate 
5mdru1p  5-Methylthio-5-deoxy-D-ribulose  1-phosphate 
5mta  5-Methylthioadenosine   
5mthf  5-Methyltetrahydrofolate   
5mtr  5-Methylthio-D-ribose   
5prdmbz  "N1-(5-Phospho-alpha-D-ribosyl)-5,6-dimethylbenzimidazole"   
6hmhpt  6-hydroxymethyl  dihydropterin 
6hmhptpp  6-hydroxymethyl-dihydropterin  pyrophosphate 
6pgc  6-Phospho-D-gluconate   
6pgl  "6-phospho-D-glucono-1,5-lactone"   
8aonn  8-Amino-7-oxononanoate   
aacald  Aminoacetaldehyde   
aacoa  Acetoacetyl-CoA   
ac  Acetate   
acac  Acetoacetate   
acACP  Acetyl-ACP   
acald  Acetaldehyde   
accoa  Acetyl-CoA   
acg5p  N-Acetyl-L-glutamyl  5-phosphate 
acg5sa  N-Acetyl-L-glutamate  5-semialdehyde 
acgam1p  N-Acetyl-D-glucosamine  1-phosphate 
acgam6p  N-Acetyl-D-glucosamine  6-phosphate 
acglu  N-Acetyl-L-glutamate   
acmana  N-Acetyl-D-mannosamine   
acmanap  N-Acetyl-D-mannosamine  6-phosphate 
acnam  N-Acetylneuraminate   
aconm  E-3-carboxy-2-pentenedioate  6-methyl  ester 
acon-T  trans-Aconitate   
acorn  N2-Acetyl-L-ornithine   
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ACP  acyl  carrier  protein   
acser  O-Acetyl-L-serine   
actACP  Acetoacetyl-ACP   
actp  Acetyl  phosphate 
ade  Adenine   
adn  Adenosine   
adocbi  Adenosyl  cobinamide   
adocbip  Adenosyl  cobinamide  phosphate 
adocbl  Adenosylcobalamin   
adp  ADP   
adpglc  ADPglucose   
agdpcbi  Adenosine-GDP-cobinamide   
agm  Agmatine   
agpc_EC  acyl-glycerophosphocholine   
agpe_EC  acyl-glycerophosphoethanolamine   
agpg_EC  acyl-glycerophosphoglycerol   
ahcys  S-Adenosyl-L-homocysteine   
ahdt  "2-Amino-4-hydroxy-6-(erythro-1,2,3-trihydroxypropyl)dihydropteridine"  
triphosphate 
aicar  5-Amino-1-(5-Phospho-D-ribosyl)imidazole-4-carboxamide   
air  5-amino-1-(5-phospho-D-ribosyl)imidazole   
akg  2-Oxoglutarate 
alaala  D-Alanyl-D-alanine   
ala-B  beta-Alanine   
alac-S  (S)-2-Acetolactate   
ala-D  D-Alanine 
ala-L  L-Alanine 
altrn  D-Altronate   
alltn  Allantoin 
alltt  Allantoate 
amet  S-Adenosyl-L-methionine   
ametam  S-Adenosylmethioninamine   
amob  S-Adenosyl-4-methylthio-2-oxobutanoate   
amp  AMP 
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anth  Anthranilate   
ap4a  P1,P4-Bis(5'-adenosyl)  tetraphosphate 
ap5a  P1,P5-Bis(5'-adenosyl)  pentaphosphate 
apg_EC  acyl  phosphatidylglycerol   
apoACP  apoprotein  [acyl  carrier  protein] 
aps  Adenosine  5'-phosphosulfate 
ara5p  D-Arabinose  5-phosphate   
arab-L  L-Arabinose   
arbt6p  Arbutin  6-phosphate 
arg-L  L-Arginine   
argsuc  N(omega)-(L-Arginino)succinate   
asn-L  L-Asparagine 
asp-L  L-Aspartate 
aspsa  L-Aspartate  4-semialdehyde 
atp  ATP 
bbtcoa  gamma-butyrobetainyl-CoA   
betald  Betaine  aldehyde 
btcoa  Butanoyl-CoA   
btn  Biotin   
btnso  d-biotin  d-sulfoxide   
but  Butyrate  (n-C4:0) 
camp  cAMP   
cbasp  N-Carbamoyl-L-aspartate   
cbi  Cobinamide   
cbl1  Cob(I)alamin   
cbp  Carbamoyl  phosphate 
cdp  CDP   
cdpdag1  CDPdiacylglycerol   
cdpea  CDPethanolamine   
cechddd  cis-3-(3-carboxyethyl)-3,5-cyclohexadiene-1,2-diol   
cenchddd  cis-3-(3-carboxyethenyl)-3,5-cyclohexadiene-1,2-diol   
cinnm  trans-Cinnamate   
cit  Citrate   
citr-L  L-Citrulline   
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ckdo  CMP-3-deoxy-D-manno-octulosonate   
clpn_EC  Cardiolipin   
cmp  CMP   
co2  CO2   
coa  Coenzyme  A 
cpppg3  Coproporphyrinogen  III 
crn  L-Carnitine   
crncoa  Carnitinyl-CoA   
csn  Cytosine 
ctbt  crotonobetaine   
ctbtcoa  crotonobetainyl-CoA   
ctp  CTP   
cyan  Cyanide   
cynt  Cyanate 
cys-L  L-Cysteine   
cyst-L  L-Cystathionine 
cytd  Cytidine   
chol  Choline   
chor  Chorismate   
dad-2  Deoxyadenosine   
dadp  dADP   
damp  dAMP   
dann  7,8-Diaminononanoate 
datp  dATP   
db4p  3,4-dihydroxy-2-butanone  4-phosphate 
dcamp  N6-(1,2-Dicarboxyethyl)-AMP   
dcdp  dCDP   
dcmp  dCMP   
dctp  dCTP   
dcyt  Deoxycytidine   
ddcaACP  Dodecanoyl-ACP  (n-C12:0ACP)   
dgdp  dGDP   
dgmp  dGMP   
dgsn  Deoxyguanosine   
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dgtp  dGTP   
dha  Dihydroxyacetone   
dhap  Dihydroxyacetone  phosphate 
dhcinnm  2,3-dihydroxicinnamic  acid 
dhf  7,8-Dihydrofolate   
dhna  1,4-Dihydroxy-2-naphthoate   
dhnpt  2-Amino-4-hydroxy-6-(D-erythro-1,2,3-trihydroxypropyl)-7,8-
dihydropteridine   
dhor-S  (S)-Dihydroorotate   
dhpmp  Dihydroneopterin  monophosphate 
dhpppn  3-(2,3-Dihydroxyphenyl)propanoate   
dhpt  Dihydropteroate   
dhptd  4,5-dihydroxy-2,3-pentanedione 
din  Deoxyinosine   
dkmpp  2,3-diketo-5-methylthio-1-phosphopentane   
dmbzid  5,6-Dimethylbenzimidazole   
dmlz  6,7-Dimethyl-8-(1-D-ribityl)lumazine   
dmpp  Dimethylallyl  diphosphate 
dms  Dimethyl  sulfide 
dmso  Dimethyl  sulfoxide 
dnad  Deamino-NAD+   
dpcoa  Dephospho-CoA   
dtbt  Dethiobiotin   
dtdp  dTDP   
dtdp4aaddg  dTDP-4-acetamido-4,6-dideoxy-D-galactose   
dtdp4addg  dTDP-4-amino-4,6-dideoxy-D-glucose   
dtdp4d6dg  dTDP-4-dehydro-6-deoxy-D-glucose   
dtdp4d6dm  dTDP-4-dehydro-6-deoxy-L-mannose   
dtdpglu  dTDPglucose   
dtdprmn  dTDP-L-rhamnose   
dtmp  dTMP   
dttp  dTTP   
dudp  dUDP   
dump  dUMP   
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duri  Deoxyuridine   
dutp  dUTP   
dxyl  1-deoxy-D-xylulose   
dxyl5p  1-deoxy-D-xylulose  5-phosphate 
e4p  D-Erythrose  4-phosphate 
eca_EC  Enterobacterial  common  antigen  polysaccharide 
eig3p  D-erythro-1-(Imidazol-4-yl)glycerol  3-phosphate 
enter  Enterochelin   
etha  Ethanolamine   
etoh  Ethanol   
f1p  D-Fructose  1-phosphate 
f6p  D-Fructose  6-phosphate 
fad  FAD   
fadh2  FADH2   
fc1p  L-Fuculose  1-phosphate 
fcl-L  L-fuculose   
fdp  D-Fructose  1,6-bisphosphate 
fe2  Fe2+   
fgam  N2-Formyl-N1-(5-phospho-D-ribosyl)glycinamide   
fmn  FMN   
for  Formate   
fpram  2-(Formamido)-N1-(5-phospho-D-ribosyl)acetamidine   
fprica  5-Formamido-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide   
frdp  Farnesyl  diphosphate 
fru  D-Fructose   
fruur  D-Fructuronate   
fuc-L  L-Fucose   
fum  Fumarate 
g1p  D-Glucose  1-phosphate 
g3p  Glyceraldehyde  3-phosphate 
g3pc  sn-Glycero-3-phosphocholine   
g3pe  sn-Glycero-3-phosphoethanolamine   
g3pg  Glycerophosphoglycerol   
g3pi  sn-Glycero-3-phospho-1-inositol   
Metabolic pathway analysis via integer linear programming 
Francisco J. Planes                 May 2008 38
g3ps  Glycerophosphoserine   
g6p  D-Glucose  6-phosphate   
gal  D-Galactose   
gal1p  alpha-D-Galactose  1-phosphate 
galct-D  D-Galactarate   
galctn-D  D-Galactonate   
galt1p  Galactitol  1-phosphate   
galur  D-Galacturonate   
gam1p  D-Glucosamine  1-phosphate 
gam6p  D-Glucosamine  6-phosphate 
gar  N1-(5-Phospho-D-ribosyl)glycinamide   
gbbtn  gamma-butyrobetaine   
gcald  Glycolaldehyde   
gdp  GDP   
gdpddman  GDP-4-dehydro-6-deoxy-D-mannose   
gdpfuc  GDP-L-fucose   
gdpmann  GDP-D-mannose   
gdpofuc  GDP-4-oxo-L-fucose   
glc-D  D-Glucose   
glcn  D-Gluconate   
glcr  D-Glucarate   
glcur  D-Glucuronate   
gln-L  L-Glutamine 
glu1sa  L-Glutamate  1-semialdehyde 
glu5p  L-Glutamate  5-phosphate 
glu5sa  L-Glutamate  5-semialdehyde 
glucys  gamma-L-Glutamyl-L-cysteine   
glu-D  D-Glutamate   
glu-L  L-Glutamate 
glutrna  L-Glutamyl-tRNA(Glu)   
glx  Glyoxylate   
gly  Glycine   
glyald  D-Glyceraldehyde   
glyb  Glycine  betaine 
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glyc  Glycerol   
glyc3p  Glycerol  3-phosphate   
glyclt  Glycolate   
glycogen  glycogen   
glyc-R  (R)-Glycerate   
gmhep17bp  D-Glycero-D-manno-heptose  1,7-bisphosphate   
gmhep1p  D-Glycero-D-manno-heptose  1-phosphate   
gmhep7p  D-Glycero-D-manno-heptose  7-phosphate 
gmp  GMP   
gp4g  P1,P4-Bis(5'-guanosyl)  tetraphosphate 
grdp  Geranyl  diphosphate 
gsn  Guanosine   
gthox  Oxidized  glutathione 
gthrd  Reduced  glutathione 
gtp  GTP   
gtspmd  Glutathionylspermidine   
gua  Guanine   
h  H+ 
h2  H2   
h2mb4p  1-hydroxy-2-methyl-2-(E)-butenyl  4-diphosphate 
h2o  H2O 
h2o2  Hydrogen  peroxide 
h2s  Hydrogen  sulfide 
hco3  Bicarbonate   
hcys-L  L-Homocysteine 
hdca  Hexadecanoate  (n-C16:0)   
hdcea  hexadecenoate  (n-C16:1)   
hdeACP  Hexadecenoyl-ACP  (n-C16:1ACP)   
hemeO  Heme  O   
his-L  L-Histidine   
hisp  L-Histidinol  phosphate 
histd  L-Histidinol   
hkndd  2-Hydroxy-6-oxonona-2,4-diene-1,9-dioate   
hkntd  2-hydroxy-6-ketononatrienedioate   
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hmbil  Hydroxymethylbilane   
hmfurn  4-hydroxy-5-methyl-3(2H)-furanone 
hom-L  L-Homoserine 
hpyr  Hydroxypyruvate   
hqn  Hydroquinone   
hxan  Hypoxanthine   
iasp  Iminoaspartate   
icit  Isocitrate   
ichor  Isochorismate   
idon-L  L-Idonate   
idp  IDP   
ile-L  L-Isoleucine   
imacp  3-(Imidazol-4-yl)-2-oxopropyl  phosphate 
imp  IMP   
indole  Indole   
inost  myo-Inositol   
ins  Inosine 
ipdp  Isopentenyl  diphosphate 
itp  ITP   
kdo  3-Deoxy-D-manno-2-octulosonate   
kdo2lipid4  KDO(2)-lipid  IV(A)   
kdo2lipid4L  KDO(2)-lipid  IV(A)  with  laurate 
kdo2lipid4p  KDO(2)-lipid  IV(A)  with  palmitoleoyl 
kdo8p  3-Deoxy-D-manno-octulosonate  8-phosphate   
kdolipid4  KDO-lipid  IV(A)   
lac-D  D-Lactate 
lac-L  L-Lactate   
lald-L  L-Lactaldehyde   
lcts  Lactose   
leu-L  L-Leucine   
lgt-S  (R)-S-Lactoylglutathione 
lipa  KDO(2)-lipid  (A)   
lipa_cold  cold  adapted  KDO(2)-lipid  (A) 
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lipidA  2,3,2'3'-Tetrakis(beta-hydroxymyristoyl)-D-glucosaminyl-1,6-beta-D-
glucosamine  1,4'-bisphosphate   
lipidAds  Lipid  A  Disaccharide   
lipidX  2,3-Bis(3-hydroxytetradecanoyl)-beta-D-glucosaminyl  1-phosphate   
lps_EC  lipopolysaccharide   
lys-L  L-Lysine   
malACP  Malonyl-[acyl-carrier  protein] 
malcoa  Malonyl-CoA   
mal-L  L-Malate   
malt  Maltose   
malthp  Maltoheptaose   
malthx  Maltohexaose   
maltpt  Maltopentaose   
malttr  Maltotriose   
maltttr  Maltotetraose   
man1p  D-Mannose  1-phosphate 
man6p  D-Mannose  6-phosphate 
mana  D-Mannonate   
melib  Melibiose   
methf  5,10-Methenyltetrahydrofolate   
met-L  L-Methionine   
mi1p-D  1D-myo-Inositol  1-phosphate   
micit  methylisocitrate   
mlthf  5,10-Methylenetetrahydrofolate   
mmcoa-R  (R)-Methylmalonyl-CoA   
mmcoa-S  (S)-Methylmalonyl-CoA   
mnl1p  D-Mannitol  1-phosphate 
mql8  Menaquinol  8   
mqn8  Menaquinone  8   
mthgxl  Methylglyoxal 
myrsACP  Myristoyl-ACP  (n-C14:0ACP)   
N1aspmd  N1-Acetylspermidine   
n8aspmd  N8-Acetylspermidine   
nac  Nicotinate   
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nad  Nicotinamide  adenine  dinucleotide   
nadh  Nicotinamide  adenine  dinucleotide  -  reduced 
nadp  Nicotinamide  adenine  dinucleotide  phosphate   
nadph  Nicotinamide  adenine  dinucleotide  phosphate  -  reduced 
ncam  Nicotinamide   
nh4  ammonium 
nicrnt  Nicotinate  D-ribonucleotide   
nmn  NMN   
no2  Nitrite   
no3  Nitrate   
o2  O2   
o2-  Superoxide  anion   
oaa  Oxaloacetate 
ocdca  octadecanoate  (n-C18:0) 
ocdcea  octadecenoate  (n-C18:1)   
octdp  all-trans-Octaprenyl  diphosphate 
octeACP  Octadecenoyl-ACP  (n-C18:1ACP)   
ohpb  2-Oxo-3-hydroxy-4-phosphobutanoate   
op4en  2-Oxopent-4-enoate   
orn  Ornithine   
orot  Orotate   
orot5p  Orotidine  5'-phosphate 
pa_EC  phosphatidate   
pac  Phenylacetic  acid 
pacald  Phenylacetaldehyde   
palmACP  Palmitoyl-ACP  (n-C16:0ACP)   
pan4p  Pantetheine  4'-phosphate 
pant-R  (R)-Pantoate   
pap  Adenosine  3',5'-bisphosphate   
paps  3'-Phosphoadenylyl  sulfate 
pc_EC  Phosphatidylcholine   
pdx5p  Pyridoxine  5'-phosphate   
pe_EC  Phosphatidylethanolamine   
peamn  Phenethylamine   
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pep  Phosphoenolpyruvate   
peptido_EC  Peptidoglycan  subunit  of  Escherichia  coli 
pg_EC  Phosphatidylglycerol   
pgp_EC  Phosphatidylglycerophosphate   
phaccoa  Phenylacetyl-CoA   
phe-L  L-Phenylalanine   
pheme  Protoheme   
phom  O-Phospho-L-homoserine   
phpyr  Phenylpyruvate   
phthr  O-Phospho-4-hydroxy-L-threonine   
pi  Phosphate   
pmcoa  Pimeloyl-CoA   
pnto-R  (R)-Pantothenate   
ppa  Propionate   
ppap  Propanoyl  phosphate 
ppbng  Porphobilinogen   
ppcoa  Propanoyl-CoA   
pphn  Prephenate   
ppi  Diphosphate 
ppp9  Protoporphyrin   
pppg9  Protoporphyrinogen  IX 
pppi  Inorganic  triphosphate 
pppn  Phenylpropanoate   
pram  5-Phospho-beta-D-ribosylamine   
pran  N-(5-Phospho-D-ribosyl)anthranilate   
prbamp  1-(5-Phosphoribosyl)-AMP   
prbatp  1-(5-Phosphoribosyl)-ATP   
prfp  1-(5-Phosphoribosyl)-5-[(5-
phosphoribosylamino)methylideneamino]imidazole-4-carboxamide   
prlp  5-[(5-phospho-1-deoxyribulos-1-ylamino)methylideneamino]-1-(5-
phosphoribosyl)imidazole-4-carboxamide   
pro-L  L-Proline   
prpp  5-Phospho-alpha-D-ribose  1-diphosphate   
ps_EC  phosphatidylserine   
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pser-L  O-Phospho-L-serine   
ptrc  Putrescine   
pyam5p  Pyridoxamine  5'-phosphate 
pydam  Pyridoxamine   
pydx  Pyridoxal   
pydx5p  Pyridoxal  5'-phosphate   
pydxn  Pyridoxine   
pyr  Pyruvate 
q8  Ubiquinone-8   
q8h2  Ubiquinol-8   
quln  Quinolinate   
r1p  alpha-D-Ribose  1-phosphate 
r5p  alpha-D-Ribose  5-phosphate 
rbl-L  L-Ribulose   
rdmbzi  N1-(alpha-D-ribosyl)-5,6-dimethylbenzimidazole   
rhcys  S-Ribosyl-L-homocysteine 
rib-D  D-Ribose   
ribflv  Riboflavin   
rml  L-Rhamnulose   
rml1p  L-Rhamnulose  1-phosphate 
rmn  L-Rhamnose   
ru5p-D  D-Ribulose  5-phosphate   
ru5p-L  L-Ribulose  5-phosphate 
s7p  Sedoheptulose  7-phosphate   
sbt6p  D-Sorbitol  6-phosphate 
sbzcoa  O-Succinylbenzoyl-CoA   
seln  Selenide   
selnp  Selenophosphate   
seramp  L-seryl-AMP   
ser-D  D-Serine   
ser-L  L-Serine   
shcl  Sirohydrochlorin   
sheme  Siroheme   
skm  Shikimate   
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skm5p  Shikimate  5-phosphate 
sl26da  N-Succinyl-LL-2,6-diaminoheptanedioate   
sl2a6o  N-Succinyl-2-L-amino-6-oxoheptanedioate   
so3  Sulfite   
so4  Sulfate   
spmd  Spermidine   
srch  Sirochlorin   
ssaltpp  Succinate  semialdehyde-thiamin  diphosphate  anion 
suc6p  Sucrose  6-phosphate   
sucarg  N2-Succinyl-L-arginine   
sucbz  o-Succinylbenzoate   
succ  Succinate   
succoa  Succinyl-CoA   
sucglu  N2-Succinyl-L-glutamate   
sucgsa  N2-Succinyl-L-glutamate  5-semialdehyde 
sucorn  N2-Succinyl-L-ornithine   
sucsal  Succinic  semialdehyde 
suchms  O-Succinyl-L-homoserine 
tag6p-D  D-Tagatose  6-phosphate 
tagdp-D  D-Tagatose  1,6-biphosphate 
tagur  D-Tagaturonate   
tartr-L  L-tartrate   
taur  Taurine   
tcynt  Thiocyanate   
tdeACP  Tetradecenoyl-ACP  (n-C14:1ACP)   
thdp  2,3,4,5-Tetrahydrodipicolinate   
thf  5,6,7,8-Tetrahydrofolate   
thm  Thiamin   
thmmp  Thiamin  monophosphate   
thmpp  Thiamine  diphosphate   
thr-L  L-Threonine   
thym  Thymine   
thymd  Thymidine   
tma  Trimethylamine   
Metabolic pathway analysis via integer linear programming 
Francisco J. Planes                 May 2008 46
tmao  Trimethylamine  N-oxide 
trdox  Oxidized  thioredoxin 
trdrd  Reduced  thioredoxin 
tre  Trehalose   
tre6p  alpha,alpha'-Trehalose  6-phosphate 
trnaglu  tRNA  (Glu) 
trp-L  L-Tryptophan   
tsul  Thiosulfate   
ttdca  tetradecanoate  (n-C14:0)   
ttdcea  tetradecenoate  (n-C14:1)   
tyr-L  L-Tyrosine   
u23ga  UDP-2,3-bis(3-hydroxytetradecanoyl)glucosamine   
u3aga  UDP-3-O-(3-hydroxytetradecanoyl)-N-acetylglucosamine   
u3hga  UDP-3-O-(3-hydroxytetradecanoyl)-D-glucosamine   
uaagmda  Undecaprenyl-diphospho-N-acetylmuramoyl-(N-acetylglucosamine)-
L-ala-D-glu-meso-2,6-diaminopimeloyl-D-ala-D-ala   
uaccg  UDP-N-acetyl-3-O-(1-carboxyvinyl)-D-glucosamine   
uacgam  UDP-N-acetyl-D-glucosamine   
uacmam  UDP-N-acetyl-D-mannosamine   
uacmamu  UDP-N-acetyl-D-mannosaminouronate   
uagmda  Undecaprenyl-diphospho-N-acetylmuramoyl-L-alanyl-D-glutamyl-
meso-2,6-diaminopimeloyl-D-alanyl-D-alanine   
uama  UDP-N-acetylmuramoyl-L-alanine   
uamag  UDP-N-acetylmuramoyl-L-alanyl-D-glutamate   
uamr  UDP-N-acetylmuramate   
udcpdp  Undecaprenyl  diphosphate   
udcpp  Undecaprenyl  phosphate   
udp  UDP   
udpg  UDPglucose   
udpgal  UDPgalactose   
udpgalfur  UDP-D-galacto-1,4-furanose   
udpglcur  UDP-D-glucuronate   
ugmd  UDP-N-acetylmuramoyl-L-alanyl-D-gamma-glutamyl-meso-2,6-
diaminopimelate   
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ugmda  UDP-N-acetylmuramoyl-L-alanyl-D-glutamyl-meso-2,6-
diaminopimeloyl-D-alanyl-D-alanine   
ump  UMP   
unaga  Undecaprenyl  diphospho  N-acetyl-glucosamine 
unagamu  Undecaprenyl-diphospho-N-acetylglucosamine-N-
acetylmannosaminuronate   
unagamuf  Undecaprenyl-diphospho  N-acetylglucosamine-N-
acetylmannosaminuronate-N-acetamido-4,6-dideoxy-D-galactose   
uppg3  Uroporphyrinogen  III 
ura  Uracil   
urdglyc  (-)-Ureidoglycolate 
urea  Urea   
uri  Uridine   
utp  UTP   
val-L  L-Valine   
xan  Xanthine   
xmp  Xanthosine  5'-phosphate 
xtsn  Xanthosine   
xu5p-D  D-Xylulose  5-phosphate 
xu5p-L  L-Xylulose  5-phosphate 
xyl-D  D-Xylose   
xylu-D  D-Xylulose   
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Appendix C: Pathway details  
For each of the metabolic pathways considered we give below a picture of the 
experimentally determined pathway that we used in this thesis. These pathways were 
drawn from the sources indicated below. The compound and reaction 
labelling/numbering is as listed in the data also provided in Appendices A and B.  
To illustrate the notation we use the picture below shows an example metabolic 
pathway. 
 
The reactions and the compounds (labelled R and C respectively) are the nodes 
in the above directed graph. The numbers associated with each arc are the number of 
molecules of each compound. For example reaction R3 takes two molecules of C6 and 
transforms them into one molecule of C3, C7 and C8 and two molecules of C5. The 
source and target compounds (C1 and C7 respectively) are coloured yellow and two 
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molecules of C1 are transformed into one molecule of C7. The numbers in brackets 
after each reaction label are the number of ticks, so for example reaction R1 ticks twice, 
each time converting one molecule of C1 and C3 into one molecule of C2 and C4. 
Compounds coloured blue are produced to excess (number of molecules needed is less 
than the number produced) whilst compounds coloured red are freely available (number 
of molecules needed is greater than the number produced). Compounds shown in white 
are balanced (number of molecules needed is equal to the number produced). 
In our pathway pictures: 
• for the compounds the number in brackets after the compound label is the 
percentage presence of the compound, δc defined using δc=100(number of 
reactions in which the compound appears)/(total number of reactions). So 
above, for example, C6 has a percentage presence of 3.4%. 
• reversible reactions are split into two non-reversible reactions and (arbitrarily) 
labelled using an ‘a’ and a ‘b’ at the end of the reaction number. If a reaction is 
not reversible then no ‘a’ or ‘b’ is associated with it. So above, for example, R1 
and R3 are not reversible, but R2b is a reversible reaction with the reverse of 
R2b being R2a. 
The Beasley-Planes (BP) model distinguishes between compounds according to 
their percentage presence. Compounds for which percentage presence ≤ Δ (where Δ is 
an input parameter) are called low presence compounds. Compounds for which δc > Δ 
are called high presence compounds. In the computational results reported below we 
(as in Chapter 3) use Δ=4%. So above, for example, C6 is a low presence compound but 
C4 is a high presence compound. 
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In the notation of the BP model QS is the number of molecules of the source 
compound and QT is the number of molecules of the target compound. For those cases 
in which the BP model recovers the pathway structure (i.e. the reactions involved in the 
pathway and their appropriate ticks) we give below a table detailing, for each (QS,QT) 
pair (QS,QT≤6), the number of reactions and excess ATP associated with the 
optimisation solution from the BP model. Situations where that optimisation model 
indicated that no feasible solution exists are indicated by a ‘X’. In other words in these 
cases no values for the decision variables in the BP model exist which satisfy all the 
constraints of that model for the particular (QS,QT) pair examined. The purpose of this 
(QS,QT) analysis is to determine whether, in addition to recovering the pathway, we can 
also recover the (QS,QT) pair seen in the experimentally determined pathway. The BP 
model considers two possible objectives: 
• objective (3.13), giving primary weight to minimising the total number of 
reactions and secondary weight to maximising excess ATP 
• objective (3.14), giving primary weight to maximising excess ATP and 
secondary weight to minimising the total number of reactions. 
Below we give details of the (QS,QT) analysis for those cases among the 40 
experimentally determined pathways where the BP model achieved recovery.  
With respect to the path finding approach presented in Chapter 5, we provide 
below the pictures of the metabolic path associated with the first ten experimentally 
determined metabolic pathways (as noted in Chapter 5) for both the R-R case and the C-
C case. Given the set of reactions and compounds that comprise a particular metabolic 
pathway, the associated metabolic path is defined in this thesis as the shortest path 
(under the distance metric as described in Chapter 5) that links the initial compound 
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(reaction) and the final compound (reaction) of the pathway via balanced intermediate 
compounds. As noted above, balanced compounds (shown in white colouring) are those 
compounds where the number of molecules produced by reactions involved in the 
pathway is equal to the number of molecules consumed by reactions involved in the 
pathway. Note that for a given pathway (as discussed in Chapter 5) the metabolic path 
may not be uniquely defined. In addition, for each metabolic pathway considered the 
metabolic path (R-R and C-C case) and the computed shortest paths (for k=1,2,…,10) 
are systematically compared according to the correspondence criteria described in 
Chapter 5.  
For the Improved Beasley Planes (IBP) model we, similarly to the BP model, 
give below details as to the (QS,QT) discussion. As noted in Chapter 6, the IBP model 
considers two different objectives:  
• objective (6.26), giving primary weight to minimising the specificity (Ψ) and 
secondary weight to minimising the number of main compounds (W) 
• objective (6.27), giving primary weight to minimising the length (L) and 
secondary weight to minimising the number of main compounds (W). 
We have carried out the (QS,QT) discussion in those cases in which the IBP 
model achieved recovery of the pathway. We also include the (QS,QT) discussion for the 
cyclic pathways we recovered. In addition, we present the (QS,QT) discussion for 
Glycolysis (Pathway 3) when constraints related to atp production are included in the 
IBP model. Note that some cases take excessive computation time. This usually happens 
when the IBP model cannot find a biologically meaningful solution and outputs 
solutions containing cycles with an objective value far from the optimal value. In these 
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cases we applied a time limit of 30 minutes. This situation is indicated by a red 
colouring in the tables for (QS,QT) pairs below. 
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Pathway 1: Gluconeogenesis 
Source compound Pyruvate (pyr) 
Target compound D-Glucose 6-phosphate 
(g6p) 
(QS,QT) (2,1) 
Low presence compounds that are not forced to be 
balanced 
None 
(Number of reactions, excess ATP) (9,-4) 
Number of unbalanced main compounds (W) 0 
Specificity (Ψ) 8.57 
Note that the fourth and fifth rows of the above table relates to the BP model. 
Specifically, we give the low presence unbalanced compounds and the number of 
reactions and excess ATP of the pathway under study. The last two items relate to the 
IBP model, whose objective function involves the number of unbalanced main 
compounds and the specificity value. Note that the Ψ value shown above is for the 
maximum number of metabolic paths K=2. 
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Pathway description 
This pathway has been taken from EcoCyc (http://biocyc.org/ECOLI/NEW-
IMAGE?type=PATHWAY&object=GLUCONEO-PWY) and Lehninger (fourth 
edition) page 544. 
In Lehninger the pathway is described as being from two molecules of pyruvate to 
one of glucose. However in EcoCyc it is described as being from malate to D-glucose-
6-phosphate, without giving information about the number of molecules consumed or 
produced. Since the Lehninger description appears to be the more common one it is that 
which has informed the pathway picture seen below. 
As shown below, the target compound is D-glucose-6-phosphate. According to 
our reaction database, a reaction to go from D-glucose-6-phosphate to glucose does not 
exist. This agrees with EcoCyc database. That is why the target compound is D-glucose-
6-phosphate and not glucose. 
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(QS,QT) discussion for the BP model 
This pathway was recovered with objective (3.13). Thus, the (QS,QT) discussion 
is carried out for objective (3.13). The table of pairs for objective (3.13) is shown 
below. 
Number of molecules QT of target compound (number of reactions, 
excess ATP) 1 2 3 4 5 6 
1 X X X X X X 
2 (9,-4)
* X X X X X 
3 X X X X X X 
4 X (9,-8) X X X X 
5 X X X X X X 
Number 
of 
molecules 
QS of 
source 
compound 6 X X (9,-12) X X X 
It can be seen that the majority of (QS,QT) pairs are infeasible. The three pairs 
seen are all repeats of each other, doubling and then tripling the number of source and 
target molecules (and excess ATP), whilst involving the same number of reactions. For 
this pathway the BP model indicates that the pair (QS,QT)=(2,1) dominates all other 
cases, since it involves fewer reactions and uses less ATP (and this is indicated by the * 
superscript on that entry in the above table). Hence in this case the BP model recovers 
the (QS,QT)=(2,1) pair observed in the experimentally determined pathway.  
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Metabolic path for the R-R case: correspondence values 
 
 
 
k True False False Sensitivity Positive Accuracy
shortest 
path 
positives positives negatives  predictive 
value 
 
k (TP) (FP) (FN) (Sn) (PPV) (Ac) 
1 5 2 8 0.385 0.714 0.549 
2 10 1 3 0.769 0.909 0.839 
3 10 1 3 0.769 0.909 0.839 
4 3 4 10 0.231 0.429 0.330 
5 3 4 10 0.231 0.429 0.330 
6 13 0 0 1 1 1 
7 2 13 11 0.154 0.133 0.144 
8 2 13 11 0.154 0.133 0.144 
9 2 13 11 0.154 0.133 0.144 
10 10 3 3 0.769 0.769 0.769 
 
 
For this pathway the metabolic path, from the first reaction R456 in the pathway, 
to the last reaction R454b in the pathway, is as shown above. 
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Metabolic path for the C-C case: correspondence values 
 
 
k True False False Sensitivity Positive Accuracy
shortest 
path 
positives positives negatives  predictive 
value 
 
k (TP) (FP) (FN) (Sn) (PPV) (Ac) 
1 2 15 13 0.133 0.118 0.125 
2 7 2 8 0.467 0.778 0.622 
3 0 21 15 0 0 0 
4 0 27 15 0 0 0 
5 2 23 13 0.133 0.080 0.107 
6 2 21 13 0.133 0.087 0.110 
7 0 18 15 0 0 0 
8 0 23 15 0 0 0 
9 2 23 13 0.133 0.080 0.107 
10 0 20 15 0 0 0  
For this pathway the metabolic path, from the source compound pyr in the 
pathway, to the target compound g6p in the pathway, is as shown above.  
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(QS,QT) discussion for the IBP model 
This pathway was recovered with both objective (6.26) and objective (6.27). 
Thus, the (QS,QT) discussion is carried out for objective (6.26) and objective (6.27). The 
table of pairs for objective (6.26) is shown below. 
Number of molecules QT of target compound 
(Ψ,W) 
1 2 3 4 5 6 
1 (8.13,1)
* (9.02,4) (8.96,3) (9.02,4) (8.96,3) (9.02,4) 
2 (8.57,0) (8.13,1) (9.02,4) (8.96,3) (9.02,4) (9.06,2) 
3 (9.09,3) (9.19,1) (8.13,1) (9.02,4) (8.96,3) (9.02,4) 
4 (9.09,3) (8.57,0) (9.19,1) (8.13,1) (9.02,4) (8.96,3) 
5 (9.09,3) (9.09,3) (9.19,1) (9.19,1) (8.13,1) (9.02,4) 
Number 
of 
molecules 
QS of 
source 
compound 6 (9.09,3) (9.09,3) (8.57,0) (9.19,1) (9.19,1) (8.13,1) 
For this pathway the IBP model indicates that the pair (QS,QT)=(1,1) dominates 
all other cases. This is indicated by the * superscript on that entry in the above table. 
Hence in this case the IBP model does not recover the (QS,QT)=(2,1) pair observed in 
the experimentally determined pathway.  
The results for objective (6.27) are shown below. 
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Number of molecules QT of target compound 
(L,W) 
1 2 3 4 5 6 
1 (7,1)
* (8,8) (9,3) (9,3) (9,3) (9,3) 
2 (9,0) (7,1) (9,3) (8,8) (9,3) (9,3) 
3 (10,2) (10,1) (7,1) (9,3) (9,3) (8,8) 
4 (10,2) (9,0) (10,1) (7,1) (9,3) (9,3) 
5 (10,2) (10,2) (10,1) (10,1) (7,1) (9,3) 
Number 
of 
molecules 
QS of 
source 
compound 6 (10,2) (10,2) (9,0) (10,1) (10,1) (7,1) 
We obtain the same dominant pair as objective (6.26). Hence for this objective 
the IBP model does not recover the (QS,QT)=(2,1) pair observed in the experimentally 
determined pathway. 
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 Pathway 2: Glycogen 
Source compound D-Glucose 6-phosphate (g6p) 
Target compound Glycogen (glycogen) 
(QS,QT) (1,1) 
Low presence compounds that are not forced to be balanced None 
(Number of reactions, excess ATP) (3,-1) 
Number of unbalanced main compounds (W) 0 
Specificity (Ψ) 3 
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Pathway description 
This pathway has been taken from EcoCyc (http://biocyc.org/ECOLI/NEW-
IMAGE?type=PATHWAY&object=GLYCOGENSYNTH-PWY) and Lehninger 
(fourth edition) pages 568 and 596. 
In Lehninger the pathway is described as being from one molecule of glucose-6-
phosphate to elongated glycogen with n+1 residues. However in EcoCyc it is described 
as being from glucose-1-phosphate to elongated glycogen with n+1 residues. EcoCyc 
does not include the first reaction in Lehninger: D-Glucose-6-phosphate → D-Glucose-
1-phosphate. 
Since the Lehninger description appears to be the more general one and is 
consistent with our reaction database, it is that which has informed the pathway picture 
seen below. 
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Note here that we have one allowable c-cycle (see Chapter 3) in this pathway. 
More precisely the 2-cycle adpglc-R448-h-R449-adpglc which contains one high 
presence balanced compound (h). 
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(QS,QT) discussion for the BP model 
This pathway was recovered with objective (3.13). Thus, the (QS,QT) discussion 
is carried out for objective (3.13). The table of pairs for objective (3.13) is shown 
below. 
Number of molecules QT of target compound (number of reactions, 
excess ATP) 1 2 3 4 5 6 
1 (3,-1)* X X X X X 
2 (15,0) (3,-2) X X X X 
3 (15,0) (13,0) (3,-3) X X X 
4 (15,1) (15,0) (13,0) (3,-4) X X 
5 (15,2) (15,0) (15,0) (13,0) (3,-5) X 
Number 
of 
molecules 
QS of 
source 
compound 6 (15,3) (15,1) (15,0) (13,0) (13,0) (3,-6) 
Applying this procedure to the above table the dominant pair is (QS,QT)=(1,1). 
Hence in this case the BP model recovers the (QS,QT)=(1,1) pair observed in the 
experimentally determined pathway.  
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Metabolic path for the R-R case: correspondence values 
 
 
k True False False Sensitivity Positive Accuracy
shortest 
path 
positives positives negatives  predictive 
value 
 
k (TP) (FP) (FN) (Sn) (PPV) (Ac) 
1 3 0 0 1 1 1 
2 3 4 0 1 0.429 0.714 
3 3 12 0 1 0.200 0.600 
4 3 6 0 1 0.333 0.667 
5 3 6 0 1 0.333 0.667 
6 3 6 0 1 0.333 0.667 
7 3 8 0 1 0.273 0.636 
8 3 6 0 1 0.333 0.667 
9 3 6 0 1 0.333 0.667 
10 3 6 0 1 0.333 0.667 
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Metabolic path for the C-C case: correspondence values  
 
 
k True False False Sensitivity Positive Accuracy
shortest 
path 
positives positives negatives  predictive 
value 
 
k (TP) (FP) (FN) (Sn) (PPV) (Ac) 
1 5 0 0 1 1 1
2 4 7 1 0.800 0.364 0.582
3 4 21 1 0.800 0.160 0.480
4 4 21 1 0.800 0.160 0.480
5 4 27 1 0.800 0.129 0.465
6 4 17 1 0.800 0.190 0.495
7 4 29 1 0.800 0.121 0.461
8 4 19 1 0.800 0.174 0.487
9 4 21 1 0.800 0.160 0.480
10 4 27 1 0.800 0.129 0.465
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(QS,QT) discussion for the IBP model 
This pathway was recovered with both objective (6.26) and objective (6.27). 
Thus, the (QS,QT) discussion is carried out for objective (6.26) and objective (6.27). The 
table of pairs for objective (6.26) is shown below. 
Number of molecules QT of target compound 
(Ψ,W) 
1 2 3 4 5 6 
1 (3,0)* X X X X X 
2 (8.63,3) (3,0) X X X X 
3 (8.63,3) (8.63,3) (3,0) X X X 
4 (8.63,3) (8.63,3) (8.63,3) (3,0) X X 
5 (8.63,3) (8.63,3) (8.63,3) (8.63,3) (3,0) X 
Number 
of 
molecules 
QS of 
source 
compound 6 (8.63,3) (8.63,3) (8.63,3) (8.63,3) (8.63,3) (3,0) 
For this pathway the IBP model indicates that the pair (QS,QT)=(1,1) dominates 
all other cases. Hence in this case the IBP model recover the (QS,QT)=(1,1) pair 
observed in the experimentally determined pathway. 
The results for objective (6.27) are shown below. 
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Number of molecules QT of target compound 
(L,W) 
1 2 3 4 5 6 
1 (3,0) * X X X X X 
2 (12,5) (3,0) X X X X 
3 (12,5) (12,5) (3,0) X X X 
4 (12,5) (12,5) (12,5) (3,0) X X 
5 (12,5) (12,5) (12,5) (12,5) (3,0) X 
Number 
of 
molecules 
QS of 
source 
compound 6 (12,5) (12,5) (12,5) (12,5) (12,5) (3,0) 
We obtain the same dominant pair as objective (6.26). Hence for this objective 
the IBP model also recovers the (QS,QT)=(1,1) pair observed in the experimentally 
determined pathway. 
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Pathway 3: Glycolysis 
Source compound D-Glucose (glc-D) 
Target compound Pyruvate (pyr) 
(QS,QT) (1,2) 
Low presence compounds that are not forced to be balanced None 
(Number of reactions, excess ATP) (10,2) 
Number of unbalanced main compounds (W) 0 
Specificity (Ψ) 9.57 
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Pathway description 
This pathway has been taken from EcoCyc (http://biocyc.org/ECOLI/NEW-
IMAGE?type=PATHWAY&object=GLYCOLYSIS) and Lehninger (fourth edition) 
page 524. 
In Lehninger the pathway is described as being from one molecule of D-glucose 
to two molecules of pyruvate. However in EcoCyc it is described as being from one 
molecule of D-glucose-6-phosphate to two molecules of pyruvate. EcoCyc does not 
include first reaction in Lehninger: D-Glucose → D-Glucose-6-phosphate.  
Since the Lehninger description appears to be the more general one and is 
consistent with our reaction database, it is that which has informed the pathway picture 
seen below. 
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(QS,QT) discussion for the BP model 
This pathway was recovered with both objective (3.13) and objective (3.14). 
Thus, the (QS,QT) discussion is carried out for objective (3.13) and objective (3.14). The 
table of pairs for objective (3.13) is shown below. 
Number of molecules QT of target compound (number of reactions, 
excess ATP) 1 2 3 4 5 6 
1 X (10,2)* X X X X 
2 X X X (10,4) X X 
3 X X X X X (10,6) 
4 X X X X X X 
5 X X X X X X 
Number 
of 
molecules 
QS of 
source 
compound 6 X X X X X X 
It can be seen that the majority of (QS,QT) pairs are infeasible. The three pairs 
seen are all repeats of each other, doubling and then tripling the number of source and 
target molecules (and excess ATP). Hence in this case the BP model recovers the 
(QS,QT)=(1,2) pair observed in the experimentally determined pathway. 
The results for objective (3.14) are shown below. 
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Number of molecules QT of target compound (number of reactions, 
excess ATP) 1 2 3 4 5 6 
1 X (10,2)* X X X X 
2 X X X (10,4) X X 
3 X X X X X (10,6) 
4 X X X X X X 
5 X X X X X X 
Number 
of 
molecules 
QS of 
source 
compound 6 X X X X X X 
We get the same results as objective (3.13). Hence for this objective the BP 
model also recovers the (QS,QT)=(1,2) pair observed in the experimentally determined 
pathway. 
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Metabolic path for the R-R case: correspondence values 
 
 
k True False False Sensitivity Positive Accuracy
shortest 
path 
positives positives negatives  predictive 
value 
 
k (TP) (FP) (FN) (Sn) (PPV) (Ac) 
1 10 7 5 0.667 0.588 0.627 
2 2 9 13 0.133 0.182 0.158 
3 12 1 3 0.800 0.923 0.862 
4 12 1 3 0.800 0.923 0.862 
5 15 0 0 1 1 1 
6 10 9 5 0.667 0.526 0.596 
7 10 9 5 0.667 0.526 0.596 
8 12 3 3 0.800 0.800 0.800 
9 2 21 13 0.133 0.087 0.110 
10 4 5 11 0.267 0.444 0.356  
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Metabolic path for the C-C case: correspondence values 
 
 
k True False False Sensitivity Positive Accuracy
shortest 
path 
positives positives negatives  predictive 
value 
 
k (TP) (FP) (FN) (Sn) (PPV) (Ac) 
1 0 7 17 0 0 0
2 2 7 15 0.118 0.222 0.170
3 4 3 13 0.235 0.571 0.403
4 0 17 17 0 0 0
5 0 5 17 0 0 0
6 0 5 17 0 0 0
7 0 5 17 0 0 0
8 0 5 17 0 0 0
9 0 5 17 0 0 0
10 0 5 17 0 0 0 
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(QS,QT) discussion for the IBP model 
This pathway was not recovered with either objective (6.26) or objective (6.27). 
However, when we include the constraints related to the production of atp as described 
in Chapter 6, we achieved recovery with objective (6.26).  Thus, the (QS,QT) discussion 
is carried out for objective (6.26) under situation, i.e. atp forced to be produced. The 
table of pairs for objective (6.26) is shown below. Note here that we used K=1. The Ψ 
value of the pathway changes when K is modified. As seen below, the Ψ value for K=1 
is precisely 10 for this pathway, whilst for K=2 the Ψ value is 9.57, as can be noted 
above.  
Number of molecules QT of target compound 
(Ψ,W) 
1 2 3 4 5 6 
1 (10.39,1) (10,0)* (11.03,1) (15.17,2) (16.16,1) (15.68,7) 
2 (17.46,4) (10.5,0) (15.13,2) (10,0) (16,1) (11.03,1) 
3 (17.81,4) (16.78,7) (10.39,1) (15.68,7) (15.68,7) (10,0) 
4 (18.05,7) (17.46,4) (16.68,8) (10.39,1) (15.68,7) (15.13,2) 
5 (18.05,7) (17.97,5) (16.68,8) (16.68,8) (10.39,1) (15.68,7) 
Number 
of 
molecules 
QS of 
source 
compound 6 (18.15,6) (17.81,4) (17.46,4) (16.68,8) (16.68,8) (10.39,1) 
For this pathway the IBP model indicates that the pair (QS,QT)=(1,2) dominates 
all other cases. Hence in this case the IBP model recover the (QS,QT)=(1,2) pair 
observed in the experimentally determined pathway. 
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 Pathway 4: Proline biosynthesis 
Source compound 2-Oxoglutarate alpha-ketoglutarate 
(akg) 
Target compound L-Proline (pro-L) 
(QS,QT) (1,1) 
Low presence compounds that are not forced to be 
balanced 
None 
(Number of reactions, excess ATP) (5,-1) 
Number of unbalanced main compounds (W) 0 
Specificity (Ψ) 5 
 
Metabolic pathway analysis via integer linear programming 
Francisco J. Planes                 May 2008 78
Pathway description 
This pathway has been taken from EcoCyc (http://biocyc.org/ECOLI/NEW-
IMAGE?type=PATHWAY&object=PROSYN-PWY&detail-level=3) and Lehninger 
(fourth edition) pages 842 and 843. 
In Lehninger the pathway is described as being from one molecule of alpha-
ketoglutarate to one molecule of proline. This pathway is described in the same way in 
EcoCyc.  
 
 
 
Metabolic pathway analysis via integer linear programming 
Francisco J. Planes                 May 2008 79
(QS,QT) discussion for the BP model 
This pathway was recovered with objective (3.13). Thus, the (QS,QT) discussion 
is carried out for objective (3.13). The table of pairs for objective (3.13) is shown 
below. 
Number of molecules QT of target compound (number of reactions, 
excess ATP) 1 2 3 4 5 6 
1 (5,-1)* (7,-2) (7,-3) (7,-4) (7,-5) (7,-6) 
2 (7,-1) (5,-2) (7,-3) (7,-4) (7,-5) (7,-6) 
3 (7,-1) (7,-2) (5,-3) (7,-4) (7,-5) (7,-6) 
4 (7,-1) (7,-2) (7,-3) (5,-4) (7,-5) (7,-6) 
5 (7,-1) (7,-2) (7,-3) (7,-4) (5,-5) (7,-6) 
Number 
of 
molecules 
QS of 
source 
compound 6 (7,-1) (7,-2) (7,-3) (7,-4) (7,-5) (5,-6) 
For this pathway the dominant pair is (QS,QT)=(1,1). Hence in this case the BP 
model recovers the (QS,QT)=(1,1) pair observed in the experimentally determined 
pathway. 
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Metabolic path for the R-R case: correspondence values 
 
 
k True False False Sensitivity Positive Accuracy
shortest 
path 
positives positives negatives  predictive 
value 
 
k (TP) (FP) (FN) (Sn) (PPV) (Ac) 
1 7 0 0 1 1 1 
2 4 5 3 0.571 0.444 0.508 
3 4 7 3 0.571 0.364 0.468 
4 4 11 3 0.571 0.267 0.419 
5 2 8 5 0.286 0.200 0.243 
6 1 14 6 0.143 0.067 0.105 
7 4 3 3 0.571 0.571 0.571 
8 4 3 3 0.571 0.571 0.571 
9 4 3 3 0.571 0.571 0.571 
10 4 3 3 0.571 0.571 0.571  
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Metabolic path for the C-C case: correspondence values 
 
 
k True False False Sensitivity Positive Accuracy
shortest 
path 
positives positives negatives  predictive 
value 
 
k (TP) (FP) (FN) (Sn) (PPV) (Ac) 
1 4 1 5 0.444 0.800 0.622
2 4 3 5 0.444 0.571 0.508
3 2 7 7 0.222 0.222 0.222
4 2 9 7 0.222 0.182 0.202
5 2 9 7 0.222 0.182 0.202
6 2 11 7 0.222 0.154 0.188
7 2 9 7 0.222 0.182 0.202
8 2 13 7 0.222 0.133 0.178
9 2 9 7 0.222 0.182 0.202
10 2 13 7 0.222 0.133 0.178 
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(QS,QT) discussion for the IBP model 
This pathway was recovered with objective (6.26). Thus, the (QS,QT) discussion 
is carried out for objective (6.26). The table of pairs for objective (6.26) is shown 
below. 
Number of molecules QT of target compound 
(Ψ,W) 
1 2 3 4 5 6 
1 (5,0)* (5.84,1) X X X X 
2 (9.6,0) (5,0) (5.42,1) (5.84,1) X X 
3 (10.95,0) (10.02,1) (5,0) (5.42,1) (5.42,1) (5.94,0) 
4 (10.95,0) (9.6,0) (11.36,8) (5,0) (5.42,1) (5.42,1) 
5 (10.95,0) (10.87,0) (11.36,1) (11.44,1) (5,0) (5.42,1) 
Number 
of 
molecules 
QS of 
source 
compound 6 (10.95,0) (10.95,0) (9.6,0) (10.02,1) (9.95,4) (5,0) 
For this pathway the IBP model indicates that the pair (QS,QT)=(1,1) dominates 
all other cases. Hence in this case the IBP model recovers the (QS,QT)=(1,1) pair 
observed in the experimentally determined pathway. 
Here the value in red (QS,QT)=(6,5) indicates that the result shown is not 
guaranteed to be optimal. Rather (9.95,4) is the best result obtained with objective 
(6.26) once our 30 minute time limit had been reached. 
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Pathway 5: Ketogluconate metabolism 
Source compound 2,5-diketo-D-gluconate 
(25dkglcn) 
Target compound 6-Phospho-D-gluconate (6pgc) 
(QS,QT) (1,1) 
Low presence compounds that are not forced to be 
balanced 
None 
(Number of reactions, excess ATP) (3,-1) 
Number of unbalanced main compounds (W) 0 
Specificity (Ψ) 3 
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Pathway description 
This pathway has been taken from EcoCyc (http://biocyc.org/ECOLI/NEW-
IMAGE?type=PATHWAY&object=KETOGLUCONMET-PWY). 
In EcoCyc the pathway is described as being from 2,5-didehydro-D-gluconate to 
6-Phospho-D-gluconate. However in our reaction database 2,5-didehydro-D-gluconate 
does not exist. Instead, 2,5-diketo-D-gluconate has been found and seems to fulfil the 
same function.  
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(QS,QT) discussion for the BP model 
This pathway was recovered with objective (3.13). Thus, the (QS,QT) discussion 
is carried out for objective (3.13). The table of pairs for objective (3.13) is shown 
below. 
Number of molecules QT of target compound (number of reactions, 
excess ATP) 1 2 3 4 5 6 
1 (3,-1)* (14,-5) (14,-9) (14,-13) (14,-7) (14,-21) 
2 X (3,-2) (14,-6) (14,-10) (14,-14) (14,-18) 
3 X X (3,-3) (14,-7) (14,-11) (14,-15) 
4 X X X (3,-4) (14,-8) (14,-12) 
5 X X X X (3,-5) (14,-9) 
Number 
of 
molecules 
QS of 
source 
compound 6 X X X X X (3,-6) 
For this pathway the dominant pair is (QS,QT)=(1,1). Hence in this case the BP 
model recovers the (QS,QT)=(1,1) pair observed in the experimentally determined 
pathway. 
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Metabolic path for the R-R case: correspondence values 
 
 
k True False False Sensitivity Positive Accuracy
shortest 
path 
positives positives negatives  predictive 
value 
 
k (TP) (FP) (FN) (Sn) (PPV) (Ac) 
1 3 0 0 1 1 1 
2 0 5 3 0 0 0 
3 0 7 3 0 0 0 
4 2 5 1 0.667 0.286 0.476 
5 1 6 2 0.333 0.143 0.238 
6 2 7 1 0.667 0.222 0.444 
7 1 8 2 0.333 0.111 0.222 
8 0 15 3 0 0 0 
9 0 7 3 0 0 0 
10 0 11 3 0 0 0  
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Metabolic path for the C-C case: correspondence values 
 
 
k True False False Sensitivity Positive Accuracy
shortest 
path 
positives positives negatives  predictive 
value 
 
k (TP) (FP) (FN) (Sn) (PPV) (Ac) 
1 5 0 0 1 1 1
2 4 1 1 0.800 0.800 0.800
3 4 5 1 0.800 0.444 0.622
4 4 5 1 0.800 0.444 0.622
5 1 4 4 0.200 0.200 0.200
6 0 5 5 0 0 0
7 0 7 5 0 0 0
8 2 5 3 0.400 0.286 0.343
9 3 4 2 0.600 0.429 0.514
10 1 6 4 0.200 0.143 0.171 
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(QS,QT) discussion for the IBP model 
This pathway was recovered with both objective (6.26) and objective (6.27). 
Thus, the (QS,QT) discussion is carried out for objective (6.26) and objective (6.27). The 
table of pairs for objective (6.26) is shown below. 
Number of molecules QT of target compound 
(Ψ,W) 
1 2 3 4 5 6 
1 (3,0)* X X X X X 
2 X (3,0) X X X X 
3 X X (3,0) X X X 
4 X X X (3,0) X X 
5 X X X X (3,0) X 
Number 
of 
molecules 
QS of 
source 
compound 6 X X X X X (3,0) 
For this pathway the IBP model indicates that the pair (QS,QT)=(1,1) dominates 
all other cases. Hence in this case the IBP model recovers the (QS,QT)=(1,1) pair 
observed in the experimentally determined pathway. 
The results for objective (6.27) are shown below. 
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Number of molecules QT of target compound 
(L,W) 
1 2 3 4 5 6 
1 (3,0) X X X X X 
2 X (3,0) X X X X 
3 X X (3,0) X X X 
4 X X X (3,0) X X 
5 X X X X (3,0) X 
Number 
of 
molecules 
QS of 
source 
compound 6 X X X X X (3,0) 
We obtain the same dominant pair as objective (6.26). Hence for this objective 
the IBP model also recovers the (QS,QT)=(1,1) pair observed in the experimentally 
determined pathway. 
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Pathway 6: Pentose phosphate 
Source compound D-Glucose 6-phosphate (g6p) 
Target compound D-Fructose 6-phosphate (f6p) 
(QS,QT) (3,2) 
Low presence compounds that are not forced to be 
balanced 
Glyceraldehyde 3-phosphate 
(g3p)  
(Number of reactions, excess ATP) (8,0) 
Number of unbalanced main compounds (W) 1 
Specificity (Ψ) 6.03 
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Pathway description 
This pathway has been taken from EcoCyc (http://biocyc.org/ECOLI/NEW-
IMAGE?type=PATHWAY&object=PENTOSE-P-PWY) and Lehninger (fourth edition) 
pages 549 to 553. 
Both in Lehninger and EcoCyc, the pathway is described as being from three 
molecules of D-Glucose-6-phosphate to two molecules of D-Fructose 6-phosphate. 
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(QS,QT) discussion for the BP model 
This pathway was recovered with objective (3.13). Thus, the (QS,QT) discussion 
is carried out for objective (3.13). The table of pairs for objective (3.13) is shown 
below. 
Number of molecules QT of target compound (number of reactions, 
excess ATP) 1 2 3 4 5 6 
1 (1,0)* (4,0) (4,0) (4,0) (4,0) (4,0) 
2 (7,0) (1,0) (4,0) (4,0) (4,0) (4,0) 
3 (13,1) (8,0) (1,0) (4,0) (4,0) (4,0) 
4 (13,2) (7,0) (8,0) (1,0) (4,0) (4,0) 
5 (13,3) (13,2) (8,0) (8,0) (1,0) (4,0) 
Number 
of 
molecules 
QS of 
source 
compound 6 (13,4) (13,3) (7,0) (8,0) (8,0) (1,0) 
Note the presence of a single reaction pathway involving no excess ATP as 
indicated down the diagonal of the above table. Technically, in the BP model, a single 
reaction pathway can be found if there exists a reaction converting the source compound 
into the target compound which also only involves (if at all) high presence compounds. 
Here there is a single reaction (R454a in our reaction database) associated with glucose-
6-phosphate isomerase that directly converts D-Glucose 6-phosphate into D-Fructose 6-
phosphate (and does not involve any other compounds). 
The dominant pair is (QS,QT)=(1,1). Hence in this case the BP model cannot 
recover the (QS,QT)=(3,2) pair associated with the experimentally determined pathway.  
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Metabolic path for the R-R case: correspondence values 
 
 
k True False False Sensitivity Positive Accuracy
shortest 
path 
positives positives negatives  predictive 
value 
 
k (TP) (FP) (FN) (Sn) (PPV) (Ac) 
1 7 0 0 1 1 1 
2 7 4 0 1 0.636 0.818 
3 5 6 2 0.714 0.455 0.584 
4 3 6 4 0.429 0.333 0.381 
5 4 5 3 0.571 0.444 0.508 
6 7 4 0 1 0.636 0.818 
7 5 6 2 0.714 0.455 0.584 
8 6 7 1 0.857 0.462 0.659 
9 4 9 3 0.571 0.308 0.440 
10 5 16 2 0.714 0.238 0.476  
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Metabolic path for the C-C case: correspondence values 
 
 
k True False False Sensitivity Positive Accuracy
shortest 
path 
positives positives negatives  predictive 
value 
 
k (TP) (FP) (FN) (Sn) (PPV) (Ac) 
1 0 1 9 0 0 0
2 9 0 0 1 1 1
3 8 3 1 0.889 0.727 0.808
4 6 5 3 0.667 0.545 0.606
5 4 5 5 0.444 0.444 0.444
6 4 5 5 0.444 0.444 0.444
7 9 4 0 1 0.692 0.846
8 4 7 5 0.444 0.364 0.404
9 7 6 2 0.778 0.538 0.658
10 5 6 4 0.556 0.455 0.505
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(QS,QT) discussion for the IBP model 
This pathway was recovered with both objective (6.26) and objective (6.27). 
Thus, the (QS,QT) discussion is carried out for objective (6.26) and objective (6.27). The 
table of pairs for objective (6.26) is shown below. 
Number of molecules QT of target compound 
(Ψ,W) 
1 2 3 4 5 6 
1 (5.13,2)* (6.26,2) (6.96,3) (7.02,4) (6.96,3) (7.02,4) 
2 (6.56,0) (5.13,2) (5.63,2) (6.26,2) (7.02,4) (6.96,3) 
3 (9.36,4) (6.03,1) (5.13,2) (5.63,2) (5.63,2) (6.26,2) 
4 (9.53,0) (6.56,0) (6.16,0) (5.13,2) (5.63,2) (5.63,2) 
5 (9.77,6) (8.95,6) (6.03,2) (6.13,1) (5.13,2) (5.63,2) 
Number 
of 
molecules 
QS of 
source 
compound 6 (9.77,6) (8.95,6) (6.56,0) (6.03,1) (6.06,1) (5.13,2) 
For this pathway the IBP model indicates that the pair (QS,QT)=(1,1) dominates 
all other cases. Hence in this case the IBP model does not recover the (QS,QT)=(3,2) 
pair observed in the experimentally determined pathway. 
The results for objective (6.27) are shown below. 
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Number of molecules QT of target compound 
(Ψ,W) 
1 2 3 4 5 6 
1 (5,1)* (6,1) (7,3) (7,3) (7,3) (7,3) 
2 (7,0) (5,1) (7,3) (6,1) (7,3) (7,3) 
3 (8,7) (8,1) (5,1) (7,3) (7,3) (6,1) 
4 (8,7) (7,0) (8,1) (5,1) (7,3) (7,3) 
5 (8,7) (8,7) (8,1) (8,1) (5,1) (7,3) 
Number 
of 
molecules 
QS of 
source 
compound 6 (8,7) (8,7) (7,0) (8,1) (8,1) (5,1) 
We obtain the same dominant pair as objective (6.26). Hence for this objective 
the IBP model does not recover the (QS,QT)=(3,2) pair observed in the experimentally 
determined pathway. 
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Pathway 7: Salvage pathway deoxythymidine phosphate 
Source compound Deoxycytidine (dcyt) 
Target compound dTMP (dtmp) 
(QS,QT) (1,1) 
Low presence compounds that are not forced to be balanced Uracil (ura)  
Thymine (thym)  
(Number of reactions, excess ATP) (4,-1) 
Number of unbalanced main compounds (W) 2 
Specificity (Ψ) 6.95 
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Pathway description 
This pathway has been taken from EcoCyc (http://biocyc.org/ECOLI/NEW-
IMAGE?type=PATHWAY&object=PWY0-181). 
In EcoCyc the pathway is described as being from deoxycitidine to dTMP. The 
same set of reactions is present in our reaction database.  
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Note here that we have two allowable c-cycles in this pathway. More precisely: 
• the 2-cycle 2dr1p-R536b-pi-R537a-2dr1p which contains one high presence 
balanced compound (pi). 
• the 4-cycle 2dr1p-R536b-thymd-R574-h-R529-duri-R537a-2dr1p which 
contains one high presence balanced compound (h). 
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(QS,QT) discussion for the BP model 
This pathway was recovered with objective (3.13). Thus, the (QS,QT) discussion 
is carried out for objective (3.13). The table of pairs for objective (3.13) is shown 
below. 
Number of molecules QT of target compound (number of reactions, 
excess ATP) 
1 2 3 4 5 6 
1 (4,-1)* X X X X X 
2 X (4,-2) X X X X 
3 X X (4,-3) X X X 
4 X X X (4,-4) X X 
5 X X X X (4,-5) X 
Number 
of 
molecules 
QS of 
source 
compound 6 X X X X X (4,-6) 
The pairs seen down the diagonal are all repeats of each other, doubling and then 
tripling, etc the number of source and target molecules (and excess ATP). The dominant 
pair is (QS,QT)=(1,1). Hence in this case the BP model recovers the (QS,QT)=(1,1) pair 
observed in the experimentally determined pathway.  
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Metabolic path for the R-R case: correspondence values 
 
 
k True False False Sensitivity Positive Accuracy
shortest 
path 
positives positives negatives  predictive 
value 
 
k (TP) (FP) (FN) (Sn) (PPV) (Ac) 
1 2 5 3 0.400 0.286 0.343 
2 5 0 0 1 1  
3 3 12 2 0.600 0.200 0.400 
4 3 14 2 0.600 0.176 0.388 
5 3 14 2 0.600 0.176 0.388 
6 5 12 0 1 0.294 0.647 
7 5 12 0 1 0.294 0.647 
8 4 15 1 0.800 0.211 0.505 
9 3 14 2 0.600 0.176 0.388 
10 3 16 2 0.600 0.158 0.379  
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Metabolic path for the C-C case: correspondence values 
 
 
k True False False Sensitivity Positive Accuracy
shortest 
path 
positives positives negatives  predictive 
value 
 
k (TP) (FP) (FN) (Sn) (PPV) (Ac) 
1 2 3 5 0.286 0.400 0.343
2 7 0 0 1 1 1
3 3 10 4 0.429 0.231 0.330
4 3 12 4 0.429 0.200 0.314
5 3 12 4 0.429 0.200 0.314
6 4 13 3 0.571 0.235 0.403
7 3 12 4 0.429 0.200 0.314
8 3 14 4 0.429 0.176 0.303
9 3 14 4 0.429 0.176 0.303
10 3 16 4 0.429 0.158 0.293 
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(QS,QT) discussion for the IBP model 
This pathway was not recovered with either objective (6.26) or objective (6.27). 
For this reason (QS,QT) pairs discussion is omitted for this pathway. 
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Pathway 8: Tricarboxylic acid (citric acid, citrate, TCA, Krebs) cycle 
Source compound Oxaloacetate (oaa) 
Target compound Oxaloacetate (oaa) 
(QS,QT) (1,1) 
Low presence compounds that are not forced to be balanced FAD (fad) 
FADH2 (fadh2) 
Acetyl-CoA (accoa) 
(Number of reactions, excess ATP) (8,1) 
Number of unbalanced main compounds (W) 0 
Specificity (Ψ) 8 
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Pathway description 
This pathway has been taken from EcoCyc (http://biocyc.org/ECOLI/NEW-
IMAGE?type=PATHWAY&object=TCA) and Lehninger (fourth edition) page 607. 
Both in Lehninger and EcoCyc, the pathway is described as being a cycle 
starting and finishing at oxaloacetate with the same set of reactions involved. 
The only difference is that EcoCyc produces ubiquinol and Lehninger produces 
fadh2 in the reaction in which succinate is converted to fumarate. Since our reaction 
database contains this reaction with fadh2, we have selected the Lehninger pathway. 
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Note here that we have a number of allowable c-cycles in this pathway. There is 
an 8-cycle oaa-R272-cit-R267a-icit-R273a-akg-R274-succoa-R279b-succ-R278-fum-
R271a-(mal-L)-R275a-oaa that starts and ends at the source/target compound (oaa). In 
terms of 2-cycles we have, for example, succoa-R279b-coa-R274-succoa that contains 
one high presence balanced compound (coa). 
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(QS,QT) discussion for the BP model 
This pathway was recovered with objective (3.14). Thus, the (QS,QT) discussion 
is carried out for objective (3.14). The table of pairs for objective (3.14) is shown 
below. 
Number of molecules QT of target compound (number of reactions, 
excess ATP) 
1 2 3 4 5 6 
1 (8,1)* (9,2) (9,3) (9,4) (9,5) (9,6) 
2 (11,1) (8,2) (9,3) (9,4) (9,5) (9,6) 
3 (11,1) (11,2) (8,3) (9,4) (9,5) (9,6) 
4 (11,1) (11,2) (11,3) (8,4) (9,5) (9,6) 
5 (11,1) (11,2) (11,3) (11,4) (8,5) (9,6) 
Number 
of 
molecules 
QS of 
source 
compound 6 (11,1) (11,2) (11,3) (11,4) (11,5) (8,6) 
In this pathway the source compound and the target compound are the same, 
moreover in the experimentally determined pathway the source/target compound is 
balanced (since QS=QT=1). It is therefore possible to interpret this pathway, a cycle, 
such that the only valid cases in the above (QS,QT) table of pairs are the diagonal entries 
(which are the only cases where the source/target compound is balanced). 
Adopting this interpretation the diagonal pairs. are all repeats of each other, 
doubling and then tripling, etc the number of source/target molecules. The dominant 
pair is (QS,QT)=(1,1). Hence in this case the BP model recovers the (QS,QT)=(1,1) pair 
observed in the experimentally determined pathway. 
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Metabolic path for the R-R case: correspondence values 
 
 
k True False False Sensitivity Positive Accuracy
shortest 
path 
positives positives negatives  predictive 
value 
 
k (TP) (FP) (FN) (Sn) (PPV) (Ac) 
1 4 3 9 0.308 0.571 0.440 
2 8 1 5 0.615 0.889 0.752 
3 4 5 9 0.308 0.444 0.376 
4 2 5 11 0.154 0.286 0.220 
5 4 7 9 0.308 0.364 0.336 
6 4 7 9 0.308 0.364 0.336 
7 4 7 9 0.308 0.364 0.336 
8 2 7 11 0.154 0.222 0.188 
9 6 9 7 0.462 0.400 0.431 
10 7 6 6 0.538 0.538 0.538  
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Metabolic path for the C-C case: correspondence values 
 
 
k True False False Sensitivity Positive Accuracy
shortest 
path 
positives positives negatives  predictive 
value 
 
k (TP) (FP) (FN) (Sn) (PPV) (Ac) 
1 2 1 13 0.133 0.667 0.400
2 1 2 14 0.067 0.333 0.200
3 1 2 14 0.067 0.333 0.200
4 0 3 15 0 0 0
5 6 3 9 0.400 0.667 0.533
6 5 4 10 0.333 0.556 0.444
7 5 4 10 0.333 0.556 0.444
8 2 5 13 0.133 0.286 0.210
9 3 4 12 0.200 0.429 0.314
10 3 4 12 0.200 0.429 0.314 
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(QS,QT) discussion for the IBP model 
This pathway was not recovered with either objective (6.26) or objective (6.27). 
However, as noted above, this pathway constitutes a cycle. When equations (6.28) and 
(6.29) related to cyclic pathways (as described in Chapter 6) were included in the IBP 
model, we achieved recovery for objective (6.26). The (QS,QT) discussion for objective 
(6.26) under this situation is shown below. As in the BP model, the only valid cases are 
those in the main diagonal. For this reason we neglected off-diagonal entries.  
Number of molecules QT of target compound 
(Ψ,W) 
1 2 3 4 5 6 
1 (8,0) - - - - - 
2 - (8,0) - - - - 
3 - - (8,0) - - - 
4 - - - (8,0) - - 
5 - - - - (8,0) - 
Number 
of 
molecules 
QS of 
source 
compound 6 - - - - - (8,0) 
The IBP model indicates that the pair (QS,QT)=(1,1) dominates all other cases. 
Hence in this case the IBP model recovers the (QS,QT)=(1,1) pair observed in the 
experimentally determined pathway. 
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Pathway 9: NAD biosynthesis 
Source compound L-Aspartate (asp-L) 
Target compound Nicotinamide adenine dinucleotide 
(nad) 
(QS,QT) (1,1) 
Low presence compounds that are not forced 
to be balanced 
Dihydroxyacetone phosphate (dhap) 
Oxygen (o2) 
Hydrogen peroxide (h2o2) 
5-Phospho-alpha-D-ribose 1-
diphosphate (prpp) 
(Number of reactions, excess ATP) (5,-2) 
Number of unbalanced main compounds (W) 2 
Specificity (Ψ) 5.6 
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Pathway description 
This pathway has been taken from EcoCyc (http://biocyc.org/ECOLI/NEW-
IMAGE?type=PATHWAY&object=PYRIDNUCSYN-PWY). 
In EcoCyc the pathway is described as being from L-Aspartate to NAD. The 
same set of reactions is found in our database, except that the last step can be carried out 
by two different reactions in EcoCyc. We only found one of these reactions in our 
reaction database.  
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(QS,QT) discussion for the BP model 
This pathway was recovered with objective (3.13). Thus, the (QS,QT) discussion 
is carried out for objective (3.13). The table of pairs for objective (3.13) is shown 
below. 
Number of molecules QT of target compound (number of reactions, 
excess ATP) 
1 2 3 4 5 6 
1 (5,-2)* (6,0) (6,0) (6,0) (6,0) (6,0) 
2 (6,0) (5,-4) (6,0) (6,0) (6,0) (6,0) 
3 (6,0) (6,0) (5,-6) (6,0) (6,0) (6,0) 
4 (6,0) (6,0) (6,0) (5,-8) (6,0) (6,0) 
5 (6,0) (6,0) (6,0) (6,0) (5,-10) (6,0) 
Number 
of 
molecules 
QS of 
source 
compound 6 (6,0) (6,0) (6,0) (6,0) (6,0) (5,-12) 
The pairs seen down the diagonal are all repeats of each other, doubling and then 
tripling, etc the number of source and target molecules (and excess ATP). The dominant 
pair is (QS,QT)=(1,1). Hence in this case the BP model recovers the (QS,QT)=(1,1) pair 
observed in the experimentally determined pathway.  
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Metabolic path for the R-R case: correspondence values 
 
 
k True False False Sensitivity Positive Accuracy
shortest 
path 
positives positives negatives  predictive 
value 
 
k (TP) (FP) (FN) (Sn) (PPV) (Ac) 
1 7 0 0 1 1 1 
2 7 8 0 1 0.467 0.733 
3 7 8 0 1 0.467 0.733 
4 7 6 0 1 0.538 0.769 
5 7 6 0 1 0.538 0.769 
6 7 6 0 1 0.538 0.769 
7 7 6 0 1 0.538 0.769 
8 7 10 0 1 0.412 0.706 
9 7 10 0 1 0.412 0.706 
10 7 12 0 1 0.368 0.684  
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Metabolic path for the C-C case: correspondence values 
 
 
k True False False Sensitivity Positive Accuracy
shortest 
path 
positives positives negatives  predictive 
value 
 
k (TP) (FP) (FN) (Sn) (PPV) (Ac) 
1 0 3 9 0 0 0
2 8 1 1 0.889 0.889 0.889
3 8 1 1 0.889 0.889 0.889
4 8 1 1 0.889 0.889 0.889
5 9 0 0 1 1 1
6 0 5 9 0 0 0
7 0 5 9 0 0 0
8 0 5 9 0 0 0
9 0 9 9 0 0 0
10 0 5 9 0 0 0 
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(QS,QT) discussion for the IBP model 
This pathway was recovered with objective (6.26). Thus, the (QS,QT) discussion 
is carried out for objective (6.26). The table of pairs for objective (6.26) is shown 
below. 
Number of molecules QT of target compound 
(Ψ,W) 
1 2 3 4 5 6 
1 (5.6,2)* (7.82,1) (8.67,1) (8.67,1) (8.67,1) (8.67,1) 
2 (6.17,3) (5.6,2) (7.67,1) (7.67,1) (7.67,1) (7.67,1) 
3 (7.58,1) (6.09,3) (5.6,2) (7.77,0) (7.67,1) (7.67,1) 
4 (7.58,1) (6.26,2) (6.09,3) (5.6,2) (7.67,1) (7.67,1) 
5 (7.58,1) (7.58,1) (6.09,3) (6.09,3) (5.6,2) (7.67,1) 
Number 
of 
molecules 
QS of 
source 
compound 6 (7.58,1) (7.58,1) (6.17,3) (6.09,3) (6.09,3) (5.6,2) 
For this pathway the IBP model indicates that the pair (QS,QT)=(1,1) dominates 
all other cases. Hence in this case the IBP model recovers the (QS,QT)=(1,1) pair 
observed in the experimentally determined pathway. 
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Pathway 10: Arginine biosynthesis 
Source compound L-Glutamate (glu-L) 
Target compound L-Arginine (arg-L) 
(QS,QT) (2,1) 
Low presence compounds that are not forced to be 
balanced 
2-Oxoglutarate (akg) 
L-Aspartate (asp-L) 
Fumarate (fum) 
Acetate (ac) 
Acetyl-CoA (accoa) 
Carbamoyl phosphate 
(cbp) 
(Number of reactions, excess ATP) (8,-2) 
Number of unbalanced main compounds (W) 4 
Specificity (Ψ) 8.33 
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Pathway description 
This pathway has been taken from EcoCyc (http://biocyc.org/ECOLI/NEW-
IMAGE?type=PATHWAY&object=ARGSYN-PWY) and Lehninger (fourth edition) 
pages 842 and 843. 
In Lehninger the pathway is described as being from two molecules of L-
Glutamate to one molecule of L-Arginine. This pathway is described in the same way in 
EcoCyc with the same set of reactions, except that EcoCyc includes one additional 
reaction to produce carbamoyl phosphate (cbp).  
Since the Lehninger description appears to be the clearer one it is that which has 
informed the pathway picture seen below. 
Note that although 2-Oxoglutarate (akg) is shown below as having a percentage 
presence of 4.0 (which implies that it is a high presence compound) this is the result of 
rounding. The actual percentage presence value for this compound is 3.98% and so it is 
classed as a low presence compound. 
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(QS,QT) discussion for the BP model 
This pathway was recovered with objective (3.13). Thus, the (QS,QT) discussion 
is carried out for objective (3.13). The table of pairs for objective (3.13) is shown 
below. 
Number of molecules QT of target compound (number of reactions, 
excess ATP) 
1 2 3 4 5 6 
1 X X X X X X 
2 (8,-2)* X X X X X 
3 (11,-2) X X X X X 
4 (12,-4) (8,-4) X X X X 
5 (12,-5) (11,-6) X X X X 
Number 
of 
molecules 
QS of 
source 
compound 6 (12,-6) (11,-4) (8,-6) X X X 
The dominant pair is (QS,QT)=(2,1). Hence in this case the BP model recovers 
the (QS,QT)=(2,1) pair observed in the experimentally determined pathway.  
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Metabolic path for the R-R case: correspondence values 
For this pathway we have the source compound being involved in two reactions, 
R155 and R158b. Hence for the R-R case below we have two metabolic paths, one from 
R155 to R162a, the other from R158b to R162a. 
 
 
k True False False Sensitivity Positive Accuracy
shortest 
path 
positives positives negatives  predictive 
value 
 
k (TP) (FP) (FN) (Sn) (PPV) (Ac) 
1 7 0 0 1 1 1 
2 5 18 2 0.714 0.217 0.466 
3 7 10 0 1 0.412 0.706 
4 5 16 2 0.714 0.238 0.476 
5 5 20 2 0.714 0.200 0.457 
6 5 16 2 0.714 0.238 0.476 
7 5 16 2 0.714 0.238 0.476 
8 2 9 5 0.286 0.182 0.234 
9 7 12 0 1 0.368 0.684 
10 5 20 2 0.714 0.200 0.457  
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Metabolic path for the R-R case: correspondence values 
 
 
k True False False Sensitivity Positive Accuracy
shortest 
path 
positives positives negatives  predictive 
value 
 
k (TP) (FP) (FN) (Sn) (PPV) (Ac) 
1 13 0 0 1 1 1 
2 4 7 9 0.308 0.364 0.336 
3 7 16 6 0.538 0.304 0.421 
4 11 18 2 0.846 0.379 0.613 
5 13 10 0 1 0.565 0.783 
6 13 6 0 1 0.684 0.842 
7 11 20 2 0.846 0.355 0.600 
8 11 16 2 0.846 0.407 0.627 
9 11 16 2 0.846 0.407 0.627 
10 11 16 2 0.846 0.407 0.627  
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Metabolic path for the C-C case: correspondence values 
 
 
k True False False Sensitivity Positive Accuracy
shortest 
path 
positives positives negatives  predictive 
value 
 
k (TP) (FP) (FN) (Sn) (PPV) (Ac) 
1 9 0 0 1 1 1
2 3 2 6 0.333 0.600 0.467
3 5 4 4 0.556 0.556 0.556
4 9 6 0 1 0.600 0.800
5 3 6 6 0.333 0.333 0.333
6 3 8 6 0.333 0.273 0.303
7 3 10 6 0.333 0.231 0.282
8 5 4 4 0.556 0.556 0.556
9 5 12 4 0.556 0.294 0.425
10 3 10 6 0.333 0.231 0.282 
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(QS,QT) discussion for the IBP model 
This pathway was recovered with objective (6.26). Thus, the (QS,QT) discussion 
is carried out for objective (6.26). The table of pairs for objective (6.26) is shown 
below. 
Number of molecules QT of target compound 
(Ψ,W) 
1 2 3 4 5 6 
1 (7.17,3)* (11.59,3) (11.59,3) (11.59,3) (11.59,3) (11.59,3) 
2 (8.33,4) (7.17,3) (11.06,4) (11.16,3) (11.06,4) (11.06,4) 
3 (7.75,4) (9.38,3) (7.17,3) (11.06,4) (11.06,4) (11.06,4) 
4 (9.38,3) (8.33,4) (9.38,3) (7.17,3) (11.06,4) (11.16,3) 
5 (9.38,3) (9.38,3) (9.38,3) (9.38,3) (7.17,3) (11.06,4) 
Number 
of 
molecules 
QS of 
source 
compound 6 (9.38,3) (7.75,4) (8.33,4) (9.38,3) (9.38,3) (7.17,3) 
For this pathway the IBP model indicates that the pair (QS,QT)=(1,1) dominates 
all other cases. This is indicated by the * superscript. Hence in this case the IBP model 
does not recover the (QS,QT)=(2,1) pair observed in the experimentally determined 
pathway. 
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Pathway 11: Sperdimine biosynthesis 
Source compound Ornithine (orn) 
Target compound Spermidine (spmd) 
(QS,QT) (1,1) 
Low presence compounds that are not forced to 
be balanced 
5-Methylthioadenosine (5mta) 
S-Adenosylmethioninamine 
(ametam) 
(Number of reactions, excess ATP) (2,0) 
Number of unbalanced main compounds (W) 2 
Specificity (Ψ) 2.89 
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Pathway description 
This pathway has been taken from EcoCyc (http://biocyc.org/ECOLI/NEW-
IMAGE?type=PATHWAY&object=BSUBPOLYAMSYN-PWY) and Lehninger 
(fourth edition) pages 860 and 861. 
In Lehninger the pathway is described as being from one molecule of Ornithine 
to one molecule of Spermidine. On the other hand, EcoCyc presents two different 
alternative pathways to synthesise sperdimine, one of them being identical to Lehninger. 
It is that which has informed the pathway picture seen below. 
 
Note here that we have one allowable c-cycle (see Chapter 3) in this pathway. 
More precisely the 2-cycle ptrc-R184-h-R182-ptrc which contains one high presence 
balanced compound (h). 
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(QS,QT) discussion for the BP model 
This pathway was recovered with both objective (3.13) and objective (3.14). 
Thus, the (QS,QT) discussion is carried out for objective (3.13) and objective (3.14). The 
table of pairs for objective (3.13) is shown below.  
Number of molecules QT of target compound (number of 
reactions, excess 
ATP) 1 2 3 4 5 6 
1 (2,0)* X X X X X 
2 (11,-3) (2,0) X X X X 
3 (11,-6) (11,-3) (2,0) X X X 
4 (11,-9) (11,-6) (11,-3) (2,0) X X 
5 (11,-12) (11,-9) (11,-6) (11,-3) (2,0) X 
Number 
of 
molecules 
QS of 
source 
compound 6 (11,-15) (11,-12) (11,-9) (11,-6) (11,-3) (2,0) 
The pairs seen down the diagonal are all repeats of each other, doubling and then 
tripling, etc the number of source and target molecules. The dominant pair is 
(QS,QT)=(1,1). Hence in this case the BP model recovers the (QS,QT)=(1,1) pair 
observed in the experimentally determined pathway.  
The results for objective (3.14) are shown below. 
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Number of molecules QT of target compound (number of reactions, 
excess ATP) 
1 2 3 4 5 6 
1 (2,0)* X X X X X 
2 (12,0) (2,0) X X X X 
3 (12,0) (12,0) (2,0) X X X 
4 (12,0) (12,0) (12,0) (2,0) X X 
5 (12,0) (12,0) (12,0) (12,0) (2,0) X 
Number 
of 
molecules 
QS of 
source 
compound 6 (12,0) (12,0) (12,0) (12,0) (12,0) (2,0) 
The pairs seen down the diagonal are all repeats of each other, doubling and then 
tripling, etc the number of source and target molecules. The dominant pair is 
(QS,QT)=(1,1). Hence in this case the BP model recovers the (QS,QT)=(1,1) pair 
observed in the experimentally determined pathway. 
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(QS,QT) discussion for the IBP model 
This pathway was recovered with both objective (6.26) and objective (6.27). 
Thus, the (QS,QT) discussion is carried out for objective (6.26) and objective (6.27). The 
table of pairs for objective (6.26) is shown below. 
Number of molecules QT of target compound 
(Ψ,W) 
1 2 3 4 5 6 
1 (2.89,2)* (12.22,6) (13.63,10) (13.89,9) (14.72,9) (14.72,9) 
2 (8.43,6) (2.89,2) (13.1,10) (12.22,6) (13.1,10) (13.73,9) 
3 (10.83,4) (7.55,5) (2.89,2) (12.03,7) (13.1,10) (12.22,6) 
4 (10.43,8) (8.43,6) (10.43,8) (2.89,2) (12.03,7) (12.03,7) 
5 (10.43,8) (10.53,7) (10.43,8) (10.43,8) (2.89,2) (12.03,7) 
Number 
of 
molecules 
QS of 
source 
compound 6 (10.43,8) (10.83,4) (8.43,6) (7.55,5) (10.43,8) (2.89,2) 
For this pathway the IBP model indicates that the pair (QS,QT)=(1,1) dominates 
all other cases. Hence in this case the IBP model recovers the (QS,QT)=(1,1) pair 
observed in the experimentally determined pathway. 
The results for objective (6.27) are shown below. 
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Number of molecules QT of target compound 
(L,W) 
1 2 3 4 5 6 
1 (2,2)* (9,6) (13,6) (13,9) (14,7) (15,7) 
2 (12,8) (2,2) X (9,6) (14,8) (14,6) 
3 (12,5) (10,5) (2,2) (13,5) X (9,6) 
4 (11,5) (12,5) (12,5) (2,2) (13,6) (13,5) 
5 (12,6) (12,5) (12,5) (12,5) (2,2) (13,5) 
Number 
of 
molecules 
QS of 
source 
compound 6 (12,6) (12,5) (12,3) (10,5) (12,6) (2,2) 
We obtain the same dominant pair as objective (6.26). Hence for this objective 
the IBP model recovers the (QS,QT)=(1,1) pair observed in the experimentally 
determined pathway. 
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 Pathway 12: Threonine degradation to synthesise glycine 
Source compound L-Threonine (thr-L) 
Target compound Glycine (gly) 
(QS,QT) (1,1) 
Low presence compounds that are not forced to be balanced Acetyl-Coa (accoa) 
(Number of reactions, excess ATP) (2,0) 
Number of unbalanced main compounds (W) 0 
Specificity (Ψ) 2 
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Pathway description 
This pathway has been taken from EcoCyc (http://biocyc.org/ECOLI/NEW-
IMAGE?type=PATHWAY&object=THREOCAT-PWY) and Lehninger (fourth 
edition) pages 675, 677 and 682. 
In Lehninger the pathway is described as being from one molecule of L-
Threonine to one molecule of Glycine. On the other hand, EcoCyc presents seven 
different alternative pathways to degrade L-Threonine, one of them being identical to 
Lehninger. It is that which has informed the pathway picture seen below. 
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(QS,QT) discussion for the BP model 
This pathway was recovered with both objective (3.13) and objective (3.14). 
Thus, the (QS,QT) discussion is carried out for objective (3.13) and objective (3.14). The 
table of pairs for objective (3.13) is shown below. 
Number of molecules QT of target compound (number of reactions, 
excess ATP) 
1 2 3 4 5 6 
1 (2,0)* X X X X X 
2 X (2,0) X X X X 
3 X X (2,0) X X X 
4 X X X (2,0) X X 
5 X X X X (2,0) X 
Number 
of 
molecules 
QS of 
source 
compound 6 X X X X X (2,0) 
The pairs seen down the diagonal are all repeats of each other, doubling and then 
tripling, etc the number of source and target molecules. The dominant pair is 
(QS,QT)=(1,1). Hence in this case the BP model recovers the (QS,QT)=(1,1) pair 
observed in the experimentally determined pathway.  
The results for objective (3.14) are shown below. 
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Number of molecules QT of target compound (number of reactions, 
excess ATP) 
1 2 3 4 5 6 
1 (2,0)* X X X X X 
2 X (2,0) X X X X 
3 X X (2,0) X X X 
4 X X X (2,0) X X 
5 X X X X (2,0) X 
Number 
of 
molecules 
QS of 
source 
compound 6 X X X X X (2,0) 
The pairs seen down the diagonal are all repeats of each other, doubling and then 
tripling, etc the number of source and target molecules. The dominant pair is 
(QS,QT)=(1,1). Hence in this case the BP model recovers the (QS,QT)=(1,1) pair 
observed in the experimentally determined pathway.  
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(QS,QT) discussion for the IBP model 
This pathway was recovered with both objective (6.26) and objective (6.27). 
Thus, the (QS,QT) discussion is carried out for objective (6.26) and objective (6.27). The 
table of pairs for objective (6.26) is shown below. 
Number of molecules QT of target compound 
(Ψ,W) 
1 2 3 4 5 6 
1 (2,0)* (8.81,4) (8.81,4) (8.81,4) (8.81,4) (8.81,4) 
2 (8.81,4) (2,0) (6.17,4) (6.17,4) (6.17,4) (6.17,4) 
3 (8.81,4) (6.17,4) (2,0) (6.17,4) (6.17,4) (6.17,4) 
4 (8.81,4) (6.17,4) (6.17,4) (2,0) (6.17,4) (6.17,4) 
5 (8.81,4) (6.17,4) (6.17,4) (6.17,4) (2,0) (6.17,4) 
Number 
of 
molecules 
QS of 
source 
compound 6 (8.81,4) (6.17,4) (6.17,4) (6.17,4) (6.17,4) (2,0) 
For this pathway the IBP model indicates that the pair (QS,QT)=(1,1) dominates 
all other cases. Hence in this case the IBP model recovers the (QS,QT)=(1,1) pair 
observed in the experimentally determined pathway. 
The results for objective (6.27) are shown below. 
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Number of molecules QT of target compound 
(L,W) 
1 2 3 4 5 6 
1 (2,0)* (8,4) (8,4) (8,4) (8,4) (8,4) 
2 (8,4) (2,0) (8,4) (8,4) (8,4) (8,4) 
3 (8,4) (8,4) (2,0) (8,4) (8,4) (8,4) 
4 (8,4) (8,4) (8,4) (2,0) (8,4) (8,4) 
5 (8,4) (8,4) (8,4) (8,4) (2,0) (8,4) 
Number 
of 
molecules 
QS of 
source 
compound 6 (8,4) (8,4) (8,4) (8,4) (8,4) (2,0) 
We obtain the same dominant pair as objective (6.26). Hence for this objective 
the IBP model recovers the (QS,QT)=(1,1) pair observed in the experimentally 
determined pathway. 
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 Pathway 13: Serine biosynthesis 
Source compound 3-Phospho-D-glycerate 
(3pg) 
Target compound L-Serine (ser-L) 
(QS,QT) (1,1) 
Low presence compounds that are not forced to be 
balanced 
2-Oxoglutarate (akg) 
(Number of reactions, excess ATP) (3,0) 
Number of unbalanced main compounds (W) 0 
Specificity (Ψ) 3 
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Pathway description 
This pathway has been taken from EcoCyc (http://biocyc.org/ECOLI/NEW-
IMAGE?type=PATHWAY&object=SERSYN-PWY) and Lehninger (fourth edition) 
page 844. 
Both in EcoCyc and Lehninger the pathway is described as being from one 
molecule of 3-Phospho-D-glycerate to one molecule of L-serine. The set of reactions is 
also the same in both EcoCyc and Lehninger. 
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(QS,QT) discussion for the BP model 
This pathway was recovered with both objective (3.13) and objective (3.14). 
Thus, the (QS,QT) discussion is carried out for objective (3.13) and objective (3.14). The 
table of pairs for objective (3.13) is shown below. 
Number of molecules QT of target compound (number of reactions, 
excess ATP) 
1 2 3 4 5 6 
1 (3,0)* X X X X X 
2 (8,0) (3,0) X X X X 
3 (8,0) (8,0) (3,0) X X X 
4 (8,0) (8,0) (8,0) (3,0) X X 
5 (8,0) (8,0) (8,0) (8,0) (3,0) X 
Number 
of 
molecules 
QS of 
source 
compound 6 (8,0) (8,0) (8,0) (8,0) (8,0) (3,0) 
The pairs seen down the diagonal are all repeats of each other, doubling and then 
tripling, etc the number of source and target molecules. The dominant pair is 
(QS,QT)=(1,1). Hence in this case the BP model recovers the (QS,QT)=(1,1) pair 
observed in the experimentally determined pathway. 
The results for objective (3.14) are shown below.  
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Number of molecules QT of target compound (number of reactions, 
excess ATP) 
1 2 3 4 5 6 
1 (3,0) X X X X X 
2 (8,0) (3,0) X X X X 
3 (13,1)* (8,0) (3,0) X X X 
4 (8,0) (8,0) (8,0) (3,0) X X 
5 (17,1) (8,0) (8,0) (8,0) (3,0) X 
Number 
of 
molecules 
QS of 
source 
compound 6 (8,0) (13,2) (8,0) (8,0) (8,0) (3,0) 
The pairs seen down the diagonal are all repeats of each other, doubling and then 
tripling, etc the number of source and target molecules. The dominant pair is 
(QS,QT)=(3,1). Hence in this case the BP model does not recover the (QS,QT)=(1,1) pair 
observed in the experimentally determined pathway. 
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(QS,QT) discussion for the IBP model 
This pathway was recovered with both objective (6.26) and objective (6.27). 
Thus, the (QS,QT) discussion is carried out for objective (6.26) and objective (6.27). The 
table of pairs for objective (6.26) is shown below. 
Number of molecules QT of target compound 
(Ψ,W) 
1 2 3 4 5 6 
1 (3,0)* X X X X X 
2 X (3,0) X X X X 
3 X X (3,0) X X X 
4 X X X (3,0) X X 
5 X X X X (3,0) X 
Number 
of 
molecules 
QS of 
source 
compound 6 X X X X X (3,0) 
For this pathway the IBP model indicates that the pair (QS,QT)=(1,1) dominates 
all other cases. Hence in this case the IBP model recovers the (QS,QT)=(1,1) pair 
observed in the experimentally determined pathway. 
The results for objective (6.27) are shown below. 
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Number of molecules QT of target compound 
(L,W) 
1 2 3 4 5 6 
1 (3,0)* X X X X X 
2 X (3,0) X X X X 
3 X X (3,0) X X X 
4 X X X (3,0) X X 
5 X X X X (3,0) X 
Number 
of 
molecules 
QS of 
source 
compound 6 X X X X X (3,0) 
We obtain the same dominant pair as objective (6.26). Hence for this objective 
the IBP model recovers the (QS,QT)=(1,1) pair observed in the experimentally 
determined pathway. 
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 Pathway 14: Histidine biosynthesis  
Source compound 5-Phospho-alpha-D-ribose 1-diphosphate 
(prpp) 
Target compound L-Histidine (his-L) 
(QS,QT) (1,1) 
Low presence compounds that are not 
forced to be balanced 
2-Oxoglutarate (akg) 
5-Amino-1-(5-Phospho-D-ribosyl)imidazole-
4-carboxamide (aicar) 
L-Glutamine (gln-L) 
(Number of reactions, excess ATP) (9,-1) 
Number of unbalanced main 
compounds (W) 
2 
Specificity (Ψ) 9 
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Pathway description 
This pathway has been taken from EcoCyc (http://biocyc.org/ECOLI/NEW-
IMAGE?type=PATHWAY&object=HISTSYN-PWY) and Lehninger (fourth edition) 
page 852. 
Both in EcoCyc and Lehninger the pathway is described as being from one 
molecule of 5-Phospho-alpha-D-ribose 1-diphosphate to one molecule of L-histidine. 
The set of reactions is also the same in both EcoCyc and Lehninger.  
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(QS,QT) discussion for the BP model 
This pathway was recovered with objective (3.13). Thus, the (QS,QT) discussion 
is carried out for objective (3.13). The table of pairs for objective (3.13) is shown 
below. 
Number of molecules QT of target compound (number of reactions, 
excess ATP) 
1 2 3 4 5 6 
1 (9,-1)* X X X X X 
2 X (9,-2) X X X X 
3 X X (9,-3) X X X 
4 X X X (9,-4) X X 
5 X X X X (9,-5) X 
Number 
of 
molecules 
QS of 
source 
compound 6 X X X X X (9,-6) 
The pairs seen down the diagonal are all repeats of each other, doubling and then 
tripling, etc the number of source and target molecules (and ATP excess). The dominant 
pair is (QS,QT)=(1,1). Hence in this case the BP model recovers the (QS,QT)=(1,1) pair 
observed in the experimentally determined pathway.  
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(QS,QT) discussion for the IBP model 
This pathway was recovered with both objective (6.26) and objective (6.27). 
Thus, the (QS,QT) discussion is carried out for objective (6.26) and objective (6.27). The 
table of pairs for objective (6.26) is shown below. 
Number of molecules QT of target compound 
(Ψ,W) 
1 2 3 4 5 6 
1 (9,2)* (17.5,7) (17.6,6) (17.5,7) (17.5,7) (17.6,6) 
2 (13.25,6) (9,2) (17.5,7) (17.5,7) (17.5,7) (17.5,7) 
3 (13.25,6) (13.25,6) (9,2) (17.5,7) (17.6,6) (17.5,7) 
4 (13.25,6) (13.25,6) (13.25,6) (9,2) (17.5,7) (17.5,7) 
5 (13.25,6) (13.25,6) (13.25,6) (13.35,5) (9,2) (17.5,7) 
Number 
of 
molecules 
QS of 
source 
compound 6 (13.25,6) (13.25,6) (13.25,6) (13.25,6) (13.25,6) (9,2) 
For this pathway the IBP model indicates that the pair (QS,QT)=(1,1) dominates 
all other cases. Hence in this case the IBP model recovers the (QS,QT)=(1,1) pair 
observed in the experimentally determined pathway. 
The results for objective (6.27) are shown below. 
Metabolic pathway analysis via integer linear programming 
Francisco J. Planes                 May 2008 151
 
Number of molecules QT of target compound 
(L,W) 
1 2 3 4 5 6 
1 (9,2)* (11,3) (11,3) (11,3) (11,3) (11,3) 
2 (11,3) (9,2) (11,3) (11,3) (11,3) (11,3) 
3 (11,3) (11,3) (9,2) (11,3) (11,3) (11,3) 
4 (11,3) (11,3) (11,3) (9,2) (11,3) (11,3) 
5 (11,3) (11,3) (11,3) (11,3) (9,2) (11,3) 
Number 
of 
molecules 
QS of 
source 
compound 6 (11,3) (11,3) (11,3) (11,3) (11,3) (9,2) 
We obtain the same dominant pair as objective (6.26). Hence for this objective 
the IBP model recovers the (QS,QT)=(1,1) pair observed in the experimentally 
determined pathway. 
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 Pathway 15: Tirosine biosynthesis 
Source compound Chorismate (chor) 
Target compound L-Tyrosine (tyr-L) 
(QS,QT) (1,1) 
Low presence compounds that are not forced to be balanced 2-Oxoglutarate (akg) 
(Number of reactions, excess ATP) (3,0) 
Number of unbalanced main compounds (W) 0 
Specificity (Ψ) 3 
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Pathway description 
This pathway has been taken from EcoCyc (http://biocyc.org/ECOLI/NEW-
IMAGE?type=PATHWAY&object=TYRSYN) and Lehninger (fourth edition) page 
851. 
Both in EcoCyc and Lehninger the pathway is described as being from one 
molecule of chorismate to one molecule of L-Tyrosine. The set of reactions is also the 
same in both EcoCyc and Lehninger. 
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(QS,QT) discussion for the BP model 
This pathway was recovered with both objective (3.13) and objective (3.14). 
Thus, the (QS,QT) discussion is carried out for objective (3.13) and objective (3.14). The 
table of pairs for objective (3.13) is shown below. 
Number of molecules QT of target compound (number of reactions, 
excess ATP) 
1 2 3 4 5 6 
1 (3,0)* X X X X X 
2 X (3,0) X X X X 
3 X X (3,0) X X X 
4 X X X (3,0) X X 
5 X X X X (3,0) X 
Number 
of 
molecules 
QS of 
source 
compound 6 X X X X X (3,0) 
The pairs seen down the diagonal are all repeats of each other, doubling and then 
tripling, etc the number of source and target molecules. The dominant pair is 
(QS,QT)=(1,1). Hence in this case the BP model recovers the (QS,QT)=(1,1) pair 
observed in the experimentally determined pathway.  
The results for objective (3.14) are presented below. 
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Number of molecules QT of target compound (number of reactions, 
excess ATP) 
1 2 3 4 5 6 
1 (3,0)* X X X X X 
2 X (3,0) X X X X 
3 X X (3,0) X X X 
4 X X X (3,0) X X 
5 X X X X (3,0) X 
Number 
of 
molecules 
QS of 
source 
compound 6 X X X X X (3,0) 
The pairs seen down the diagonal are all repeats of each other, doubling and then 
tripling, etc the number of source and target molecules. The dominant pair is 
(QS,QT)=(1,1). Hence in this case the BP model recovers the (QS,QT)=(1,1) pair 
observed in the experimentally determined pathway.  
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(QS,QT) discussion for the IBP model 
This pathway was recovered with both objective (6.26) and objective (6.27). 
Thus, the (QS,QT) discussion is carried out for objective (6.26) and objective (6.27). The 
table of pairs for objective (6.26) is shown below. 
Number of molecules QT of target compound 
(Ψ,W) 
1 2 3 4 5 6 
1 (3,0)* X X X X X 
2 X (3,0) X X X X 
3 X X (3,0) X X X 
4 X X (12.44,4) (3,0) X X 
5 (15.03,5) (12.55,3) X (12.44,4) (3,0) X 
Number 
of 
molecules 
QS of 
source 
compound 6 X (12.55,3) (17.64,10) (12.44,4) (12.49,3) (3,0) 
For this pathway the IBP model indicates that the pair (QS,QT)=(1,1) dominates 
all other cases. Hence in this case the IBP model recovers the (QS,QT)=(1,1) pair 
observed in the experimentally determined pathway. 
The results for objective (6.27) are shown below. 
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Number of molecules QT of target compound 
(L,W) 
1 2 3 4 5 6 
1 (3,0)* X X X X X 
2 X (3,0) X X X X 
3 X X (3,0) X X X 
4 X X (17,2) (3,0) X X 
5 (15,3) (18,2) (17,2) (17,2) (3,0) X 
Number 
of 
molecules 
QS of 
source 
compound 6 X (15,3) (16,3) (17,2) (15,3) (3,0) 
We obtain the same dominant pair as objective (6.26). Hence for this objective 
the IBP model recovers the (QS,QT)=(1,1) pair observed in the experimentally 
determined pathway. 
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 Pathway 16: Coenzyme A biosynthesis  
Source compound (R)-Pantothenate (pnto-R)
Target compound Coenzyme A (coa) 
(QS,QT) (1,1) 
Low presence compounds that are not forced to be 
balanced 
CTP (ctp) 
CMP (cmp) 
L-Cysteine (cys-L) 
(Number of reactions, excess ATP) (5,-3) 
Number of unbalanced main compounds (W) 3 
Specificity (Ψ) 5 
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Pathway description 
This pathway has been taken from EcoCyc (http://biocyc.org/ECOLI/NEW-
IMAGE?type=PATHWAY&object=ARGSYN-PWY). 
In EcoCyc the pathway is described as being from one molecule of (R)-
Pantothenate to one molecule of Coenzyme A. The same set of reactions is present in 
our reaction database. 
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(QS,QT) discussion for the BP model 
This pathway was recovered with objective (3.13). Thus, the (QS,QT) discussion 
is carried out for objective (3.13). The table of pairs for objective (3.13) is shown 
below. 
Number of molecules QT of target compound (number of reactions, 
excess ATP) 1 2 3 4 5 6 
1 (5,-3)* X X X X X 
2 X (5,-6) X X X X 
3 X X (5,-9) X X X 
4 X X X (5,-12) X X 
5 X X X X (5,-15) X 
Number 
of 
molecules 
QS of 
source 
compound 6 X X X X X (5,-18) 
The pairs seen down the diagonal are all repeats of each other, doubling and then 
tripling, etc the number of source and target molecules (and excess ATP). The dominant 
pair is (QS,QT)=(1,1). Hence in this case the BP model recovers the (QS,QT)=(1,1) pair 
observed in the experimentally determined pathway.  
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(QS,QT) discussion for the IBP model 
This pathway was recovered with both objective (6.26) and objective (6.27). 
Thus, the (QS,QT) discussion is carried out for objective (6.26) and objective (6.27). The 
table of pairs for objective (6.26) is shown below. 
Number of molecules QT of target compound 
(Ψ,W) 
1 2 3 4 5 6 
1 (5,3)* (15.16,5) (24.17,16) X X (9.04,4) 
2 (18.39,7) (5,3) X X (9.06,4) (9.53,4) 
3 (18.39,7) (18.39,7) (5,3) X (10.46,4) X 
4 (18.39,7) (18.39,7) (18.29,8) (5,3) (8.96,6) (20.39,11) 
5 (18.29,8) (18.29,8) (18.39,7) (18.29,8) (5,3) X 
Number 
of 
molecules 
QS of 
source 
compound 6 (18.39,7) (18.39,7) (18.39,7) (18.29,8) (18.39,7) (5,3) 
For this pathway the IBP model indicates that the pair (QS,QT)=(1,1) dominates 
all other cases. Hence in this case the IBP model recovers the (QS,QT)=(1,1) pair 
observed in the experimentally determined pathway. 
The results for objective (6.27) are shown below. 
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Number of molecules QT of target compound 
(L,W) 
1 2 3 4 5 6 
1 (5,3)* (8,7) (8,7) (8,7) (8,7) (8,7) 
2 (8,7) (5,3) (8,7) (8,7) (8,7) (8,7) 
3 (8,7) (8,7) (5,3) (8,7) (8,7) (8,7) 
4 (8,7) (8,7) (8,7) (5,3) (8,7) (8,7) 
5 (8,7) (8,7) (8,7) (8,7) (5,3) (8,7) 
Number 
of 
molecules 
QS of 
source 
compound 6 (8,7) (8,7) (8,7) (8,7) (8,7) (5,3) 
We obtain the same dominant pair as objective (6.26). Hence for this objective 
the IBP model recovers the (QS,QT)=(1,1) pair observed in the experimentally 
determined pathway. 
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 Pathway 17: Pantothenate biosynthesis 
Source compound L-Valine (val-L) 
Target compound (R)-Pantothenate (pnto-R) 
(QS,QT) (1,1) 
Low presence compounds that are not forced to be 
balanced 
2-Oxoglutarate (akg) 
5,6,7,8-Tetrahydrofolate (thf) 
5,10Methylenetetrahydrofolate 
(mlthf) 
beta-Alanine (ala-B) 
(Number of reactions, excess ATP) (4,-1) 
Number of unbalanced main compounds (W) 3 
Specificity (Ψ) 4 
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Pathway description 
This pathway has been taken from EcoCyc (http://biocyc.org/ECOLI/NEW-
IMAGE?type=PATHWAY&object=PANTO-PWY). 
In EcoCyc the pathway is described as being from one molecule of L-Valine to 
one molecule of (R)-Pantothenate. The same set of reactions is present in our reaction 
database. 
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Note here that we have one allowable c-cycle in this pathway. More precisely 
the 2-cycle (pant-R)-R372-h-R374-(pant-R) which contains one high presence balanced 
compound (h). 
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(QS,QT) discussion for the BP model 
This pathway was recovered with objective (3.13). Thus, the (QS,QT) discussion 
is carried out for objective (3.13). The table of pairs for objective (3.13) is shown 
below. 
Number of molecules QT of target compound (number of reactions, 
excess ATP) 
1 2 3 4 5 6 
1 (4,-1)* (7,-2) (7,-3) (7,-4) (7,-5) (7,-6) 
2 X (4,-2) (7,-3) (7,-4) (7,-5) (7,-6) 
3 X X (4,-3) (7,-4) (7,-5) (7,-6) 
4 X X X (4,-4) (7,-5) (7,-6) 
5 X X X X (4,-5) (7,-6) 
Number 
of 
molecules 
QS of 
source 
compound 6 X X X X X (4,-6) 
The pairs seen down the diagonal are all repeats of each other, doubling and then 
tripling, etc the number of source and target molecules (and excess ATP). The dominant 
pair is (QS,QT)=(1,1). Hence in this case the BP model recovers the (QS,QT)=(1,1) pair 
observed in the experimentally determined pathway.  
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(QS,QT) discussion for the IBP model 
This pathway was recovered with both objective (6.26) and objective (6.27). 
Thus, the (QS,QT) discussion is carried out for objective (6.26) and objective (6.27). The 
table of pairs for objective (6.26) is shown below. 
Number of molecules QT of target compound 
(Ψ,W) 
1 2 3 4 5 6 
1 (4,3)* (17.37,11) (16.3,10) X X X 
2 (16.25,10) (4,3) X X (16.3,10) (17.17,10)
3 (16.28,13) (16.21,11) (4,3) X X X 
4 (16.52,13) (16.25,10) (16.42,9) (4,3) X (18.19,10)
5 (16.52,13) (16.52,13) (16.42,9) (16.52,8) (4,3) X 
Number 
of 
molecules 
QS of 
source 
compound 6 (16.62,12) (17.17,10) (16.25,10) X (16.52,8) (4,3) 
For this pathway the IBP model indicates that the pair (QS,QT)=(1,1) dominates 
all other cases. Hence in this case the IBP model recovers the (QS,QT)=(1,1) pair 
observed in the experimentally determined pathway. 
The results for objective (6.27) are shown below. 
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Number of molecules QT of target compound 
(L,W) 
1 2 3 4 5 6 
1 (4,3)* (15,8) (15,8) (15,8) (15,8) (15,8) 
2 (14,1) (4,3) (12,1) (12,1) X X 
3 (24,6) (14,1) (4,3) (12,1) X X 
4 (14,1) (14,1) (14,1) (4,3) (13,1) X 
5 X (14,1) X (14,1) (4,3) (13,1) 
Number 
of 
molecules 
QS of 
source 
compound 6 (14,1) X X (15,1) (14,1) (4,3) 
We obtain the same dominant pair as objective (6.26). Hence for this objective 
the IBP model recovers the (QS,QT)=(1,1) pair observed in the experimentally 
determined pathway. 
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 Pathway 18: Tetrahydrofolate biosynthesis 
Source compound GTP (gtp) 
Target compound 5,6,7,8-Tetrahydrofolate 
(thf) 
(QS,QT) (1,1) 
Low presence compounds that are not forced to be 
balanced 
4-Aminobenzoate (4abz) 
Formate (for) 
Glycolaldehyde (gcald) 
(Number of reactions, excess ATP) (8,-2) 
Number of unbalanced main compounds (W) 3 
Specificity (Ψ) 8 
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Pathway description 
This pathway has been taken from EcoCyc (http://biocyc.org/ECOLI/NEW-
IMAGE?type=PATHWAY&object=FOLSYN-PWY) and Lehninger (fourth edition) 
pages 672 and 673. 
In EcoCyc the pathway is described as being from one molecule of GTP to one 
molecule of 5,6,7,8-Tetrahydrofolate. The same set of reactions is present in our 
reaction database. Precursors of this pathway are explained in Lehninger. 
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(QS,QT) discussion for the BP model 
This pathway was recovered with objective (3.13). Thus, the (QS,QT) discussion 
is carried out for objective (3.13). The table of pairs for objective (3.13) is shown 
below. 
Number of molecules QT of target compound  
1 2 3 4 5 6 
1 (8,-2)* X X X X X 
2 X (8,-4) X X X X 
3 X X (8,-6) X X X 
4 X X X (8,-8) X X 
5 X X X X (8,-10) X 
Number 
of 
molecules 
QS of 
source 
compound 6 X X X X X (8,-12) 
The pairs seen down the diagonal are all repeats of each other, doubling and then 
tripling, etc the number of source and target molecules (and excess ATP). The dominant 
pair is (QS,QT)=(1,1). Hence in this case the BP model recovers the (QS,QT)=(1,1) pair 
observed in the experimentally determined pathway.  
Metabolic pathway analysis via integer linear programming 
Francisco J. Planes                 May 2008 173
(QS,QT) discussion for the IBP model 
This pathway was not recovered with either objective (6.26) or objective (6.27). 
For this reason (QS,QT) pairs discussion is omitted for this pathway. 
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Pathway 19: Riboflavin and FMN and FAD biosynthesis 
Source compound GTP (gtp) 
Target compound FAD (fad) 
(QS,QT) (1,1) 
Low presence compounds that are not forced to 
be balanced 
3,4-dihydroxy-2-butanone 4-
phosphate (db4p) 
Formate (for) 
(Number of reactions, excess ATP) (8,-2) 
Number of unbalanced main compounds (W) 2 
Specificity (Ψ) 8.23 
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Pathway description 
This pathway has been taken from EcoCyc (http://biocyc.org/ECOLI/NEW-
IMAGE?type=PATHWAY&object=RIBOSYN2-PWY). 
In EcoCyc the pathway is described as being from one molecule of GTP to one 
molecule of FAD. The same set of reactions is present in our reaction database.  
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(QS,QT) discussion for the BP model 
This pathway was not recovered with either of the objectives. Since this pathway 
is not recovered, (QS,QT) pairs discussion is omitted. 
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(QS,QT) discussion for the IBP model 
This pathway was recovered with both objective (6.26) and objective (6.27). 
Thus, the (QS,QT) discussion is carried out for objective (6.26) and objective (6.27). The 
table of pairs for objective (6.26) is shown below. 
Number of molecules QT of target compound 
(Ψ,W) 
1 2 3 4 5 6 
1 (8.23,2)* (13.83,5) (13.83,5) (13.83,5) (13.93,4) (13.83,5) 
2 (10.23,3) (8.23,2) (12.03,6) (12.03,6) (12.03,6) (12.03,6) 
3 (9.23,2) (11.03,4) (8.23,2) (12.03,6) (12.03,6) (12.03,6) 
4 (11.03,4) (10.23,3) (11.03,4) (8.23,2) (12.03,6) (12.03,6) 
5 (11.03,4) (11.13,3) (11.03,4) (11.03,4) (8.23,2) (12.03,6) 
Number 
of 
molecules 
QS of 
source 
compoun
d 6 (11.03,4) (9.23,2) (10.23,3) (11.03,4) (11.03,4) (8.23,2) 
For this pathway the IBP model indicates that the pair (QS,QT)=(1,1) dominates 
all other cases. Hence in this case the IBP model recovers the (QS,QT)=(1,1) pair 
observed in the experimentally determined pathway. 
The results for objective (6.27) are shown below. 
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Number of molecules QT of target compound 
(L,W) 
1 2 3 4 5 6 
1 (8,2)* (11,5) (11,5) (11,5) (11,5) (11,5) 
2 (8,5) (8,2) (11,5) (11,5) (11,5) (11,5) 
3 (11,5) (11,5) (8,2) (11,5) (11,5) (11,5) 
4 (11,5) (8,5) (11,5) (8,2) (11,5) (11,5) 
5 (11,5) (11,5) (11,5) (11,5) (8,2) (11,5) 
Number 
of 
molecules 
QS of 
source 
compound 6 (11,5) (11,5) (8,5) (11,5) (11,5) (8,2) 
We obtain the same dominant pair as objective (6.26). Hence for this objective 
the IBP model recovers the (QS,QT)=(1,1) pair observed in the experimentally 
determined pathway. 
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 Pathway 20: Heme biosynthesis 
Source compound Uroporphyrinogen III 
(uppg3) 
Target compound  HemeO (hemeO) 
(QS,QT) (2,2) 
Low presence compounds that are not forced to be 
balanced 
O2 (o2) 
Fe2+ (fe2) 
Farnesyl diphosphate (frdp) 
(Number of reactions, excess ATP) (5,0) 
Number of unbalanced main compounds (W) 1 
Specificity (Ψ) 5 
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Pathway description 
This pathway has been taken from EcoCyc (http://biocyc.org/META/NEW-
IMAGE?type=PATHWAY&object=HEME+BIOSYNTHESIS+II). 
In EcoCyc the pathway is described as being from one molecule of 
Uroporphyrinogen III to one molecule of HemeO. However, were this to be correct, 
then R338 would need a non-integer number of molecules of o2 (namely 1.5). In order 
to avoid this difficulty, we regard the pathway as transforming two molecules of 
Uroporphyrinogen III to two molecules of HemeO. 
 
 
Metabolic pathway analysis via integer linear programming 
Francisco J. Planes                 May 2008 182
(QS,QT) discussion for the BP model 
This pathway was recovered with both objective (3.13) and objective (3.14). 
Thus, the (QS,QT) discussion is carried out for objective (3.13) and objective (3.14). The 
table of pairs for objective (3.13) is shown below. 
Number of molecules QT of target compound (number of reactions, 
excess ATP) 
1 2 3 4 5 6 
1 X X X X X X 
2 X (5,0)* X X X X 
3 X X X X X X 
4 X X X (5,0) X X 
5 X X X X X X 
Number 
of 
molecules 
QS of 
source 
compound 6 X X X X X (5,0) 
The dominant pair is (QS,QT)=(2,2). Hence in this case the BP model recovers 
the (QS,QT)=(2,2) pair observed in the experimentally determined pathway.  
On the other hand, results for objective (3.14) are shown below. 
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Number of molecules QT of target compound (number of reactions, 
excess ATP) 
1 2 3 4 5 6 
1 X X X X X X 
2 X (5,0)* X X X X 
3 X X X X X X 
4 X X X (5,0) X X 
5 X X X X X X 
Number 
of 
molecules 
QS of 
source 
compound 6 X X X X X (5,0) 
The dominant pair is (QS,QT)=(2,2). Hence in this case the BP model recovers 
the (QS,QT)=(2,2) pair observed in the experimentally determined pathway.  
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(QS,QT) discussion for the IBP model 
This pathway was recovered with both objective (6.26) and objective (6.27). 
Thus, the (QS,QT) discussion is carried out for objective (6.26) and objective (6.27). The 
table of pairs for objective (6.26) is shown below. 
Number of molecules QT of target compound 
(Ψ,W) 
1 2 3 4 5 6 
1 (19.84,9) (19.57,9) (20.82,10) (20.89,9) (20.67,9) (20.67,9) 
2 (19.65,10) (5,1)* (19.63,11) (19.47,10) (20.7,10) (20.72,11)
3 (20.07,9) (12.23,9) (19.74,10) (19.63,11) (19.63,11) (19.47,10)
4 (21.51,9) (12.5,9) (19.9,11) (5,1) (19.63,11) (19.63,11)
5 (21.41,10) (12.75,8) (19.65,10) (13.39,9) (19.74,10) (19.63,11)
Number 
of 
molecules 
QS of 
source 
compound 6 (21.51,9) (13.42,8) (19.65,10) (12.23,9) (19.9,11) (5,1) 
For this pathway the IBP model indicates that the pair (QS,QT)=(2,2) dominates 
all other cases. Hence in this case the IBP model recovers the (QS,QT)=(2,2) pair 
observed in the experimentally determined pathway. 
The results for objective (6.27) are shown below. 
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Number of molecules QT of target compound 
(L,W) 
1 2 3 4 5 6 
1 (15,8) (15,0) (14,9) (16,8) (15,8) (16,0) 
2 (16,8) (5,1)* (16,8) (15,0) (16,8) (15,8) 
3 (17,1) (16,3) (15,8) (16,8) (15,8) (15,0) 
4 (15,7) (15,8) (13,8) (5,1) X (15,8) 
5 X (16,3) (15,8) (16,8) (15,8) X 
Number 
of 
molecules 
QS of 
source 
compound 6 (18,2) (24,2) (16,8) (15,8) X (5,1) 
We obtain the same dominant pair as objective (6.26). Hence for this objective 
the IBP model recovers the (QS,QT)=(2,2) pair observed in the experimentally 
determined pathway. 
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 Pathway 21: De novo synthesis of pyrimidine ribonucletides 
Source compound Carbamoyl phosphate (cbp) 
Target compound CTP (ctp) 
(QS,QT) (1,1) 
Low presence compounds that are not forced 
to be balanced 
L-Aspartate (asp-L) 
L-Glutamine (gln-L) 
Ubiquinone-8 (q8) 
Ubiquinol-8 (q8h2) 
5-Phospho-alpha-D-ribose 1-
diphosphate (prpp) 
(Number of reactions, excess ATP) (8,-3) 
Number of unbalanced main compounds (W) 3 
Specificity (Ψ) 8 
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Pathway description 
This pathway has been taken from EcoCyc (http://biocyc.org/ECOLI/NEW-
IMAGE?type=PATHWAY&object=PWY0-162) and Lehninger (fourth edition) pages 
867 and 868. 
In Lehninger the pathway is described as being from one molecule of Carbamoyl 
phosphate to one molecule of CTP. However, this pathway is described in EcoCyc as 
being from one molecule of CO2 to one molecule of CDP. Since the Lehninger 
description appears to be the more common one it is that which has informed the 
pathway picture seen below. 
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(QS,QT) discussion for the BP model 
This pathway was recovered with objective (3.13). Thus, the (QS,QT) discussion 
is carried out for objective (3.13). The table of pairs for objective (3.13) is shown 
below. 
Number of molecules QT of target compound (number of reactions, 
excess ATP) 
1 2 3 4 5 6 
1 (8,-3)* X X X X X 
2 X (8,-6) X X X X 
3 X X (8,-9) X X X 
4 X X X (8,-12) X X 
5 X X X X (8,-15) X 
Number 
of 
molecules 
QS of 
source 
compound 6 X X X X X (8,-18) 
The pairs seen down the diagonal are all repeats of each other, doubling and then 
tripling, etc the number of source and target molecules (and excess ATP). The dominant 
pair is (QS,QT)=(1,1). Hence in this case the BP model recovers the (QS,QT)=(1,1) pair 
observed in the experimentally determined pathway.  
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(QS,QT) discussion for the IBP model 
This pathway was recovered with both objective (6.26) and objective (6.27). 
Thus, the (QS,QT) discussion is carried out for objective (6.26) and objective (6.27). The 
table of pairs for objective (6.26) is shown below. 
Number of molecules QT of target compound 
(Ψ,W) 
1 2 3 4 5 6 
1 (8,3)* (10.56,4) (10.56,4) (10.56,4) (10.56,4) (10.56,4) 
2 (9.85,5) (8,3) (10.56,4) (10.56,4) (10.56,4) (10.56,4) 
3 (9.94,4) (9.85,5) (8,3) (10.56,4) (10.56,4) (10.56,4) 
4 (9.85,5) (9.85,5) (9.85,5) (8,3) (10.56,4) (10.56,4) 
5 (9.85,5) (9.94,4) (9.94,4) (9.85,5) (8,3) (10.56,4) 
Number 
of 
molecules 
QS of 
source 
compoun
d 6 (9.85,5) (9.85,5) (9.85,5) (9.85,5) (9.85,5) (8,3) 
For this pathway the IBP model indicates that the pair (QS,QT)=(1,1) dominates 
all other cases. Hence in this case the IBP model recovers the (QS,QT)=(1,1) pair 
observed in the experimentally determined pathway. 
The results for objective (6.27) are shown below. 
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Number of molecules QT of target compound 
(L,W) 
1 2 3 4 5 6 
1 (8,3)* (9,5) (9,5) (9,5) (9,5) (9,5) 
2 (9,5) (8,3) (9,5) (9,5) (9,5) (9,5) 
3 (8,4) (9,5) (8,3) (9,5) (9,5) (9,5) 
4 (9,5) (9,5) (9,5) (8,3) (9,5) (9,5) 
5 (9,5) (9,5) (9,5) (9,5) (8,3) (9,5) 
Number 
of 
molecules 
QS of 
source 
compound 6 (9,5) (8,4) (9,5) (9,5) (9,5) (8,3) 
We obtain the same dominant pair as objective (6.26). Hence for this objective 
the IBP model recovers the (QS,QT)=(1,1) pair observed in the experimentally 
determined pathway. 
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 Pathway 22: De novo synthesis of pyrimidine deoxyribonucletides 
Source compound UTP (utp) 
Target compound dTTP (dttp) 
(QS,QT) (1,1) 
Low presence compounds that are not forced to 
be balanced 
7,8-Dihydrofolate (dhf) 
5,10-Methylenetetrahydrofolate 
(mlthf) 
Oxidized thioredoxin (trdox) 
Reduced thioredoxin (trdrd) 
(Number of reactions, excess ATP) (5,-2) 
Number of unbalanced main compounds (W) 4 
Specificity (Ψ) 5.25 
 
Metabolic pathway analysis via integer linear programming 
Francisco J. Planes                 May 2008 193
Pathway description 
This pathway has been taken from EcoCyc (http://biocyc.org/ECOLI/NEW-
IMAGE?type=PATHWAY&object=PWY0-166). 
In EcoCyC the pathway is described as being from one molecule of UTP to one 
molecule of dTTP. Our database contains the same set of reactions.  
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(QS,QT) discussion for the BP model 
This pathway was recovered with objective (3.13). Thus, the (QS,QT) discussion 
is carried out for objective (3.13). The table of pairs for objective (3.13) is shown 
below. 
Number of molecules QT of target compound (number of reactions, 
excess ATP) 
1 2 3 4 5 6 
1 (5,-2)* X X X X X 
2 X (5,-4) X X X X 
3 X X (5,-6) X X X 
4 X X X (5,-8) X X 
5 X X X X (5,-10) X 
Number 
of 
molecules 
QS of 
source 
compound 6 X X X X X (5,-12) 
The pairs seen down the diagonal are all repeats of each other, doubling and then 
tripling, etc the number of source and target molecules (and excess ATP). The dominant 
pair is (QS,QT)=(1,1). Hence in this case the BP model recovers the (QS,QT)=(1,1) pair 
observed in the experimentally determined pathway.  
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(QS,QT) discussion for the IBP model 
This pathway was recovered with both objective (6.26) and objective (6.27). 
Thus, the (QS,QT) discussion is carried out for objective (6.26) and objective (6.27). The 
table of pairs for objective (6.26) is shown below. 
Number of molecules QT of target compound 
(Ψ,W) 
1 2 3 4 5 6 
1 (5.25,4)* (6.53,3) (6.53,3) (6.53,3) (6.53,3) (6.53,3) 
2 (7.03,3) (5.25,4) (6.53,3) (6.63,2) (6.63,2) (6.53,3) 
3 (7.03,3) (7.13,2) (5.25,4) (6.63,2) (6.63,2) (6.53,3) 
4 (7.03,3) (7.03,3) (7.03,3) (5.25,4) (6.53,3) (6.53,3) 
5 (7.03,3) (7.03,3) (7.03,3) (7.03,3) (5.25,4) (6.53,3) 
Number 
of 
molecules 
QS of 
source 
compound 6 (7.03,3) (7.03,3) (7.03,3) (7.03,3) (7.03,3) (5.25,4) 
For this pathway the IBP model indicates that the pair (QS,QT)=(1,1) dominates 
all other cases. Hence in this case the IBP model recovers the (QS,QT)=(1,1) pair 
observed in the experimentally determined pathway. 
The results for objective (6.27) are shown below. 
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Number of molecules QT of target compound 
(L,W) 
1 2 3 4 5 6 
1 (5,4)* (7,4) (7,4) (7,4) (7,4) (7,4) 
2 (7,4) (5,4) (7,4) (7,4) (7,4) (7,4) 
3 (7,4) (7,4) (5,4) (7,4) (7,4) (7,4) 
4 (7,4) (7,4) (7,4) (5,4) (7,4) (7,4) 
5 (7,4) (7,4) (7,4) (7,4) (5,4) (7,4) 
Number 
of 
molecules 
QS of 
source 
compound 6 (7,4) (7,4) (7,4) (7,4) (7,4) (5,4) 
We obtain the same dominant pair as objective (6.26). Hence for this objective 
the IBP model recovers the (QS,QT)=(1,1) pair observed in the experimentally 
determined pathway. 
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 Pathway 23: Phenylethylamine degradation 
Source compound Phenethylamine (peamn) 
Target compound Phenylacetic acid (pac) 
(QS,QT) (1,1) 
Low presence compounds that are not forced to be 
balanced 
O2 (o2) 
Hydrogen peroxide 
(h2o2) 
(Number of reactions, excess ATP) (2,0) 
Number of unbalanced main compounds (W) 0 
Specificity (Ψ) 2 
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Pathway description 
This pathway has been taken from EcoCyc (http://biocyc.org/ECOLI/NEW-
IMAGE?type=PATHWAY&object=2PHENDEG-PWY). 
In EcoCyC the pathway is described as being from one molecule of 
Phenethylamine to one molecule of Phenylacetic acid. Our database contains the same 
set of reactions. 
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(QS,QT) discussion for the BP model 
This pathway was recovered with both objective (3.13) and objective (3.14). 
Thus, the (QS,QT) discussion is carried out for objective (3.13) and objective (3.14). The 
table of pairs for objective (3.13) is shown below. 
Number of molecules QT of target compound (number of reactions, 
excess ATP) 
1 2 3 4 5 6 
1 (2,0)* X X X X X 
2 X (2,0) X X X X 
3 X X (2,0) X X X 
4 X X X (2,0) X X 
5 X X X X (2,0) X 
Number 
of 
molecules 
QS of 
source 
compound 6 X X X X X (2,0) 
The pairs seen down the diagonal are all repeats of each other, doubling and then 
tripling, etc the number of source and target molecules. The dominant pair is 
(QS,QT)=(1,1). Hence in this case the BP model recovers the (QS,QT)=(1,1) pair 
observed in the experimentally determined pathway.  
On the other hand, results for objective (3.14) are shown below. 
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Number of molecules QT of target compound (number of reactions, 
excess ATP) 
1 2 3 4 5 6 
1 (2,0)* X X X X X 
2 X (2,0) X X X X 
3 X X (2,0) X X X 
4 X X X (2,0) X X 
5 X X X X (2,0) X 
Number 
of 
molecules 
QS of 
source 
compound 6 X X X X X (2,0) 
The pairs seen down the diagonal are all repeats of each other, doubling and then 
tripling, etc the number of source and target molecules. The dominant pair is 
(QS,QT)=(1,1). Hence in this case the BP model recovers the (QS,QT)=(1,1) pair 
observed in the experimentally determined pathway.  
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(QS,QT) discussion for the IBP model 
This pathway was recovered with both objective (6.26) and objective (6.27). 
Thus, the (QS,QT) discussion is carried out for objective (6.26) and objective (6.27). The 
table of pairs for objective (6.26) is shown below. 
Number of molecules QT of target compound 
(Ψ,W) 
1 2 3 4 5 6 
1 (2,0)* X X X X X 
2 X (2,0) X X X X 
3 X X (2,0) X X X 
4 X X X (2,0) X X 
5 X X X X (2,0) X 
Number 
of 
molecules 
QS of 
source 
compound 6 X X X X X (2,0) 
For this pathway the IBP model indicates that the pair (QS,QT)=(1,1) dominates 
all other cases. Hence in this case the IBP model recovers the (QS,QT)=(1,1) pair 
observed in the experimentally determined pathway. 
The results for objective (6.27) are shown below. 
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Number of molecules QT of target compound 
(L,W) 
1 2 3 4 5 6 
1 (2,0)* X X X X X 
2 X (2,0) X X X X 
3 X X (2,0) X X X 
4 X X X (2,0) X X 
5 X X X X (2,0) X 
Number 
of 
molecules 
QS of 
source 
compound 6 X X X X X (2,0) 
We obtain the same dominant pair as objective (6.26). Hence for this objective 
the IBP model recovers the (QS,QT)=(1,1) pair observed in the experimentally 
determined pathway. 
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 Pathway 24: Rhamnose degradation 
Source compound L-Rhamnose (rmn) 
Target compound Pyruvate (pyr) 
(QS,QT) (1,1) 
Low presence compounds that are not forced to be 
balanced 
Dihydroxyacetone phosphate 
(dhap) 
Ubiquinone-8 (q8) 
Ubiquinol-8 (q8h2) 
(Number of reactions, excess ATP) (5,-1) 
Number of unbalanced main compounds (W) 1 
Specificity (Ψ) 6.25 
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Pathway description 
This pathway has been taken from EcoCyc (http://biocyc.org/ECOLI/NEW-
IMAGE?type=PATHWAY&object=RHAMCAT-PWY). 
In EcoCyC the pathway is described as being from one molecule of L-Rhamnose 
to one molecule of Pyruvate. Our database contains the same set of reactions. 
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(QS,QT) discussion for the BP model 
This pathway was recovered with objective (3.13). Thus, the (QS,QT) discussion 
is carried out for objective (3.13). The table of pairs for objective (3.13) is shown 
below. 
Number of molecules QT of target compound (number of reactions, 
excess ATP) 
1 2 3 4 5 6 
1 (5,-1)* (11,1) (11,3) (11,5) (11,7) (11,9) 
2 X (5,-2) (12,-1) (11,2) (11,4) (11,6) 
3 X X (5,-3) (11,-1) (11,1) (11,3) 
4 X X X (5,-4) (11,-2) (12,-2) 
5 X X X X (5,-5) (11,-3) 
Number 
of 
molecules 
QS of 
source 
compound 6 X X X X X (5,-6) 
The pairs seen down the diagonal are all repeats of each other, doubling and then 
tripling, etc the number of source and target molecules (and excess ATP). The dominant 
pair is (QS,QT)=(1,1). Hence in this case the BP model recovers the (QS,QT)=(1,1) pair 
observed in the experimentally determined pathway.  
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(QS,QT) discussion for the IBP model 
This pathway was recovered with both objective (6.26) and objective (6.27). 
Thus, the (QS,QT) discussion is carried out for objective (6.26) and objective (6.27). The 
table of pairs for objective (6.26) is shown below. 
Number of molecules QT of target compound 
(Ψ,W) 
1 2 3 4 5 6 
1 (6.25,1)* (6.93,0) (7.95,2) (7.95,2) (7.95,2) (7.95,2) 
2 (9.81,4) (6.25,1) (7.95,2) (6.93,0) (8.05,1) (7.95,2) 
3 (9.81,4) (9.81,4) (6.25,1) (7.95,2) (7.95,2) (6.93,0) 
4 (9.81,4) (9.81,4) (9.81,4) (6.25,1) (7.95,2) (7.95,2) 
5 (9.81,4) (9.81,4) (9.81,4) (9.81,4) (6.25,1) (7.95,2) 
Number 
of 
molecules 
QS of 
source 
compound 6 (9.81,4) (9.81,4) (9.81,4) (9.81,4) (9.81,4) (6.25,1) 
For this pathway the IBP model indicates that the pair (QS,QT)=(1,1) dominates 
all other cases. Hence in this case the IBP model recovers the (QS,QT)=(1,1) pair 
observed in the experimentally determined pathway. 
The results for objective (6.27) are shown below. 
Metabolic pathway analysis via integer linear programming 
Francisco J. Planes                 May 2008 207
 
Number of molecules QT of target compound 
(L,W) 
1 2 3 4 5 6 
1 (5,1)* (9,0) (10,2) (10,2) (10,2) (10,2) 
2 (12,4) (5,1) (10,2) (9,0) (10,2) (10,2) 
3 (12,3) (11,6) (5,1) (10,2) (10,2) (9,0) 
4 (12,3) (12,3) (12,3) (5,1) (10,2) (10,2) 
5 (12,3) (12,3) (12,3) (12,3) (5,1) (10,2) 
Number 
of 
molecules 
QS of 
source 
compound 6 (12,3) (13,4) (12,5) (11,6) (13,4) (5,1) 
We obtain the same dominant pair as objective (6.26). Hence for this objective 
the IBP model recovers the (QS,QT)=(1,1) pair observed in the experimentally 
determined pathway. 
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 Pathway 25: Fucose degradation 
Source compound L-Fucose (fuc-L) 
Target compound Pyruvate (pyr) 
(QS,QT) (1,1) 
Low presence compounds that are not forced to be 
balanced 
Dihydroxyacetone phosphate 
(dhap) 
Ubiquinone-8 (q8) 
Ubiquinol-8 (q8h2) 
(Number of reactions, excess ATP) (5,-1) 
Number of unbalanced main compounds (W) 1 
Specificity (Ψ) 6.25 
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Pathway description 
This pathway has been taken from EcoCyc (http://biocyc.org/ECOLI/NEW-
IMAGE?type=PATHWAY&object=FUCCAT-PWY). 
In EcoCyC the pathway is described as being from one molecule of L-Fucose to 
one molecule of Pyruvate. Our database contains the same set of reactions. 
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(QS,QT) discussion for the BP model 
This pathway was recovered with objective (3.13). Thus, the (QS,QT) discussion 
is carried out for objective (3.13). The table of pairs for objective (3.13) is shown 
below. 
Number of molecules QT of target compound (number of reactions, 
excess ATP) 
1 2 3 4 5 6 
1 (5,-1)* (11,1) (11,3) (11,5) (11,7) (11,9) 
2 X (5,-2) (12,-1) (11,2) (11,4) (11,6) 
3 X X (5,-3) (11,-1) (11,1) (11,3) 
4 X X X (5,-4) (11,-2) (12,-2) 
5 X X X X (5,-5) (11,-3) 
Number 
of 
molecules 
QS of 
source 
compound 6 X X X X X (5,-6) 
The pairs seen down the diagonal are all repeats of each other, doubling and then 
tripling, etc the number of source and target molecules (and excess ATP). The dominant 
pair is (QS,QT)=(1,1). Hence in this case the BP model recovers the (QS,QT)=(1,1) pair 
observed in the experimentally determined pathway.  
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(QS,QT) discussion for the IBP model 
This pathway was recovered with both objective (6.26) and objective (6.27). 
Thus, the (QS,QT) discussion is carried out for objective (6.26) and objective (6.27). The 
table of pairs for objective (6.26) is shown below. 
Number of molecules QT of target compound 
(Ψ,W) 
1 2 3 4 5 6 
1 (6.25,1)* (6.93,0) (7.95,2) (7.95,2) (7.95,2) (7.95,2) 
2 (9.81,4) (6.25,1) (7.95,2) (6.93,0) (7.95,2) (7.95,2) 
3 (9.81,4) (9.9,3) (6.25,1) (7.95,2) (7.95,2) (6.93,0) 
4 (9.81,4) (9.81,4) (9.81,4) (6.25,1) (7.95,2) (7.95,2) 
5 (9.81,4) (9.81,4) (9.81,4) (9.81,4) (6.25,1) (7.95,2) 
Number 
of 
molecules 
QS of 
source 
compound 6 (9.81,4) (9.81,4) (9.81,4) (9.81,4) (9.81,4) (6.25,1) 
For this pathway the IBP model indicates that the pair (QS,QT)=(1,1) dominates 
all other cases. Hence in this case the IBP model recovers the (QS,QT)=(1,1) pair 
observed in the experimentally determined pathway. 
The results for objective (6.27) are shown below. 
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Number of molecules QT of target compound 
(L,W) 
1 2 3 4 5 6 
1 (5,1)* (9,0) (10,2) (10,2) (10,2) (10,2) 
2 (12,3) (5,1) (10,2) (9,0) (10,2) (10,2) 
3 (12,3) (11,6) (5,1) (10,2) (10,2) (9,0) 
4 (12,3) (12,3) (12,3) (5,1) (10,2) (10,2) 
5 (12,3) (11,4) (11,4) (11,4) (5,1) (10,2) 
Number 
of 
molecules 
QS of 
source 
compound 6 (11,4) (11,4) (11,4) (11,4) (11,4) (5,1) 
We obtain the same dominant pair as objective (6.26). Hence for this objective 
the IBP model recovers the (QS,QT)=(1,1) pair observed in the experimentally 
determined pathway. 
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 Pathway 26: Entner-Doudoroff  
Source compound D-Glucose 6-phosphate 
(g6p) 
Target compound Pyruvate (pyr) 
(QS,QT) (1,1) 
Low presence compounds that are not forced to be 
balanced 
None 
(Number of reactions, excess ATP) (4,0) 
Number of unbalanced main compounds (W) 0 
Specificity (Ψ) 4.41 
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Pathway description 
This pathway has been taken from EcoCyc (http://biocyc.org/ECOLI/NEW-
IMAGE?type=PATHWAY&object=ENTNER-DOUDOROFF-PWY). 
In EcoCyC the pathway is described as being from one molecule of D-Glucose 6-
phosphate to one molecule of Pyruvate. Our database contains the same set of reactions. 
 
 
Note here that we have one allowable c-cycle in this pathway. More precisely 
the 2-cycle 6pgc-R639-h2o-R637-6pgc which contains one high presence balanced 
compound (h2o). 
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 (QS,QT) discussion for the BP model 
This pathway was recovered with both objective (3.13) and objective (3.14). 
Thus, the (QS,QT) discussion is carried out for objective (3.13) and objective (3.14). The 
table of pairs for objective (3.13) is shown below. 
Number of molecules QT of target compound (number of reactions, 
excess ATP) 
1 2 3 4 5 6 
1 (4,0)* (9,3) (9,4) (9,6) (9,8) (9,10) 
2 X (4,0) (9,2) (9,6) (9,6) (9,8) 
3 X X (4,0) (9,2) (9,4) (9,9) 
4 X X X (4,0) (9,2) (9,4) 
5 X X X X (4,0) (9,2) 
Number 
of 
molecules 
QS of 
source 
compound 6 X X X X X (4,0) 
The pairs seen down the diagonal are all repeats of each other, doubling and then 
tripling, etc the number of source and target molecules. The dominant pair is 
(QS,QT)=(1,1). Hence in this case the BP model recovers the (QS,QT)=(1,1) pair 
observed in the experimentally determined pathway.  
The results for objective (3.14) are shown below. 
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Number of molecules QT of target compound (number of reactions, 
excess ATP) 
1 2 3 4 5 6 
1 (4,0) (9,3) (9,4) (9,6) (9,8) (9,10)* 
2 X (4,0) (9,2) (9,6) (9,6) (9,8) 
3 X X (4,0) (9,2) (9,4) (9,9) 
4 X X X (4,0) (9,2) (9,4) 
5 X X X X (4,0) (9,2) 
Number 
of 
molecules 
QS of 
source 
compound 6 X X X X X (4,0) 
The dominant pair is (QS,QT)=(1,6). Hence in this case the BP model does not 
recover the (QS,QT)=(1,1) pair observed in the experimentally determined pathway. 
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(QS,QT) discussion for the IBP model 
This pathway was not recovered with either objective (6.26) or objective (6.27). 
For this reason (QS,QT) pairs discussion is omitted for this pathway. 
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 Pathway 27: Anaerobic respiration 
Source compound Pyruvate (pyr) 
Target compound 2-Oxoglutarate (akg) 
(QS,QT) (1,1) 
Low presence compounds that are not forced to be balanced Oxaloacetate (oaa) 
(Number of reactions, excess ATP) (4,0) 
Number of unbalanced main compounds (W) 1 
Specificity (Ψ) 4.79 
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Pathway description 
This pathway has been taken from EcoCyc (http://biocyc.org/ECOLI/NEW-
IMAGE?type=PATHWAY&object=ANARESP1-PWY) and Lehninger (fourth edition) 
page 621. 
In Lehninger the pathway is described as being from one molecule of Pyruvate 
to one molecule of 2-Oxoglutarate. However, EcoCyc describes it as being from one 
molecule of Phosphoenolpyruvate to one molecule of 2-Oxoglutarate, Pyruvate being an 
intermediate compound.  
Since the Lehninger description appears to be the clearer one it is that which has 
informed the pathway picture seen below. 
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Note here that we have one allowable c-cycle (see Chapter 3) in this pathway. 
More precisely the 2-cycle accoa-R272-coa-R441-accoa which contains one high 
presence balanced compound (coa). 
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(QS,QT) discussion for the BP model 
This pathway was recovered with both objective (3.13) and objective (3.14). 
Thus, the (QS,QT) discussion is carried out for objective (3.13) and objective (3.14). The 
table of pairs for objective (3.13) is shown below. 
Number of molecules QT of target compound (number of reactions, 
excess ATP) 
1 2 3 4 5 6 
1 (4,0)* (5,0) (5,0) (5,0) (5,0) (5,0) 
2 (6,-1) (4,0) (5,0) (5,0) (5,0) (5,0) 
3 X X (4,0) (5,0) (5,0) (5,0) 
4 X (6,-2) (7,-2) (4,0) (5,0) (5,0) 
5 X X X X (4,0) (5,0) 
Number 
of 
molecules 
QS of 
source 
compound 6 X X (6,-3) (7,-3) (7,-3) (4,0) 
The pairs seen down the diagonal are all repeats of each other, doubling and then 
tripling, etc the number of source and target molecules. The dominant pair is 
(QS,QT)=(1,1). Hence in this case the BP model recovers the (QS,QT)=(1,1) pair 
observed in the experimentally determined pathway.  
The results for objective (3.14) are shown below. 
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Number of molecules QT of target compound (number of reactions, 
excess ATP) 
1 2 3 4 5 6 
1 (4,0)* (5,0) (5,0) (5,0) (5,0) (5,0) 
2 (7,0) (4,0) (5,0) (5,0) (5,0) (5,0) 
3 X X (4,0) (5,0) (5,0) (5,0) 
4 X (7,0) (8,0) (4,0) (5,0) (5,0) 
5 X X X X (4,0) (5,0) 
Number 
of 
molecules 
QS of 
source 
compound 6 X X (7,0) (8,0) (8,0) (4,0) 
The pairs seen down the diagonal are all repeats of each other, doubling and then 
tripling, etc the number of source and target molecules. The dominant pair is 
(QS,QT)=(1,1). Hence in this case the BP model recover the (QS,QT)=(1,1) pair observed 
in the experimentally determined pathway.  
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(QS,QT) discussion for the IBP model 
This pathway was not recovered with either objective (6.26) or objective (6.27). 
For this reason (QS,QT) pairs discussion is omitted for this pathway. 
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 Pathway 28: Arginine degradation 
Source compound L-Arginine (arg-L) 
Target compound L-Glutamate (glu-L) 
(QS,QT) (1,2) 
Low presence compounds that are not forced to be balanced 2-Oxoglutarate (akg) 
Succinyl-CoA (succoa)
Succinate (succ) 
(Number of reactions, excess ATP) (5,0) 
Number of unbalanced main compounds (W) 2 
Specificity (Ψ) 6.03 
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Pathway description 
This pathway has been taken from EcoCyc (http://biocyc.org/ECOLI/NEW-
IMAGE?type=PATHWAY&object=AST-PWY) and Lehninger (fourth edition) page 
681. 
Whilst the pathway is described as being from one molecule of L-Arginine to 
one molecule of α-Ketoglutarate in Lehninger, EcoCyc describes it as being from one 
molecule of L-Arginine to two molecules of L-Glutamate.  
Since our reaction database does not contain the set of reactions seen in 
Lehninger, but does contain those seen in EcoCyc, it is that which has informed the 
pathway picture seen below. 
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(QS,QT) discussion for the BP model 
This pathway was recovered with objective (3.13). Thus, the (QS,QT) discussion 
is carried out for objective (3.13). The table of pairs for objective (3.13) is shown 
below. 
Number of molecules QT of target compound (number of reactions, 
excess ATP) 
1 2 3 4 5 6 
1 X (5,0)* (6,0) (6,0) (6,0) (6,0) 
2 X X X (5,0) (6,0) (6,0) 
3 X X X X X (5,0) 
4 X X X X X X 
5 X X X X X X 
Number 
of 
molecules 
QS of 
source 
compound 6 X X X X X X 
The dominant pair is (QS,QT)=(1,2). Hence in this case the BP model recovers 
the (QS,QT)=(1,2) pair observed in the experimentally determined pathway. 
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(QS,QT) discussion for the IBP model 
This pathway was recovered with both objective (6.26) and objective (6.27). 
Thus, the (QS,QT) discussion is carried out for objective (6.26) and objective (6.27). The 
table of pairs for objective (6.26) is shown below. 
Number of molecules QT of target compound 
(Ψ,W) 
1 2 3 4 5 6 
1 (12.74,7) (6.03,2)* (9.99,4) (10.39,2) (10.39,2) (10.39,2) 
2 (17.27,11) (12.74,7) (9.48,8) (6.03,2) (10.39,2) (9.99,4) 
3 (17.27,11) (14.46,9) (11.18,10) (9.38,9) (9.48,8) (6.03,2) 
4 (17.27,11) (15.87,11) (12.51,12) (11.18,10) (9.38,9) (9.38,9) 
5 (17.27,11) (15.87,11) (12.51,12) (12.51,12) (11.18,10) (9.38,9) 
Number 
of 
molecules 
QS of 
source 
compound 6 (17.27,11) (15.87,11) (12.51,12) (12.51,12) (12.51,12) (11.18,10) 
For this pathway the IBP model indicates that the pair (QS,QT)=(1,2) dominates 
all other cases. Hence in this case the IBP model recovers the (QS,QT)=(1,2) pair 
observed in the experimentally determined pathway. 
The results for objective (6.27) are shown below. 
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Number of molecules QT of target compound 
(L,W) 
1 2 3 4 5 6 
1 (3,2)* (5,2) (9,4) (10,3) (10,5) (11,5) 
2 (13,0) (3,2) (8,4) (5,2) (10,5) (9,4) 
3 (12,8) (12,8) (3,2) (8,4) (8,4) (5,2) 
4 (12,8) (12,8) (12,8) (3,2) (8,4) (8,4) 
5 (13,0) (12,8) (12,8) (12,8) (3,2) (8,4) 
Number 
of 
molecules 
QS of 
source 
compound 6 (12,8) (12,8) (12,8) (12,8) (12,8) (3,2) 
In contrast with objective (6.26), the dominant pair for objective (6.27) is 
(QS,QT)=(1,1). Hence for this objective the IBP model does not recover the 
(QS,QT)=(1,2) pair observed in the experimentally determined pathway. 
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 Pathway 29: Proline degradation 
Source compound L-Proline (pro-L) 
Target compound L-Glutamate (glu-L) 
(QS,QT) (1,1) 
Low presence compounds that are not forced to be balanced FAD (fad) 
FADH2 (fadh2) 
(Number of reactions, excess ATP) (2,0) 
Number of unbalanced main compounds (W) 0 
Specificity (Ψ) 2 
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Pathway description 
This pathway has been taken from EcoCyc (http://biocyc.org/ECOLI/NEW-
IMAGE?type=PATHWAY&object=PROUT-PWY) and Lehninger (fourth edition) 
page 681. 
Whilst the pathway is described as being from one molecule of L-Proline to one 
molecule of α-Ketoglutarate (2-oxoglutarate in our database) in Lehninger, EcoCyc 
describes it as being from one molecule of L-Proline to one molecule of L-glutamate. 
Moreover, Lehninger contains two additional reactions with respect to EcoCyc.  
Since our reaction database matches to those reactions seen in EcoCyc, it is that 
which has informed the pathway picture seen below. 
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(QS,QT) discussion for the BP model 
This pathway was recovered with both objective (3.13) and objective (3.14). 
Thus, the (QS,QT) discussion is carried out for objective (3.13) and objective (3.14). The 
table of pairs for objective (3.13) is shown below. 
Number of molecules QT of target compound (number of reactions, 
excess ATP) 
1 2 3 4 5 6 
1 (2,0)* (10,-1) (10,-2) (10,-3) (10,-4) (10,-5) 
2 X (2,0) (10,-1) (10,-2) (10,-3) (10,-4) 
3 X X (2,0) (10,-1) (10,-2) (10,-3) 
4 X X X (2,0) (10,-1) (10,-2) 
5 X X X X (2,0) (10,-1) 
Number 
of 
molecules 
QS of 
source 
compound 6 X X X X X (2,0) 
The pairs seen down the diagonal are all repeats of each other, doubling and then 
tripling, etc the number of source and target molecules. The dominant pair is 
(QS,QT)=(1,1). Hence in this case the BP model recovers the (QS,QT)=(1,1) pair 
observed in the experimentally determined pathway.  
The results for objective (3.14) are shown below. 
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Number of molecules QT of target compound (number of reactions, 
excess ATP) 
1 2 3 4 5 6 
1 (2,0)* (11,0) (11,0) (11,0) (11,0) (11,0) 
2 X (2,0) (11,0) (11,0) (11,0) (11,0) 
3 X X (2,0) (11,0) (11,0) (11,0) 
4 X X X (2,0) (11,0) (11,0) 
5 X X X X (2,0) (11,0) 
Number 
of 
molecules 
QS of 
source 
compound 6 X X X X X (2,0) 
The pairs seen down the diagonal are all repeats of each other, doubling and then 
tripling, etc the number of source and target molecules. The dominant pair is 
(QS,QT)=(1,1). Hence in this case the BP model recovers the (QS,QT)=(1,1) pair 
observed in the experimentally determined pathway.  
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(QS,QT) discussion for the IBP model 
This pathway was recovered with both objective (6.26) and objective (6.27). 
Thus, the (QS,QT) discussion is carried out for objective (6.26) and objective (6.27). The 
table of pairs for objective (6.26) is shown below. 
Number of molecules QT of target compound 
(Ψ,W) 
1 2 3 4 5 6 
1 (2,0)* (6.5,5) (6.48,2) X (7.74,5) X 
2 X (2,0) (7.33,3) (6.33,5) (6.5,5) X 
3 X X (2,0) X (6.43,4) X 
4 X X X (2,0) (9.49,6) (6.33,5) 
5 X X X X (2,0) X 
Number 
of 
molecules 
QS of 
source 
compound 6 X X X X X (2,0) 
For this pathway the IBP model indicates that the pair (QS,QT)=(1,1) dominates 
all other cases. Hence in this case the IBP model recovers the (QS,QT)=(1,1) pair 
observed in the experimentally determined pathway. 
The results for objective (6.27) are shown below. 
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Number of molecules QT of target compound 
(L,W) 
1 2 3 4 5 6 
1 (2,0)* (9,3) (9,3) (9,3) (10,5) X 
2 X (2,0) (9,3) (9,3) (9,3) (9,3) 
3 X X (2,0) (9,3) (9,3) (9,3) 
4 X X X (2,0) (9,3) (9,3) 
5 X X X X (2,0) (9,3) 
Number 
of 
molecules 
QS of 
source 
compound 6 X X X X X (2,0) 
We obtain the same dominant pair as objective (6.26). Hence for this objective 
the IBP model recovers the (QS,QT)=(1,1) pair observed in the experimentally 
determined pathway. 
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 Pathway 30: Glycolate degradation 
Source compound Glycolate (glyclt) 
Target compound 3-Phospho-D-glycerate 
(3pg) 
(QS,QT) (2,1) 
Low presence compounds that are not forced to be 
balanced 
Ubiquinone-8 (q8) 
Ubiquinol-8 (q8h2) 
(Number of reactions, excess ATP) (4,-1) 
Number of unbalanced main compounds (W) 0 
Specificity (Ψ) 4 
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Pathway description 
This pathway has been taken from EcoCyc (http://biocyc.org/ECOLI/NEW-
IMAGE?type=PATHWAY&object=GLYCOLATEMET-PWY) and Lehninger (fourth 
edition) page 767. 
Whilst the pathway is described as being from two molecules of Glycolate to 
one molecule of Glycine in Lehninger, EcoCyc describes it as being from two 
molecules of Glycolate to one molecule of 3-Phospho-D-glycerate.  
Since our reaction database matches to those reactions seen in EcoCyc, it is that 
which has informed the pathway picture seen below. 
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(QS,QT) discussion for the BP model 
This pathway was recovered with objective (3.13). Thus, the (QS,QT) discussion 
is carried out for objective (3.13). The table of pairs for objective (3.13) is shown 
below. 
Number of molecules QT of target compound (number of reactions, 
excess ATP) 
1 2 3 4 5 6 
1 (7,-1) (8,-2) (8,-3) (8,-4) (8,-5) (8,-6) 
2 (4,-1)* (7,-2) (7,-3) (7,-4) (7,-5) (7,-6) 
3 (7,-1) (9,0) (7,-3) (8,-4) (8,-5) (8,-6) 
4 (7,-1) (4,-2) (7,-3) (7,-4) (7,-5) (7,-6) 
5 (7,-1) (7,-2) (9,0) (9,0) (7,-5) (8,-6) 
Number 
of 
molecules 
QS of 
source 
compound 6 (7,-1) (7,-2) (4,-3) (7,-4) (7,-5) (7,-6) 
The dominant pair is (QS,QT)=(2,1). Hence in this case the BP model recovers 
the (QS,QT)=(2,1) pair observed in the experimentally determined pathway.  
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(QS,QT) discussion for the IBP model 
This pathway was recovered with both objective (6.26) and objective (6.27). 
Thus, the (QS,QT) discussion is carried out for objective (6.26) and objective (6.27). The 
table of pairs for objective (6.26) is shown below. 
Number of molecules QT of target compound 
(Ψ,W) 
1 2 3 4 5 6 
1 (6,0) (7.38,1) (7.38,1) (7.38,1) (7.38,1) (7.38,1) 
2 (4,0)* (6,0) (5.92,3) (5.92,3) (5.92,3) (5.92,3) 
3 (7.86,4) (5,0) (6,0) (6.92,3) (6.92,3) (6.92,3) 
4 (7.86,4) (4,0) (5,0) (6,0) (5.92,3) (5.92,3) 
5 (7.96,3) (7.66,1) (5,0) (5,0) (6,0) (6.92,3) 
Number 
of 
molecules 
QS of 
source 
compound 6 (7.86,4) (7.66,1) (4,0) (5,0) (5,0) (6,0) 
For this pathway the IBP model indicates that the pair (QS,QT)=(2,1) dominates 
all other cases. Hence in this case the IBP model recovers the (QS,QT)=(2,1) pair 
observed in the experimentally determined pathway. 
The results for objective (6.27) are shown below. 
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Number of molecules QT of target compound 
(L,W) 
1 2 3 4 5 6 
1 (6,0) (6,4) (6,4) (6,4) (6,4) (6,4) 
2 (4,0)* (6,0) (6,4) (6,4) (6,4) (6,4) 
3 (6,4) (6,4) (6,0) (6,4) (6,4) (6,4) 
4 (6,4) (4,0) (6,4) (6,0) (6,4) (6,4) 
5 (6,4) (6,4) (6,4) (6,4) (6,0) (6,4) 
Number 
of 
molecules 
QS of 
source 
compound 6 (6,4) (6,4) (4,0) (6,4) (6,4) (6,0) 
We obtain the same dominant pair as objective (6.26). Hence for this objective 
the IBP model recovers the (QS,QT)=(2,1) pair observed in the experimentally 
determined pathway. 
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Pathway 31: Phospholipid biosynthesis 
Source compound CDPdiacilglycerol (cdpdag1) 
Target compound Cardiolipin (clpn_EC) 
(QS,QT) (2,1) 
Low presence compounds that are not forced to be 
balanced 
Glycerol 3-phosphate 
(glyc3p) 
CMP (cmp) 
Glycerol (glyc) 
(Number of reactions, excess ATP) (3,0) 
Number of unbalanced main compounds (W) 3 
Specificity (Ψ) 3 
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Pathway description 
This pathway has been taken from EcoCyc (http://biocyc.org/ECOLI/NEW-
IMAGE?type=PATHWAY&object=PHOSLIPSYN-PWY) and Lehninger (fourth 
edition) pages 810. 
Both in Lehninger and EcoCyc, the pathway is described as being from two 
molecules of CDPdiacilglycerol to one molecule of cardiolipin.  
Since the Lehninger description appears to be the clearer one it is that which has 
informed the pathway picture seen below. 
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(QS,QT) discussion for the BP model 
This pathway was recovered with objective (3.13). Thus, the (QS,QT) discussion 
is carried out for objective (3.13). The table of pairs for objective (3.13) is shown 
below. 
Number of molecules QT of target compound (number of reactions, 
excess ATP) 
1 2 3 4 5 6 
1 X X X X X X 
2 (3,0)* X X X X X 
3 X X X X X X 
4 X (3,0) X X X X 
5 X X X X X X 
Number 
of 
molecules 
QS of 
source 
compound 6 X X (3,0) X X X 
The dominant pair is (QS,QT)=(2,1). Hence in this case the BP model recovers 
the (QS,QT)=(2,1) pair observed in the experimentally determined pathway.  
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(QS,QT) discussion for the IBP model 
This pathway was recovered with both objective (6.26) and objective (6.27). 
Thus, the (QS,QT) discussion is carried out for objective (6.26) and objective (6.27). The 
table of pairs for objective (6.26) is shown below. 
Number of molecules QT of target compound 
(Ψ,W) 
1 2 3 4 5 6 
1 X X X X X X 
2 (3,3)* X X X X X 
3 X X X X X X 
4 X (3,3) X X X X 
5 X X X X X X 
Number 
of 
molecules 
QS of 
source 
compound 6 X X (3,3) X X X 
For this pathway the IBP model indicates that the pair (QS,QT)=(2,1) dominates 
all other cases. Hence in this case the IBP model recovers the (QS,QT)=(2,1) pair 
observed in the experimentally determined pathway. 
The results for objective (6.27) are shown below. 
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Number of molecules QT of target compound 
(L,W) 
1 2 3 4 5 6 
1 X X X X X X 
2 (3,3)* X X X X X 
3 X X X X X X 
4 X (3,3) X X X X 
5 X X X X X X 
Number 
of 
molecules 
QS of 
source 
compound 6 X X (3,3) X X X 
We obtain the same dominant pair as objective (6.26). Hence for this objective 
the IBP model recovers the (QS,QT)=(2,1) pair observed in the experimentally 
determined pathway. 
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 Pathway 32: Biosynthesis of cysteine 
Source compound L-Serine (ser-L) 
Target compound L-Cysteine (cys-L) 
(QS,QT) (1,1) 
Low presence compounds that are not forced to be balanced Acetyl-CoA (accoa) 
Hydrogen sulfide (h2s) 
Acetate (ac) 
(Number of reactions, excess ATP) (2,0) 
Number of unbalanced main compounds (W) 1 
Specificity (Ψ) 2 
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Pathway description 
This pathway has been taken from EcoCyc (http://biocyc.org/ECOLI/NEW-
IMAGE?type=PATHWAY&object=CYSTSYN-PWY) and Lehninger (fourth edition) 
pages 845. 
In Lehninger the pathway is described as being from one molecule of L-Serine 
to one molecule of L-Cysteine. This pathway is described in the same way in EcoCyc 
with the same set of reactions.  
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(QS,QT) discussion for the BP model 
This pathway was recovered with both objective (3.13) and objective (3.14). 
Thus, the (QS,QT) discussion is carried out for objective (3.13) and objective (3.14). The 
table of pairs for objective (3.13) is shown below. 
Number of molecules QT of target compound (number of reactions, 
excess ATP) 
1 2 3 4 5 6 
1 (2,0)* X X X X X 
2 (4,0) (2,0) X X X X 
3 (9,0) (5,-1) (2,0) X X X 
4 (9,0) (4,0) (5,-2) (2,0) X X 
5 (9,0) (9,0) (5,-1) (5,-3) (2,0) X 
Number 
of 
molecules 
QS of 
source 
compound 6 (9,0) (9,0) (4,0) (5,-2) (5,-4) (2,0) 
The pairs seen down the diagonal are all repeats of each other, doubling and then 
tripling, etc the number of source and target molecules. The dominant pair is 
(QS,QT)=(1,1). Hence in this case the BP model recovers the (QS,QT)=(1,1) pair 
observed in the experimentally determined pathway. 
The results for objective (3.14) are shown below.  
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Number of molecules QT of target compound (number of reactions, 
excess ATP) 
1 2 3 4 5 6 
1 (2,0)* X X X X X 
2 (4,0) (2,0) X X X X 
3 (9,0) (6,0) (2,0) X X X 
4 (9,0) (4,0) (6,0) (2,0) X X 
5 (9,0) (9,0) (6,0) (6,0) (2,0) X 
Number 
of 
molecules 
QS of 
source 
compound 6 (9,0) (9,0) (4,0) (6,0) (6,0) (2,0) 
The pairs seen down the diagonal are all repeats of each other, doubling and then 
tripling, etc the number of source and target molecules. The dominant pair is 
(QS,QT)=(1,1). Hence in this case the BP model recovers the (QS,QT)=(1,1) pair 
observed in the experimentally determined pathway. 
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(QS,QT) discussion for the IBP model 
This pathway was recovered with both objective (6.26) and objective (6.27). 
Thus, the (QS,QT) discussion is carried out for objective (6.26) and objective (6.27). The 
table of pairs for objective (6.26) is shown below. 
Number of molecules QT of target compound 
(Ψ,W) 
1 2 3 4 5 6 
1 (2,1)* (8.17,5) (8.46,4) (10.88,2) (8.61,3) X 
2 (8.42,4) (2,1) (6.15,5) (6.57,6) X (6.15,5) 
3 (9.67,9) X (2,1) X X (6.15,5) 
4 (8.34,7) (9.93,7) (10.71,9) (2,1) (6.15,5) (6.65,4) 
5 (8.43,4) (7.13,6) (7.71,5) (7.13,6) (2,1) (6.4,5) 
Number 
of 
molecules 
QS of 
source 
compound 6 (8.43,4) (7.23,5) X (7.89,10) (7.81,4) (2,1) 
For this pathway the IBP model indicates that the pair (QS,QT)=(1,1) dominates 
all other cases. Hence in this case the IBP model recovers the (QS,QT)=(1,1) pair 
observed in the experimentally determined pathway. 
The results for objective (6.27) are shown below. 
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Number of molecules QT of target compound 
(L,W) 
1 2 3 4 5 6 
1 (2,1)* (9,5) (11,4) (11,4) (11,6) (11,5) 
2 (11,4) (2,1) (11,6) (9,5) (8,4) (8,4) 
3 (7,2) (8,5) (2,1) X (8,4) (8,4) 
4 X (9,4) (13,6) (2,1) X (8,4) 
5 X (9,4) (7,5) (12,6) (2,1) (8,4) 
Number 
of 
molecules 
QS of 
source 
compound 6 (10,7) (7,2) (9,4) X X (2,1) 
We obtain the same dominant pair as objective (6.26). Hence for this objective 
the IBP model recovers the (QS,QT)=(1,1) pair observed in the experimentally 
determined pathway. 
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 Pathway 33: Allantoin degradation 
Source compound Allantoin (alltn) 
Target compound 3-Phospho-D-glycerate 
(3pg) 
(QS,QT) (2,1) 
Low presence compounds that are not forced to be 
balanced 
Urea (urea) 
(Number of reactions, excess ATP) (6,-1) 
Number of unbalanced main compounds (W) 1 
Specificity (Ψ) 6 
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Pathway description 
This pathway has been taken from EcoCyc (http://biocyc.org/ECOLI/NEW-
IMAGE?type=PATHWAY&object=PWY0-41). 
In EcoCyc the pathway is described as being from two molecules of Allantoin to 
one molecule of 3-Phospho-D-glycerate. Our database contains the same set of 
reactions. 
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(QS,QT) discussion for the BP model 
This pathway was recovered with objective (3.13). Thus, the (QS,QT) discussion 
is carried out for objective (3.13). The table of pairs for objective (3.13) is shown 
below. 
Number of molecules QT of target compound (number of reactions, 
excess ATP) 
1 2 3 4 5 6 
1 (9,-1) (10,-2) (10,-3) (10,-4) (10,-5) (10,-6) 
2 (6,-1)* (9,-2) (9,-3) (9,-4) (9,-5) (9,-6) 
3 (9,-1) (11,0) (9,-3) (10,-4) (10,-5) (10,-6) 
4 (9,-1) (6,-2) (9,-3) (9,-4) (9,-5) (9,-6) 
5 (9,-1) (9,-2) (11,0) (11,0) (9,-5) (10,-6) 
Number 
of 
molecules 
QS of 
source 
compound 6 (9,-1) (9,-2) (6,-3) (9,-4) (9,-5) (9,-6) 
The dominant pair is (QS,QT)=(2,1). Hence in this case the BP model recovers 
the (QS,QT)=(2,1) pair observed in the experimentally determined pathway.  
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(QS,QT) discussion for the IBP model 
This pathway was recovered with both objective (6.26) and objective (6.27). 
Thus, the (QS,QT) discussion is carried out for objective (6.26) and objective (6.27). The 
table of pairs for objective (6.26) is shown below. 
Number of molecules QT of target compound 
(Ψ,W) 
1 2 3 4 5 6 
1 (8.1,0) (9.38,2) (9.38,2) (9.38,2) (9.38,2) (9.48,1) 
2 (6,1)* (8,1) (8.93,4) (8.93,4) (8.93,4) (8.93,4) 
3 (12.44,3) (7,1) (8,1) (9.14,2) (9.14,2) (9.14,2) 
4 (12.44,3) (6,1) (7,1) (8,1) (8.93,4) (9.02,3) 
5 (12.44,3) (9.66,2) (7,1) (7,1) (8,1) (9.14,2) 
Number 
of 
molecules 
QS of 
source 
compound 6 (12.44,3) (9.66,2) (6,1) (7,1) (7,1) (8,1) 
For this pathway the IBP model indicates that the pair (QS,QT)=(2,1) dominates 
all other cases. Hence in this case the IBP model recovers the (QS,QT)=(2,1) pair 
observed in the experimentally determined pathway. 
The results for objective (6.27) are shown below. 
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Number of molecules QT of target compound 
(L,W) 
1 2 3 4 5 6 
1 (8,1) (11,2) (11,2) (11,2) (11,2) (11,2) 
2 (6,1)* (8,1) (11,2) (11,2) (11,2) (11,2) 
3 (12,3) (11,1) (8,1) (11,2) (11,2) (11,2) 
4 (12,3) (6,1) (11,1) (8,1) (11,2) (11,2) 
5 (12,3) (12,3) (11,1) (11,1) (8,1) (11,2) 
Number 
of 
molecules 
QS of 
source 
compound 6 (12,3) (12,3) (6,1) (11,1) (11,1) (8,1) 
We obtain the same dominant pair as objective (6.26). Hence for this objective 
the IBP model recovers the (QS,QT)=(2,1) pair observed in the experimentally 
determined pathway. 
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 Pathway 34: Deoxycytidine degradation 
Source compound Deoxycytidine (dcyt) 
Target compound Glyceraldehyde 3-phosphate 
(g3p) 
(QS,QT) (1,1) 
Low presence compounds that are not forced to be 
balanced 
Acetaldehyde (acald) 
Uracil (ura) 
(Number of reactions, excess ATP) (4,0) 
Number of unbalanced main compounds (W) 2 
Specificity (Ψ) 5.63 
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Pathway description 
This pathway has been taken from EcoCyc (http://biocyc.org/ECOLI/NEW-
IMAGE?type=PATHWAY&object=PWY0-163). 
In EcoCyc the pathway is described as being from one molecule of 
Deoxycytidine to one molecule of Glyceraldehyde 3-phosphate. Our database contains 
the same set of reactions. 
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(QS,QT) discussion for the BP model 
This pathway was recovered with both objective (3.13) and objective (3.14). 
Thus, the (QS,QT) discussion is carried out for objective (3.13) and objective (3.14). The 
table of pairs for objective (3.13) is shown below. 
Number of molecules QT of target compound (number of reactions, 
excess ATP) 
1 2 3 4 5 6 
1 (4,0)* (9,-2) (9,-4) (9,-6) (9,-8) (9,-10) 
2 X (4,0) (9,-2) (9,-4) (9,-6) (9,-8) 
3 X X (4,0) (9,-2) (9,-4) (9,-6) 
4 X X X (4,0) (9,-2) (9,-4) 
5 X X X X (4,0) (9,-2) 
Number 
of 
molecules 
QS of 
source 
compound 6 X X X X X (4,0) 
The pairs seen down the diagonal are all repeats of each other, doubling and then 
tripling, etc the number of source and target molecules. The dominant pair is 
(QS,QT)=(1,1). Hence in this case the BP model recovers the (QS,QT)=(1,1) pair 
observed in the experimentally determined pathway.  
The results for objective (3.14) are shown below. 
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Number of molecules QT of target compound (number of reactions, 
excess ATP) 
1 2 3 4 5 6 
1 (4,0)* (10,0) (10,0) (10,0) (10,0) (10,0) 
2 X (4,0) (10,0) (10,0) (10,0) (10,0) 
3 X X (4,0) (10,0) (10,0) (10,0) 
4 X X X (4,0) (10,0) (10,0) 
5 X X X X (4,0) (10,0) 
Number 
of 
molecules 
QS of 
source 
compound 6 X X X X X (4,0) 
The pairs seen down the diagonal are all repeats of each other, doubling and then 
tripling, etc the number of source and target molecules. The dominant pair is 
(QS,QT)=(1,1). Hence in this case the BP model recovers the (QS,QT)=(1,1) pair 
observed in the experimentally determined pathway.  
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(QS,QT) discussion for the IBP model 
This pathway was recovered with both objective (6.26) and objective (6.27). 
Thus, the (QS,QT) discussion is carried out for objective (6.26) and objective (6.27). The 
table of pairs for objective (6.26) is shown below. 
Number of molecules QT of target compound 
(Ψ,W) 
1 2 3 4 5 6 
1 (5.63,2)* X (9.2,5) (9.22,5) X (9.22,5) 
2 (12.02,7) (5.63,2) (9.97,4) (8.77,7) X (9.2,5) 
3 (12.02,7) (10.73,8) (5.63,2) (9.2,5) (9.3,4) (8.87,6) 
4 (12.02,7) (10.73,8) (10.73,8) (5.63,2) (9.45,6) (10.47,3) 
5 (12.02,7) (10.83,7) (10.73,8) (10.73,8) (5.63,2) (8.93,5) 
Number 
of 
molecules 
QS of 
source 
compound 6 (12.02,7) (10.73,8) (10.83,7) (10.73,8) (10.83,7) (5.63,2) 
For this pathway the IBP model indicates that the pair (QS,QT)=(1,1) dominates 
all other cases. Hence in this case the IBP model recovers the (QS,QT)=(1,1) pair 
observed in the experimentally determined pathway. 
The results for objective (6.27) are shown below. 
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Number of molecules QT of target compound 
(L,W) 
1 2 3 4 5 6 
1 (4,2)* (8,7) (8,7) (8,7) (8,7) (8,7) 
2 (8,7) (4,2) (8,7) (8,7) (8,7) (8,7) 
3 (8,7) (8,7) (4,2) (8,7) (8,7) (8,7) 
4 (8,7) (8,7) (8,7) (4,2) (8,7) (8,7) 
5 (8,7) (8,7) (8,7) (8,7) (4,2) (8,7) 
Number 
of 
molecules 
QS of 
source 
compound 6 (8,7) (8,7) (8,7) (8,7) (8,7) (4,2) 
We obtain the same dominant pair as objective (6.26). Hence for this objective 
the IBP model recovers the (QS,QT)=(1,1) pair observed in the experimentally 
determined pathway. 
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 Pathway 35: Phenylalanine biosynthesis 
Source compound Chorismate (chor) 
Target compound L-Phenylalanine (phe-L)
(QS,QT) (1,1) 
Low presence compounds that are not forced to be balanced 2-Oxoglutarate (akg) 
(Number of reactions, excess ATP) (3,0) 
Number of unbalanced main compounds (W) 0 
Specificity (Ψ) 3 
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Pathway description 
This pathway has been taken from EcoCyc (http://biocyc.org/ECOLI/NEW-
IMAGE?type=PATHWAY&object=PHESYN) and Lehninger (fourth edition) page 
851. 
In Lehninger the pathway is described as being from one molecule of 
Chorismate to one molecule of L-Phenylalanine. This pathway is described in the same 
way in EcoCyc with the same set of reactions.  
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(QS,QT) discussion for the BP model 
This pathway was recovered with both objective (3.13) and objective (3.14). 
Thus, the (QS,QT) discussion is carried out for objective (3.13) and objective (3.14). The 
table of pairs for objective (3.13) is shown below. 
Number of molecules QT of target compound (number of reactions, 
excess ATP) 
1 2 3 4 5 6 
1 (3,0)* X X X X X 
2 X (3,0) X X X X 
3 X X (3,0) X X X 
4 X X X (3,0) X X 
5 X X X X (3,0) X 
Number 
of 
molecules 
QS of 
source 
compound 6 X X X X X (3,0) 
The pairs seen down the diagonal are all repeats of each other, doubling and then 
tripling, etc the number of source and target molecules. The dominant pair is 
(QS,QT)=(1,1). Hence in this case the BP model recovers the (QS,QT)=(1,1) pair 
observed in the experimentally determined pathway.  
The results for objective (3.14) are shown below. 
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Number of molecules QT of target compound (number of reactions, 
excess ATP) 
1 2 3 4 5 6 
1 (3,0)* X X X X X 
2 X (3,0) X X X X 
3 X X (3,0) X X X 
4 X X X (3,0) X X 
5 X X X X (3,0) X 
Number 
of 
molecules 
QS of 
source 
compound 6 X X X X X (3,0) 
The pairs seen down the diagonal are all repeats of each other, doubling and then 
tripling, etc the number of source and target molecules. The dominant pair is 
(QS,QT)=(1,1). Hence in this case the BP model recovers the (QS,QT)=(1,1) pair 
observed in the experimentally determined pathway.  
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(QS,QT) discussion for the IBP model 
This pathway was recovered with both objective (6.26) and objective (6.27). 
Thus, the (QS,QT) discussion is carried out for objective (6.26) and objective (6.27). The 
table of pairs for objective (6.26) is shown below. 
Number of molecules QT of target compound 
(Ψ,W) 
1 2 3 4 5 6 
1 (3,0)* X X X X X 
2 (12.44,4) (3,0) X X X X 
3 (12.12,5) (13.12,5) (3,0) X X X 
4 (11.97,3) (11.97,3) X (3,0) X X 
5 (12.55,3) X (12.44,4) (12.55,3) (3,0) X 
Number 
of 
molecules 
QS of 
source 
compound 6 (13.12,5) (12.44,4) X (12.55,3) (12.07,3) (3,0) 
For this pathway the IBP model indicates that the pair (QS,QT)=(1,1) dominates 
all other cases. Hence in this case the IBP model recovers the (QS,QT)=(1,1) pair 
observed in the experimentally determined pathway. 
The results for objective (6.27) are shown below. 
Metabolic pathway analysis via integer linear programming 
Francisco J. Planes                 May 2008 268
 
Number of molecules QT of target compound 
(L,W) 
1 2 3 4 5 6 
1 (3,0)* X X X X X 
2 X (3,0) X X X X 
3 (15,7) (15,7) (3,0) X X X 
4 (15,8) (23,6) (17,2) (3,0) X X 
5 (15,8) (15,7) (14,8) (15,3) (3,0) X 
Number 
of 
molecules 
QS of 
source 
compound 6 (15,8) X X X X (3,0) 
We obtain the same dominant pair as objective (6.26). Hence for this objective 
the IBP model recovers the (QS,QT)=(1,1) pair observed in the experimentally 
determined pathway. 
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 Pathway 36: Glyoxylate cycle 
Source compound Glyoxylate (glx) 
Target compound Glyoxylate (glx) 
(QS,QT) (1,1) 
Low presence compounds that are not forced to be balanced Succinate (succ) 
Acetyl-CoA (accoa) 
(Number of reactions, excess ATP) (5,0) 
Number of unbalanced main compounds (W) 1 
Specificity (Ψ) 5 
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Pathway description 
This pathway has been taken from EcoCyc (http://biocyc.org/ECOLI/NEW-
IMAGE?type=PATHWAY&object=GLYOXYLATE-BYPASS) and Lehninger (fourth 
edition) pages 623 and 625. 
Both in Lehninger and EcoCyc, the pathway is described as being a cycle 
starting and finishing at glyoxylate. However, Lehninger does not include the 
intermediary reaction citrate -> cis-aconitate + H20, included in EcoCyc. Since our 
reaction database does not contain this reaction, we have selected the Lehninger 
pathway. 
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(QS,QT) discussion for the BP model 
This pathway was recovered with objective (3.13). Thus, the (QS,QT) discussion 
is carried out for objective (3.13). The table of pairs for objective (3.13) is shown 
below. 
Number of molecules QT of target compound (number of reactions, 
excess ATP) 
1 2 3 4 5 6 
1 (5,0)* (6,0) (6,0) (6,0) (6,0) (6,0) 
2 (6,0) (5,0) (6,0) (6,0) (6,0) (6,0) 
3 (6,0) (6,0) (5,0) (6,0) (6,0) (6,0) 
4 (6,0) (6,0) (6,0) (5,0) (6,0) (6,0) 
5 (6,0) (6,0) (6,0) (6,0) (5,0) (6,0) 
Number 
of 
molecules 
QS of 
source 
compound 6 (6,0) (6,0) (6,0) (6,0) (6,0) (5,0) 
The pairs seen down the diagonal are all repeats of each other, doubling and then 
tripling, etc the number of source and target molecules. The dominant pair is 
(QS,QT)=(1,1). Hence in this case the BP model recovers the (QS,QT)=(1,1) pair 
observed in the experimentally determined pathway.  
In this pathway the source compound and the target compound are the same, 
moreover in the experimentally determined pathway the source/target compound is 
balanced (since QS=QT=1). It is therefore possible to interpret this pathway, a cycle, 
such that the only valid cases in the above (QS,QT) table of pairs are the diagonal entries 
(which are the only cases where the source/target compound is balanced). However 
even if we adopt this interpretation (which we did for the TCA cycle, pathway 8, above) 
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the dominant pair is still (QS,QT)=(1,1) and the BP model still recovers the 
(QS,QT)=(1,1) pair observed in the experimentally determined pathway.  
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(QS,QT) discussion for the IBP model 
This pathway was not recovered with either objective (6.26) or objective (6.27). 
However, when applied the cyclic constraints presented in Chapter 6, we achieved 
recovery for objective (6.26). In particular, we found two cases where we achieved 
recovery, namely adding equation (6.29) or (6.30). The table of pairs for these cases are 
presented below. As noted above, we only examined pairs in the main diagonal. The 
table of pairs for (6.26) with (6.29) added is: 
Number of molecules QT of target compound 
(Ψ,W) 
1 2 3 4 5 6 
1 (5,1)* - - - - - 
2 - (5,1) - - - - 
3 - - (5,1) - - - 
4 - - - (5,1) - - 
5 - - - - (5,1) - 
Number 
of 
molecules 
QS of 
source 
compound 6 - - - - - (5,1) 
The table of pairs for (6.26) with (6.30) added is: 
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Number of molecules QT of target compound 
(Ψ,W) 
1 2 3 4 5 6 
1 (5,1)* - - - - - 
2 - (5,1) - - - - 
3 - - (5,1) - - - 
4 - - - (5,1) - - 
5 - - - - (5,1) - 
Number 
of 
molecules 
QS of 
source 
compound 6 - - - - - (5,1) 
For both cases, the dominant pair is (QS,QT)=(1,1). Hence for this objective the 
IBP model (adding constraints related to cyclic pathways) recovers the (QS,QT)=(1,1) 
pair observed in the experimentally determined pathway. 
Metabolic pathway analysis via integer linear programming 
Francisco J. Planes                 May 2008 275
 Pathway 37: Propionate degradation 
Source compound Propionate (ppa) 
Target compound Succinate (succ) 
(QS,QT) (1,1) 
Low presence compounds that are not forced to be balanced Oxaloacetate (oaa) 
(Number of reactions, excess ATP) (5,-1) 
Number of unbalanced main compounds (W) 1 
Specificity (Ψ) 5 
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Pathway description 
This pathway has been taken from EcoCyc (http://biocyc.org/ECOLI/NEW-
IMAGE?type=PATHWAY&object=PWY0-42). 
In EcoCyc the pathway is described as being from one molecule of Propionate to 
one molecule of Succinate. Our database contains the same set of reactions, only 
changing the cofactor utilised in the first reaction of the pathway. 
 
Note here that we have an allowable c-cycles in this pathway. More precisely the 
2-cycle coa-R99-ppcoa-R97-coa which contains one high presence balanced compound 
(coa). 
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(QS,QT) discussion for the BP model 
This pathway was recovered with objective (3.13). Thus, the (QS,QT) discussion 
is carried out for objective (3.13). The table of pairs for objective (3.13) is shown 
below. 
Number of molecules QT of target compound (number of reactions, 
excess ATP) 
1 2 3 4 5 6 
1 (5,-1)* (9,-1) (8,1) (8,2) (8,3) (8,4) 
2 X (5,-2) (8,-1) (9,-2) (8,1) (8,2) 
3 X X (5,-3) (8,-2) (8,-1) (9,-3) 
4 X X X (5,-4) (8,-3) (8,-2) 
5 X X X X (5,-5) (8,-4) 
Number 
of 
molecules 
QS of 
source 
compound 6 X X X X X (5,-6) 
The pairs seen down the diagonal are all repeats of each other, doubling and then 
tripling, etc the number of source and target molecules (and excess ATP). The dominant 
pair is (QS,QT)=(1,1). Hence in this case the BP model recovers the (QS,QT)=(1,1) pair 
observed in the experimentally determined pathway.  
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(QS,QT) discussion for the IBP model 
This pathway was recovered with both objective (6.26) and objective (6.27). 
Thus, the (QS,QT) discussion is carried out for objective (6.26) and objective (6.27). The 
table of pairs for objective (6.26) is shown below. 
Number of molecules QT of target compound 
(Ψ,W) 
1 2 3 4 5 6 
1 (5,1)* (7.94,2) (7.94,2) (7.94,2) (7.94,2) (7.94,2) 
2 X (5,1) (7.94,2) (7.94,2) (7.94,2) (7.94,2) 
3 X X (5,1) (7.94,2) (7.94,2) (7.94,2) 
4 X X X (5,1) (7.94,2) (7.94,2) 
5 X X X X (5,1) (7.94,2) 
Number 
of 
molecules 
QS of 
source 
compound 6 X X X X X (5,1) 
For this pathway the IBP model indicates that the pair (QS,QT)=(1,1) dominates 
all other cases. Hence in this case the IBP model recovers the (QS,QT)=(1,1) pair 
observed in the experimentally determined pathway. 
The results for objective (6.27) are shown below. 
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Number of molecules QT of target compound 
(L,W) 
1 2 3 4 5 6 
1 (5,1)* (9,2) (9,2) (9,2) (9,2) (9,2) 
2 X (5,1) (9,2) (9,2) (9,2) (9,2) 
3 X X (5,1) (9,2) (9,2) (9,2) 
4 X X X (5,1) (9,2) (9,2) 
5 X X X X (5,1) (9,2) 
Number 
of 
molecules 
QS of 
source 
compound 6 X X X X X (5,1) 
We obtain the same dominant pair as objective (6.26). Hence for this objective 
the IBP model recovers the (QS,QT)=(1,1) pair observed in the experimentally 
determined pathway. 
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 Pathway 38: Glutamate biosynthesis cycle 
Source compound L-Glutamate (glu-L) 
Target compound L-Glutamate (glu-L) 
(QS,QT) (1,2) 
Low presence compounds that are not forced to be balanced 2-Oxoglutarate (akg) 
(Number of reactions, excess ATP) (2,-1) 
Number of unbalanced main compounds (W) 0 
Specificity (Ψ) 2.16 
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Pathway description 
This pathway has been taken from EcoCyc (http://biocyc.org/ECOLI/NEW-
IMAGE?type=PATHWAY&object=AMMASSIM-PWY) and Lehninger (fourth 
edition) pages 837 and 838. 
In Lehninger the pathway is described as being from one molecule of L-
Glutamate to two molecules of L-Glutamate. This pathway is described in the same way 
in EcoCyc with the same set of reactions.  
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(QS,QT) discussion for the BP model 
This pathway was recovered with objective (3.13). Thus, the (QS,QT) discussion 
is carried out for objective (3.13). The table of pairs for objective (3.13) is shown 
below. 
Number of molecules QT of target compound (number of reactions, 
excess ATP) 
1 2 3 4 5 6 
1 (2,-1) (2,-1)* (3,-1) (3,-1) (3,-1) (3,-1) 
2 (6,-1) (2,-2) (3,-2) (2,-2) (3,-2) (3,-2) 
3 (7,-3) (7,-3) (2,-3) (3,-3) (3,-3) (2,-3) 
4 (7,-4) (6,-2) (7,-4) (2,-4) (3,-4) (3,-4) 
5 (7,-5) (7,-5) (7,-5) (7,-5) (2,-5) (3,-5) 
Number 
of 
molecules 
QS of 
source 
compound 6 (7,-6) (7,-6) (6,-3) (7,-6) (7,-6) (2,-6) 
In this pathway a tie between the entries (QS,QT)=(1,1) and (QS,QT)=(1,2) is 
observed above as both entries have the same number of reactions and molecules of 
ATP produced, (2,-1). However, one further target molecule is produced by 
(QS,QT)=(1,2) with respect to (QS,QT)=(1,1). Hence, the dominant pair is (QS,QT)=(1,2) 
and the BP model recovers the (QS,QT)=(1,2) pair observed in the experimentally 
determined pathway.  
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(QS,QT) discussion for the IBP model 
This pathway was recovered with both objective (6.26) and objective (6.27). 
Thus, the (QS,QT) discussion is carried out for objective (6.26) and objective (6.27). The 
table of pairs for objective (6.26) is shown below. 
Number of molecules QT of target compound 
(Ψ,W) 
1 2 3 4 5 6 
1 (2.32,0) (2.16,0)* (6.94,4) (7.59,2) X (9.96,6) 
2 (6.06,2) (2.32,0) (2.24,0) (2.16,0) (16.1,2) (6.57,4) 
3 (6.09,2) (6.9,2) (2.32,0) (2.24,0) (2.24,0) (2.16,0) 
4 X (6.09,2) X (2.32,0) (2.24,0) (2.24,0) 
5 (5.99,1) (6.09,1) (6.19,2) X (2.32,0) (2.24,0) 
Number 
of 
molecules 
QS of 
source 
compound 6 (6.06,2) (5.99,2) (9.27,4) (5.68,0) X (2.32,0) 
For this pathway the IBP model indicates that the pair (QS,QT)=(1,2) dominates 
all other cases. Hence in this case the IBP model recovers the (QS,QT)=(1,2) pair 
observed in the experimentally determined pathway. 
The results for objective (6.27) are shown below. 
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Number of molecules QT of target compound 
(L,W) 
1 2 3 4 5 6 
1 (2,0) (2,0)* (3,3) (6,4) (6,4) (6,4) 
2 (3,1) (2,0) (3,0) (2,0) (4,3) (3,3) 
3 (6,2) (4,2) (2,0) (3,0) (3,0) (2,0) 
4 (6,2) (3,1) (4,2) (2,0) (3,0) (3,0) 
5 (6,4) (8,7) (4,2) (4,2) (2,0) (3,0) 
Number 
of 
molecules 
QS of 
source 
compound 6 X (6,2) (3,1) (4,2) (4,2) (2,0) 
We obtain the same dominant pair as objective (6.26). Hence for this objective 
the IBP model recovers the (QS,QT)=(1,2) pair observed in the experimentally 
determined pathway. 
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 Pathway 39: Biotin biosynthesis 
Source compound Pimeloyl-CoA (pmcoa) 
Target compound Biotin (btn) 
(QS,QT) (1,1) 
Low presence compounds that are not forced 
to be balanced 
S-Adenosyl-L-methionine (amet) 
L-Cysteine (cys-L) 
S-Adenosyl-4-methylthio-2-
oxobutanoate (amob) 
(Number of reactions, excess ATP) (4,-1) 
Number of unbalanced main compounds (W) 3 
Specificity (Ψ) 4.47 
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Pathway description 
This pathway has been taken from EcoCyc (http://biocyc.org/ECOLI/NEW-
IMAGE?type=PATHWAY&object=BIOTIN-SYNTHESIS-PWY). 
In EcoCyC the pathway is described as being from one molecule of Pimeloyl-
CoA to one molecule of Biotin. Our database contains the same reactions, aside from 
the last one in which a different cofactor is used, L-Cysteine instead of S-Adenosyl-L-
methionine.  
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(QS,QT) discussion for the BP model 
This pathway was not recovered with either of the objectives. Since this pathway 
is not recovered, (QS,QT) pairs discussion is omitted. 
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(QS,QT) discussion for the IBP model 
This pathway was recovered with both objective (6.26) and objective (6.27). 
Thus, the (QS,QT) discussion is carried out for objective (6.26) and objective (6.27). The 
table of pairs for objective (6.26) is shown below. 
Number of molecules QT of target compound 
(Ψ,W) 
1 2 3 4 5 6 
1 (4.47,3)* X X X X X 
2 X (4.47,3) X X X X 
3 X X (4.47,3) X X X 
4 X X X (4.47,3) X X 
5 X X X X (4.47,3) X 
Number 
of 
molecules 
QS of 
source 
compound 6 X X X X X (4.47,3) 
For this pathway the IBP model indicates that the pair (QS,QT)=(1,1) dominates 
all other cases. Hence in this case the IBP model recovers the (QS,QT)=(1,1) pair 
observed in the experimentally determined pathway. 
The results for objective (6.27) are shown below. 
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Number of molecules QT of target compound 
(L,W) 
1 2 3 4 5 6 
1 (4,3)* X X X X X 
2 X (4,3) X X X X 
3 X X (4,3) X X X 
4 X X X (4,3) X X 
5 X X X X (4,3) X 
Number 
of 
molecules 
QS of 
source 
compound 6 X X X X X (4,3) 
We obtain the same dominant pair as objective (6.26). Hence for this objective 
the IBP model recover the (QS,QT)=(1,1) pair observed in the experimentally 
determined pathway. 
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Pathway 40: Glycerol degradation 
Source compound Glycerol (glyc) 
Target compound Glyceraldehyde 3-phosphate (g3p) 
(QS,QT) (1,1) 
Low presence compounds that are not forced to be 
balanced 
 
(Number of reactions, excess ATP) (3,-1) 
Number of unbalanced main compounds (W) 0 
Specificity (Ψ) 3 
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Pathway description 
This pathway has been taken from EcoCyc (http://biocyc.org/ECOLI/NEW-
IMAGE?type=PATHWAY&object=PWY0-381) and Lehninger (fourth edition) page 
635. 
In Lehninger the pathway is described as being from one molecule of glycerol to 
one molecule of Glyceraldehyde 3-phosphate. This pathway is described in the same 
way in EcoCyc with the same set of reactions, except that EcoCyc does not include the 
last reaction, producing one molecule of Dihydroxyacetone phosphate instead of one 
molecule of Glyceraldehyde 3-phosphate.  
Since the Lehninger description appears to be the clearer one it is that which has 
informed the pathway picture seen below. 
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 (QS,QT) discussion for the BP model 
This pathway was recovered with objective (3.13). Thus, the (QS,QT) discussion 
is carried out for objective (3.13). The table of pairs for objective (3.13) is shown 
below. 
Number of molecules QT of target compound (number of reactions, 
excess ATP) 
1 2 3 4 5 6 
1 (3,-1)* (8,-3) (8,-5) (8,-7) (8,-9) (8,-11) 
2 X (3,-2) (8,-4) (8,-6) (8,-8) (8,-10) 
3 X X (3,-3) (8,-5) (8,-7) (8,-9) 
4 X X X (3,-4) (8,-6) (8,-8) 
5 X X X X (3,-5) (8,-7) 
Number 
of 
molecules 
QS of 
source 
compound 6 X X X X X (3,-6) 
The pairs seen down the diagonal are all repeats of each other, doubling and then 
tripling, etc the number of source and target molecules (and excess ATP). The dominant 
pair is (QS,QT)=(1,1). Hence in this case the BP model recovers the (QS,QT)=(1,1) pair 
observed in the experimentally determined pathway.  
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(QS,QT) discussion for the IBP model 
This pathway was recovered with both objective (6.26) and objective (6.27). 
Thus, the (QS,QT) discussion is carried out for objective (6.26) and objective (6.27). The 
table of pairs for objective (6.26) is shown below. 
Number of molecules QT of target compound 
(Ψ,W) 
1 2 3 4 5 6 
1 (3,0)* (7.64,4) (7.74,3) (7.74,3) (7.64,4) (7.64,4) 
2 (10.29,4) (3,0) (6.64,3) (6.64,3) (6.64,3) (6.74,2) 
3 (10.29,4) (8.12,4) (3,0) (6.64,3) (6.74,2) (6.64,3) 
4 (10.29,4) (9.64,5) (8.12,4) (3,0) (6.64,3) (6.64,3) 
5 (10.29,4) (9.74,4) (8.12,4) (8.22,3) (3,0) (6.74,2) 
Number 
of 
molecules 
QS of 
source 
compound 6 (10.29,4) (9.64,5) (9.64,5) (8.22,3) (8.22,3) (3,0) 
For this pathway the IBP model indicates that the pair (QS,QT)=(1,1) dominates 
all other cases. Hence in this case the IBP model recovers the (QS,QT)=(1,1) pair 
observed in the experimentally determined pathway. 
The results for objective (6.27) are shown below. 
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Number of molecules QT of target compound 
(L,W) 
1 2 3 4 5 6 
1 (3,0)* (9,4) (9,4) (10,3) (9,4) (9,4) 
2 (9,4) (3,0) (11,5) (9,4) (9,4) (9,4) 
3 (9,4) (9,4) (3,0) (9,4) (9,4) (9,4) 
4 (9,4) (9,4) (9,4) (3,0) (10,3) (10,3) 
5 (9,3) (9,4) (9,3) (9,3) (3,0) (9,4) 
Number 
of 
molecules 
QS of 
source 
compound 6 (9,4) (9,4) (9,4) X (11,3) (3,0) 
We obtain the same dominant pair as objective (6.26). Hence for this objective 
the IBP model recovers the (QS,QT)=(1,1) pair observed in the experimentally 
determined pathway. 
